Gastric cancer
Information
- Disease name
- Gastric cancer
- Disease ID
- Description
Disease area statistics
Chromosome band
| Gene symbol | Chromosome | Start | Stop | The number of variant |
|---|---|---|---|---|
| PMS2 | 7 | 5,970,957 | 6,009,122 | 244 |
| MSH6 | 2 | 47,783,145 | 47,806,953 | 220 |
| FBXO11 | 2 | 47,806,920 | 47,906,498 | 188 |
| MSH2 | 2 | 47,403,156 | 47,483,223 | 182 |
| MLH1 | 3 | 36,993,518 | 37,050,846 | 136 |
| EPCAM | 2 | 47,369,311 | 47,387,020 | 52 |
| KCNK12 | 2 | 47,509,290 | 47,570,985 | 36 |
| ARID1A | 1 | 26,696,015 | 26,782,104 | 14 |
| TP53 | 17 | 7,668,421 | 7,687,490 | 6 |
| CTNNB1 | 3 | 41,220,551 | 41,239,888 | 4 |
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT06301464 | Active, not recruiting | Pepsinogen II and Helicobacter Pylori Test in Gastric Cancer | March 1, 2003 | December 31, 2025 | |
| NCT04068896 | Active, not recruiting | Phase 1/Phase 2 | Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | October 16, 2019 | January 2025 |
| NCT05311618 | Active, not recruiting | Phase 1 | Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors | May 11, 2022 | June 2025 |
| NCT02496273 | Active, not recruiting | Phase 1 | Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer | January 2016 | December 2030 |
| NCT03620643 | Active, not recruiting | Phase 2 | Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours | May 9, 2019 | July 1, 2024 |
| NCT04116320 | Active, not recruiting | Phase 1 | Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors | November 21, 2019 | February 2024 |
| NCT03775525 | Active, not recruiting | Phase 1 | Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer | March 1, 2019 | December 2023 |
| NCT04907591 | Active, not recruiting | N/A | Postoperative Prognosis Management Service Based mHealth for Gastric Cancer Patients | May 17, 2021 | May 30, 2024 |
| NCT01924819 | Active, not recruiting | Phase 2/Phase 3 | Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma | September 2009 | December 31, 2026 |
| NCT02338518 | Active, not recruiting | Phase 3 | Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients | January 4, 2015 | October 2023 |
| NCT04294784 | Active, not recruiting | Phase 2 | Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancer | April 3, 2020 | June 30, 2023 |
| NCT04250948 | Active, not recruiting | Phase 2 | Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric Cancer | October 12, 2019 | October 5, 2024 |
| NCT03724851 | Active, not recruiting | Phase 1/Phase 2 | Vactosertib in Combination With Pembrolizumab in Metastatic Colorectal or Gastric Cancer | December 20, 2018 | August 31, 2024 |
| NCT04062656 | Active, not recruiting | Phase 2 | Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG | September 26, 2019 | June 1, 2025 |
| NCT01678027 | Active, not recruiting | Phase 3 | Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication | November 2004 | December 2035 |
| NCT03132922 | Active, not recruiting | Phase 1 | MAGE-A4ᶜ¹º³²T for Multi-Tumor | May 15, 2017 | September 2032 |
| NCT05104567 | Active, not recruiting | Phase 2 | A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203) | December 9, 2021 | September 10, 2024 |
| NCT04164069 | Active, not recruiting | Phase 1 | Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab | September 2, 2020 | December 31, 2023 |
| NCT04234113 | Active, not recruiting | Phase 1 | Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors | June 13, 2019 | November 2024 |
| NCT04152018 | Active, not recruiting | Phase 1 | Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. | November 13, 2019 | August 30, 2024 |
| NCT01191697 | Active, not recruiting | Phase 2 | CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer | February 2011 | July 2024 |
| NCT04363801 | Active, not recruiting | Phase 2 | A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer | July 29, 2020 | December 2025 |
| NCT03760822 | Active, not recruiting | Phase 2 | Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients | November 16, 2018 | September 2024 |
| NCT04611997 | Active, not recruiting | Phase 3 | IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy | November 16, 2020 | October 1, 2026 |
| NCT02578368 | Active, not recruiting | Phase 3 | Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction | February 2016 | February 2026 |
| NCT03686488 | Active, not recruiting | Phase 2 | TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma | December 20, 2018 | July 1, 2024 |
| NCT03829501 | Active, not recruiting | Phase 1/Phase 2 | Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer | January 28, 2019 | August 5, 2024 |
| NCT04798781 | Active, not recruiting | Phase 2 | Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma | July 28, 2021 | February 14, 2025 |
| NCT05693519 | Active, not recruiting | GastroIntestinal Cancer in Children and Adolescents | December 22, 2022 | June 22, 2023 | |
| NCT06260293 | Active, not recruiting | N/A | The Effect of Post-operative Exercise in Gastric Cancer Patients: A Randomized Controlled Trial (RCT) Study | January 3, 2023 | April 30, 2024 |
| NCT02794428 | Active, not recruiting | Phase 2 | Chemoprevention of Gastric Carcinogenesis | September 19, 2016 | July 1, 2024 |
| NCT04276493 | Active, not recruiting | Phase 1/Phase 2 | Anti-HER2 Bispecific Antibody ZW25 Activity in Combination With Chemotherapy With/Without Tislelizumab | March 26, 2020 | December 31, 2026 |
| NCT04902872 | Active, not recruiting | Phase 1/Phase 2 | Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors | May 3, 2021 | September 2024 |
| NCT04223401 | Active, not recruiting | N/A | Prehabilitation for Gastrectomy | February 6, 2020 | December 31, 2023 |
| NCT05229874 | Active, not recruiting | Phase 2 | Effect of CNSI vs. ICG in Lymph Node Tracing During Gastrectomy | January 20, 2022 | January 20, 2025 |
| NCT03399110 | Active, not recruiting | Phase 3 | XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC) | December 1, 2017 | August 1, 2026 |
| NCT03539822 | Active, not recruiting | Phase 1/Phase 2 | Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies | October 22, 2018 | November 30, 2027 |
| NCT04772989 | Active, not recruiting | Phase 1 | A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies | March 19, 2021 | September 2025 |
| NCT04181333 | Active, not recruiting | Safety and Efficacy of Trastuzumab BS | August 9, 2023 | September 8, 2025 | |
| NCT04661150 | Active, not recruiting | Phase 2 | A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction | March 12, 2021 | August 30, 2026 |
| NCT03170960 | Active, not recruiting | Phase 1/Phase 2 | Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | September 5, 2017 | August 2024 |
| NCT00582257 | Active, not recruiting | Early Onset and Familial Gastric Cancer Registry | December 2005 | December 2024 | |
| NCT04579757 | Active, not recruiting | Phase 1/Phase 2 | Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors | March 5, 2021 | June 30, 2024 |
| NCT00582647 | Active, not recruiting | Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract | March 2000 | December 2024 | |
| NCT04034251 | Active, not recruiting | Phase 2 | Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis | June 9, 2020 | January 30, 2027 |
| NCT02951091 | Active, not recruiting | Phase 2 | Biomarker-Integrated Umbrella, Advanced Gastric Cancer | January 2016 | December 2022 |
| NCT03228667 | Active, not recruiting | Phase 2 | QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors | December 11, 2018 | December 2024 |
| NCT04249739 | Active, not recruiting | Phase 2 | Pembrolizumab + Capecitabine／Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 Positive | September 29, 2020 | March 2025 |
| NCT03092518 | Active, not recruiting | Phase 2 | Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology | June 5, 2017 | October 1, 2027 |
| NCT05144854 | Active, not recruiting | Phase 3 | A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer) | November 5, 2021 | May 2027 |
| NCT03835663 | Active, not recruiting | The Bacterial Composition of the Stomach in Reflux Disease | June 4, 2018 | December 31, 2024 | |
| NCT03221426 | Active, not recruiting | Phase 3 | Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585) | October 9, 2017 | June 27, 2025 |
| NCT06204523 | Active, not recruiting | Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer | October 26, 2018 | August 30, 2024 | |
| NCT03208621 | Active, not recruiting | Evaluation of PET and Laparoscopy in STagIng Advanced Gastric Cancer | August 1, 2017 | August 1, 2025 | |
| NCT00407186 | Active, not recruiting | Phase 3 | Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS) | January 11, 2007 | December 2025 |
| NCT04219332 | Active, not recruiting | Phase 3 | Randomized Controlled Trial on Effect of Lymph Node Mapping by Indocyanine Green Via Submucosal or Subserosal Injection | December 31, 2019 | October 28, 2023 |
| NCT05985577 | Active, not recruiting | Mechanism of Gastric Signet Ring Cell Carcinoma Based on Microproteomics | March 2, 2023 | July 30, 2024 | |
| NCT03623464 | Active, not recruiting | N/A | RCT of Mobile Apps & FitBit v. Usual Care | May 31, 2017 | February 2025 |
| NCT04878783 | Active, not recruiting | Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG | December 20, 2019 | October 30, 2027 | |
| NCT06134011 | Active, not recruiting | A Multi-omics-based Metabolic Typing Study of Gastric Cancer | September 10, 2023 | September 10, 2024 | |
| NCT06452329 | Active, not recruiting | A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction Cancer | February 28, 2024 | July 31, 2025 | |
| NCT03044613 | Active, not recruiting | Phase 1 | Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer | July 11, 2017 | February 2025 |
| NCT04082364 | Active, not recruiting | Phase 2/Phase 3 | Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer | September 30, 2019 | June 2025 |
| NCT04513223 | Active, not recruiting | Phase 1 | A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors | March 30, 2021 | December 2024 |
| NCT02112214 | Active, not recruiting | Phase 3 | Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population | June 2014 | December 2029 |
| NCT04404595 | Active, not recruiting | Phase 1/Phase 2 | Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers | October 23, 2020 | September 1, 2035 |
| NCT04913337 | Active, not recruiting | Phase 1/Phase 2 | Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies | June 9, 2021 | July 2025 |
| NCT04882241 | Active, not recruiting | Phase 3 | Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension | July 29, 2020 | June 27, 2025 |
| NCT03950271 | Active, not recruiting | Phase 2 | SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma | January 20, 2020 | December 31, 2026 |
| NCT04908813 | Active, not recruiting | Phase 2 | Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer | September 29, 2021 | December 2025 |
| NCT05631015 | Active, not recruiting | Artificial Intelligence for Determination of Gastroscopy Surveillance Intervals | January 1, 2012 | December 31, 2023 | |
| NCT04593615 | Active, not recruiting | N/A | Indocyanine Green Tracer Using in Laparoscopic Radical Gastrectomy for Locally Advanced Gastric Cancer | November 10, 2020 | August 17, 2028 |
| NCT02931890 | Active, not recruiting | Phase 2 | Multicentric Randomised Trial for Resectable Gastric Cancer | December 21, 2017 | March 2029 |
| NCT05419362 | Active, not recruiting | Phase 2 | GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer | April 7, 2022 | December 2024 |
| NCT03797326 | Active, not recruiting | Phase 2 | Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) | February 12, 2019 | December 20, 2024 |
| NCT03959293 | Active, not recruiting | Phase 2 | Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma | July 17, 2019 | September 27, 2023 |
| NCT04937738 | Active, not recruiting | Phase 2 | Perioperative Chemotherapy in Gastric Cancer | July 21, 2021 | July 1, 2029 |
| NCT05311176 | Active, not recruiting | Phase 2 | A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON) | August 17, 2022 | July 1, 2026 |
| NCT02872116 | Active, not recruiting | Phase 3 | Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer | October 12, 2016 | May 31, 2024 |
| NCT04454476 | Active, not recruiting | Phase 1 | Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor | November 9, 2022 | May 2025 |
| NCT04566393 | Available | Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies | |||
| NCT05974410 | Available | Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients | |||
| NCT04681248 | Available | Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors | |||
| NCT02318329 | Completed | Phase 1 | Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors | November 2014 | June 30, 2019 |
| NCT02458573 | Completed | Phase 4 | Comparison of the Effects of Continuous Epidural Analgesia and Continuous Intravenous Analgesia on Postoperative Bowel Movement in Patients Undergoing Laparoscopic Gastrectomy | June 4, 2015 | March 28, 2016 |
| NCT00323830 | Completed | Phase 3 | Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma | October 2004 | April 2011 |
| NCT02960594 | Completed | Phase 1 | hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse | December 2014 | November 9, 2018 |
| NCT00152243 | Completed | Phase 3 | A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC) | June 1997 | August 2007 |
| NCT01381913 | Completed | Feasibility Trial of Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer | October 2005 | May 2011 | |
| NCT02130726 | Completed | N/A | Surgical Technique, Open Versus Minimally-invasive Gastrectomy After CHemotherapy | December 2014 | June 2019 |
| NCT03960775 | Completed | N/A | The Influence of Perioperative Administration of Dexmedetomidine on Inflammation Response and Postoperative Recovery in Patients Undergoing Robot or Laparoscopic Assisted Gastrectomy | April 30, 2019 | November 29, 2019 |
| NCT00002722 | Completed | Phase 2 | High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer | January 1996 | |
| NCT05540145 | Completed | Neo-Sequence 1: Neoadjuvant Chemotherapy With or Without Antiangiogenesis and Sequential Immunotherapy for HER2-negative MMR-proficient Locally Advanced Gastric or Gastroesophageal Adenocarcinoma | May 1, 2022 | December 31, 2023 | |
| NCT06103435 | Completed | Multivisceral Resections for Locally Advanced Gastric Cancer | January 1996 | December 2020 | |
| NCT04504916 | Completed | Phase 2 | A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Solid Tumors (MK-2140-002) | October 7, 2020 | June 12, 2023 |
| NCT00718913 | Completed | Phase 2 | Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer | April 2008 | September 2009 |
| NCT00699881 | Completed | Phase 2 | Study of Cetuximab to Treat Gastric Cancer | May 2008 | October 2009 |
| NCT00027534 | Completed | Phase 1 | Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | January 2002 | October 2007 |
| NCT05518929 | Completed | Phase 4 | Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity Patients | September 8, 2022 | August 30, 2023 |
| NCT00447967 | Completed | Phase 2 | Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients | July 2004 | September 2008 |
| NCT00004065 | Completed | Phase 1 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | July 1999 | March 2005 |
| NCT05186402 | Completed | Predictive Factors of Morbidity and Mortality and Overall Survival of Patients With Gastric Cancer : a Case Series | January 1, 2016 | December 31, 2018 | |
| NCT00831571 | Completed | Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin | February 2009 | April 2022 | |
| NCT02560974 | Completed | Phase 3 | A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancer | June 2006 | November 2012 |
| NCT05982899 | Completed | A Web-based Calculator Predicts Heterogeneous Frailty Trajectories | March 1, 2021 | April 1, 2023 | |
| NCT00529412 | Completed | Phase 3 | Bioresorbable Membrane to Reduce Postoperative Small Bowel Obstruction | August 2003 | March 2007 |
| NCT03083613 | Completed | Phase 2 | Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma | May 2015 | December 1, 2018 |
| NCT00074009 | Completed | Phase 2 | Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | October 2003 | |
| NCT00217581 | Completed | Phase 2 | Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer | October 2004 | January 2013 |
| NCT01220934 | Completed | An Observational Study of Herceptin (Trastuzumab) in Patients With HER2-positive Advanced Gastric Cancer | April 16, 2010 | June 1, 2016 | |
| NCT05253430 | Completed | D1 vs D2 Lymphadenectomy in Gastric Cancer | April 1990 | February 2021 | |
| NCT05663450 | Completed | Extended Resection After Positive Intraoperative Pathology in Gastric Cancer Surgery | May 1, 1996 | March 31, 2022 | |
| NCT02252913 | Completed | Phase 1 | A Study of Safety and Pharmacokinetics of Volitinib With Docetaxel in Patients With Advanced Gastric Cancer | September 2014 | December 2015 |
| NCT01926743 | Completed | N/A | Identification of Complete Lymph Node Removal by Application of Near Infrared Fluorescence Imaging in Laparoscopic and Robotic Gastrectomy | August 1, 2013 | January 31, 2014 |
| NCT03841110 | Completed | Phase 1 | FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors | February 15, 2019 | November 15, 2022 |
| NCT00182611 | Completed | Phase 3 | S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer | April 2004 | November 2008 |
| NCT02518529 | Completed | Phase 2 | Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patients | February 2001 | December 2002 |
| NCT03425058 | Completed | Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer | November 22, 2017 | October 1, 2021 | |
| NCT00580281 | Completed | N/A | Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors | November 2006 | October 2013 |
| NCT01379482 | Completed | Phase 2 | Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer | January 2005 | March 2009 |
| NCT02955173 | Completed | N/A | Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer | December 2016 | August 3, 2021 |
| NCT00982449 | Completed | N/A | 124I-FIAU Imaging in EBV and KSHV Associated Cancers | December 2010 | July 2013 |
| NCT03393182 | Completed | N/A | Comparing the Quality of Life Between LADG and TLDG for Gastric Cancer_KLASS07 (CKLASS01)). | March 1, 2018 | February 18, 2022 |
| NCT05715775 | Completed | Learning Curve and Optimization of Robotic Gastrectomy | August 1, 2016 | December 1, 2022 | |
| NCT05465993 | Completed | the Optimal Surveillance Frequency for Stage II/III Gastric Cancer | July 1, 2017 | July 15, 2022 | |
| NCT02009631 | Completed | Phase 1 | A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors | November 2013 | December 2014 |
| NCT02501603 | Completed | Phase 2 | Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancer | July 2016 | December 20, 2022 |
| NCT06023121 | Completed | Use of a Liquid Biopsy Signature to Detect Early-onset Gastric Cancer | January 1, 2018 | August 30, 2023 | |
| NCT01045538 | Completed | Phase 1/Phase 2 | Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer: Zolinza+XP | February 2010 | April 2016 |
| NCT03957486 | Completed | N/A | Effect of Arterial Cannulation on the Continuous and Non-invasive Hemoglobin Monitoring | May 14, 2019 | June 26, 2019 |
| NCT02444897 | Completed | Phase 3 | The Comparison Between Epidural and Intravenous Patient-controlled Analgesia for Laparoscopic Gastrectomy | September 2013 | December 2014 |
| NCT00544193 | Completed | Phase 1 | Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | December 1997 | August 2012 |
| NCT00072787 | Completed | Phase 1/Phase 2 | Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer | October 2003 | May 2006 |
| NCT00096707 | Completed | Phase 1 | Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors | February 2004 | July 2008 |
| NCT03006705 | Completed | Phase 3 | Study of Adjuvant ONO-4538 With Resected Gastric Cancer | January 31, 2017 | March 31, 2023 |
| NCT02711969 | Completed | Phase 1 | A Study of Apatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard Treatment | March 2016 | March 2019 |
| NCT04768218 | Completed | BLI for the Diagnosis of Precancerous Conditions | March 1, 2021 | December 30, 2023 | |
| NCT00917384 | Completed | Phase 3 | Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma | August 2009 | December 2015 |
| NCT00002883 | Completed | Phase 3 | Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus | October 1996 | August 2010 |
| NCT03188406 | Completed | Gastric Cancer Precursor Lesions (GCPL) Study | May 2, 2017 | April 28, 2020 | |
| NCT04227951 | Completed | N/A | Gastrectomy With or Without Drainage (ADiGe)? | December 17, 2019 | March 29, 2023 |
| NCT01033695 | Completed | Interobserver Agreement of Endoscopic Ultrasonography and Endoscopic Sonoelastography in the Evaluation of Lymph Nodes | January 2008 | June 2009 | |
| NCT00020761 | Completed | Phase 2 | Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach | April 2000 | August 2005 |
| NCT03780439 | Completed | Procalcitonin to Predict Infection After Gastrectomy for Gastric Cancer | June 1, 2018 | July 28, 2019 | |
| NCT04649372 | Completed | N/A | EndoVE endosCopic Treatment for Oesophageal and Gastric canceR | January 13, 2021 | July 20, 2022 |
| NCT02853474 | Completed | Phase 3 | Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy | October 2016 | December 2022 |
| NCT02672865 | Completed | Phase 1 | Adjuvant Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Gastric Cancer | February 2, 2016 | October 3, 2018 |
| NCT01748773 | Completed | Phase 2 | A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction Cancer | January 29, 2013 | June 15, 2017 |
| NCT02287168 | Completed | Early Phase 1 | Effect of Peritoneal Lavage on Surgery-induced Positive Peritoneal Cytology in Gastric Cancer Patients | October 2014 | December 2015 |
| NCT00654160 | Completed | Phase 1 | Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer | June 2008 | December 3, 2012 |
| NCT06282484 | Completed | A Study on the Relationship Between Gastric Xanthoma and Gastric Cancer and Precancerous Lesions | September 1, 2022 | September 29, 2023 | |
| NCT02233712 | Completed | Phase 2 | Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer. | August 1999 | |
| NCT00719550 | Completed | Phase 1/Phase 2 | AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer | February 2009 | June 2013 |
| NCT01373346 | Completed | N/A | Safety and Efficacy of Long Limb Roux-en Y Reconstruction | February 2010 | January 2012 |
| NCT04384575 | Completed | Study on the Effectiveness of Gastroscope Operation Quality Control Based on Artificial Intelligence Technology | February 22, 2020 | May 1, 2022 | |
| NCT03639792 | Completed | Escorting Octogenarian for Gastric Cancer Surgery | January 1, 2016 | December 31, 2017 | |
| NCT03332433 | Completed | N/A | High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Gastroscopy Sedated by Propofol | November 10, 2017 | March 30, 2018 |
| NCT00595972 | Completed | Phase 2 | Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer | November 2007 | December 2010 |
| NCT04830618 | Completed | Aberrant DNA Methylation to Predict Metachronous Gastric Neoplasms | September 11, 2012 | December 31, 2020 | |
| NCT03418298 | Completed | N/A | Prehabilitation in Patients With Esophageal or Gastric Cancers | February 27, 2018 | December 15, 2019 |
| NCT01876927 | Completed | Phase 2 | Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer | September 2010 | March 2017 |
| NCT02450032 | Completed | Phase 2 | Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancer | February 2000 | May 2001 |
| NCT03745170 | Completed | Phase 3 | Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric Cancer | December 19, 2018 | October 21, 2022 |
| NCT01360086 | Completed | Phase 2 | Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction | June 2011 | March 2013 |
| NCT04678492 | Completed | Phase 4 | Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy | December 20, 2020 | December 20, 2021 |
| NCT01366586 | Completed | Confocal Laser Endomicroscopy for in Vivo Molecular Imaging of Gastric Cancer by Targeting MG7-Ag | May 2011 | July 2011 | |
| NCT04603339 | Completed | N/A | ReStOre@Home: Feasibility Study of a 12-week Multidisciplinary Telehealth Rehabilitation Programme for Survivors of Upper Gastrointestinal (UGI) Cancer | May 1, 2021 | January 1, 2022 |
| NCT01073046 | Completed | Gastric Decompression After Sub-total Gastrectomy | January 2010 | June 2012 | |
| NCT01518023 | Completed | Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy | January 2011 | December 2011 | |
| NCT00525785 | Completed | Phase 2 | Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) | January 2004 | January 2016 |
| NCT00534001 | Completed | Phase 2 | Bupropion in Helping Adults Stop Smoking | January 2006 | July 2015 |
| NCT00216034 | Completed | Phase 3 | Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK | March 2005 | February 2016 |
| NCT00142350 | Completed | Phase 3 | A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer | November 2000 | January 2007 |
| NCT01515748 | Completed | Phase 3 | Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer | December 30, 2011 | December 13, 2021 |
| NCT02689284 | Completed | Phase 1/Phase 2 | Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer | January 2016 | January 2021 |
| NCT03076567 | Completed | Discovery and Validation of Plasma DNA Methylation Biomarker for Detection of Stomach Cancer | March 9, 2017 | February 21, 2020 | |
| NCT06185907 | Completed | In-hospital Outcomes of Older Patients With Gastric Cancer and Their Risk Factors | April 15, 2021 | August 10, 2023 | |
| NCT03382600 | Completed | Phase 2 | Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With TS-1+Cisplatin or TS-1+Oxaliplatin as First Line Chemotherapy in Gastric Cancer (MK-3475-659/KEYNOTE-659) | March 26, 2018 | May 30, 2021 |
| NCT02033551 | Completed | Phase 1 | A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors | December 2013 | September 2016 |
| NCT01517009 | Completed | Phase 2 | A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer | June 2008 | May 2013 |
| NCT05966246 | Completed | N/A | The Effect of Prucalopride Succinate on Gastrointestinal Motility After Laparoscopic Gastrectomy : Prospective Double Blind Case-control Study | January 25, 2022 | June 30, 2023 |
| NCT02395640 | Completed | Phase 3 | The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer | March 2015 | February 23, 2021 |
| NCT02892643 | Completed | N/A | Comparison of Laparoscopic Proximal Gastrectomy and Laparoscopic Total Gastrectomy | October 27, 2016 | September 17, 2020 |
| NCT00209638 | Completed | Phase 1/Phase 2 | Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer | May 2000 | April 2003 |
| NCT03409848 | Completed | Phase 2 | Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma | March 1, 2018 | March 5, 2022 |
| NCT01099085 | Completed | Phase 3 | Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients | February 2009 | January 2015 |
| NCT03694522 | Completed | Phase 2 | A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer | September 14, 2018 | May 13, 2022 |
| NCT00661167 | Completed | Phase 2 | Phase II Study of ABI-007 for Gastric Cancer | April 2008 | December 2011 |
| NCT01286766 | Completed | Phase 2 | Neoadjuvant Combination Chemotherapy of DCS (Cisplatin + Docetaxel + S-1) and DCF (Docetaxel + Cisplatin + 5-FU) in Patients With Locally Advanced Gastric Adenocarcinoma | September 2009 | June 2012 |
| NCT01962272 | Completed | Phase 4 | The Effect of Nutritional Counseling for Cancer Patients | January 2010 | September 2010 |
| NCT00062257 | Completed | Phase 2 | Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer | June 2003 | September 2006 |
| NCT01299688 | Completed | HER2 Circulating Tumor Cells in Gastric Cancer | March 2010 | March 11, 2013 | |
| NCT02624271 | Completed | N/A | Diagnosis of Gastric Precancerous Lesions by a Blood Test GastroPanel in Patients With Increased Gastric Cancer Risk | August 4, 2016 | May 9, 2019 |
| NCT06205173 | Completed | N/A | Explored About Temperature Packing Care to Improve the Quality of Life for Chemotherapy Induced Peripheral Neuropathy (CIPN) in Colorectal Cancer and Gastric Cancer Patient | August 19, 2020 | August 30, 2021 |
| NCT01345773 | Completed | Incidence of Venous Thromboembolism Following Surgery in Patients With Gastric Cancer | May 2010 | ||
| NCT02574663 | Completed | Phase 1 | TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors | September 11, 2015 | August 2018 |
| NCT01961752 | Completed | N/A | The Efficacy of Topical Bupivacaine and Triamcinolone Acetonide Injection in the Relief of Pain After Endoscopic Submucosal Dissection for Gastric Neoplasia: A Randomized Double-blind, Placebo-controlled Trial | July 2012 | April 2013 |
| NCT04208958 | Completed | Phase 1/Phase 2 | Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer | January 23, 2020 | February 23, 2023 |
| NCT02349412 | Completed | Phase 3 | Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers | April 2015 | July 15, 2019 |
| NCT00857246 | Completed | Phase 2 | Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer | July 2005 | October 2015 |
| NCT00195572 | Completed | Phase 3 | Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer | May 2002 | August 2008 |
| NCT01956149 | Completed | Phase 2 | Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer | September 2013 | April 4, 2018 |
| NCT00533533 | Completed | Phase 1/Phase 2 | A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer | January 2006 | June 2008 |
| NCT02555358 | Completed | Phase 2 | Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study | November 2014 | June 2022 |
| NCT00502502 | Completed | Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients | November 2002 | July 2010 | |
| NCT01002443 | Completed | Phase 2 | Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer | July 2003 | March 2009 |
| NCT05999019 | Completed | Intraoperative Adverse Events in Robotic Radical Gastrectomy for Gastric Cancer | August 1, 2016 | June 1, 2023 | |
| NCT01401894 | Completed | Perception Prognosis, Goals of Treatment, and Communication | October 2010 | June 2014 | |
| NCT00960349 | Completed | Phase 1 | Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients | August 2009 | March 2011 |
| NCT00952497 | Completed | Phase 2 | A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer | June 2009 | January 2012 |
| NCT01063517 | Completed | Phase 2 | Efficacy Study of Olaparib With Paclitaxel Versus Paclitaxel in Gastric Cancer Patients | February 2, 2010 | June 29, 2023 |
| NCT05604378 | Completed | Relationship of EBV-positive Gastric Cancer and Multiple Genes Associated With Gastric Carcinogenesis | August 3, 2022 | October 28, 2022 | |
| NCT00675194 | Completed | Phase 2 | Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric Cancer | October 2003 | October 2007 |
| NCT00009880 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach | April 2001 | |
| NCT06337279 | Completed | Systemic Oxidative Stress Score as a Predictor of Gastric Cancer Survival and Recurrence Risk | December 10, 2022 | March 20, 2024 | |
| NCT02638584 | Completed | Phase 4 | Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD. | December 2015 | March 2018 |
| NCT01582906 | Completed | A Survivorship Care Plan for Gynaecological Cancer Patients | August 2011 | April 2015 | |
| NCT03636893 | Completed | Phase 2 | Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer | August 24, 2018 | March 31, 2020 |
| NCT00666978 | Completed | Phase 4 | Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | December 2007 | June 2010 |
| NCT02372747 | Completed | N/A | Comparison of Delta-Shaped and Billroth II After TLDG | October 2012 | December 2014 |
| NCT00287768 | Completed | Phase 3 | Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer | March 2006 | October 2010 |
| NCT01470404 | Completed | Pharmacogenomic Study (Adjuvant Chemotherapy) | July 10, 2008 | July 10, 2013 | |
| NCT04660123 | Completed | Phase 4 | A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication | December 20, 2020 | December 30, 2021 |
| NCT03756597 | Completed | PAN-study: Pan-Cancer Early Detection Study (PAN) | September 26, 2018 | July 6, 2023 | |
| NCT04742959 | Completed | Phase 1/Phase 2 | Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | March 14, 2021 | February 20, 2024 |
| NCT00072332 | Completed | Phase 1 | Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | August 2003 | December 2009 |
| NCT00790569 | Completed | N/A | Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking | September 2008 | October 2012 |
| NCT05969444 | Completed | Endoscopic Surveillance on a High-risk Population for Gastric Cancer in Latin America: The ECHOS Cohort Study. | June 1, 2015 | March 6, 2023 | |
| NCT01896310 | Completed | New Classification of Stomach Using Probe-based Confocal Laser Endomicroscopy | June 2013 | September 2013 | |
| NCT03067012 | Completed | N/A | Nutritional Safety and Metabolic Benefits of Oncometabolic Surgery for Obese Gastric Cancer Patients | September 1, 2015 | July 30, 2017 |
| NCT00757640 | Completed | N/A | Gastrectomy Plus Prophylactic Cholecystectomy in Gastric Cancer Surgery | September 2008 | September 2015 |
| NCT00941655 | Completed | Phase 3 | Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial | July 22, 2009 | June 18, 2012 |
| NCT01471756 | Completed | Phase 4 | Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia | October 2011 | May 2014 |
| NCT06208046 | Completed | Predict 5-Year Survival in Elderly Gastric Cancer | July 1, 2023 | January 4, 2024 | |
| NCT00911820 | Completed | Phase 2 | Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer | July 2009 | August 2013 |
| NCT05259488 | Completed | Preoperative Immunonutrition in Laparoscopic Total D2 Gastrectomy | January 1, 2014 | January 1, 2022 | |
| NCT00004873 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer | August 1999 | July 2003 |
| NCT05075421 | Completed | Prognostic Values of Inflammation-based Indices in Gastric Cancer | January 1, 2012 | December 31, 2021 | |
| NCT01614522 | Completed | Phase 2 | A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2 | March 2012 | March 2013 |
| NCT02229058 | Completed | Phase 2 | Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer | February 2012 | February 2017 |
| NCT02178722 | Completed | Phase 1/Phase 2 | Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers | July 17, 2014 | November 6, 2020 |
| NCT03648879 | Completed | Phase 2 | Confocal Endoscopic Microscopy for Detection of Early Stage Gastric Cancer in Subjects With Hereditary Diffuse Gastric Cancer Syndrome | February 11, 2019 | May 5, 2020 |
| NCT01172028 | Completed | Phase 1 | Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | September 2005 | July 2014 |
| NCT05400915 | Completed | Phase 1/Phase 2 | Two-Part, Phase Ib/II, Open Label, Single-Arm, Multi-center Study to Evaluate the Safety and Efficacy of Varlitinib in Combination With Weekly Paclitaxel in EGFR/HER2 Co-expressing Advanced or Metastatic Gastric Cancer Patients | July 23, 2019 | June 13, 2022 |
| NCT02789826 | Completed | N/A | Laparoscopic Versus Open Resection of Cancer Stomach | June 2016 | January 2020 |
| NCT05493358 | Completed | Long-term Outcomes of Open Versus Laparoscopic Distal Gastrectomy for T4a Gastric Cancer | January 1, 2013 | June 30, 2022 | |
| NCT04292496 | Completed | N/A | Anastomotic Leak Testing in Gastrectomy | September 1, 2018 | March 13, 2023 |
| NCT02954536 | Completed | Phase 2 | Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer | November 3, 2016 | March 14, 2023 |
| NCT04114006 | Completed | Novel Screening Modality for Early Gastric Cancer | October 1, 2019 | March 15, 2023 | |
| NCT03419663 | Completed | Systematic Review and Meta-analysis of Cereal or Grain Consumption and Gastric Cancer | September 12, 2017 | January 10, 2018 | |
| NCT00464893 | Completed | Phase 2 | Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection | April 2007 | April 2013 |
| NCT00003748 | Completed | Phase 2 | Irinotecan in Treating Patients With Esophageal or Stomach Cancer | August 1998 | January 2005 |
| NCT00005049 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer | May 1997 | |
| NCT02903914 | Completed | Phase 1/Phase 2 | Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors | September 14, 2016 | August 15, 2022 |
| NCT02971631 | Completed | N/A | Gastrectomy, Eating Behaviour and GLP-1 | August 10, 2017 | September 16, 2018 |
| NCT06250075 | Completed | N/A | Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer | December 12, 2020 | April 26, 2024 |
| NCT02852252 | Completed | Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry | July 2016 | February 2020 | |
| NCT01715233 | Completed | Phase 2 | Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer. | December 2012 | April 2017 |
| NCT02267343 | Completed | Phase 3 | Study of ONO-4538 in Unresectable Advanced or Recurrent Gastric Cancer | October 2014 | January 2021 |
| NCT03958032 | Completed | Effects of Sarcopenia on Early Postoperative Outcomes in Patients Undergoing Surgical Treatment for Gastric Cancer | December 3, 2016 | June 10, 2020 | |
| NCT00215462 | Completed | Phase 2 | Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma | June 2000 | August 2005 |
| NCT03652077 | Completed | Phase 1 | A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies | September 24, 2018 | August 18, 2021 |
| NCT02810652 | Completed | N/A | Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection | September 2016 | January 2022 |
| NCT04481828 | Completed | Comparison With Open and Totally Laparoscopic Gastrectomy for Gastric Cancer | January 2014 | January 2020 | |
| NCT04600518 | Completed | Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric Cancer | October 7, 2020 | June 22, 2023 | |
| NCT00746161 | Completed | Phase 3 | Evaluation of Double Tract Reconstruction After Total Gastrectomy in Patients With Gastric Cancer | April 2002 | April 2008 |
| NCT03283761 | Completed | Phase 2 | FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma | September 21, 2017 | January 16, 2023 |
| NCT05266300 | Completed | Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines. | September 1, 2020 | October 1, 2022 | |
| NCT04697186 | Completed | Phase 4 | Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy | January 7, 2021 | December 20, 2021 |
| NCT03253939 | Completed | Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric Cancer | February 1, 2017 | July 1, 2017 | |
| NCT00735566 | Completed | Antiangiogenic Factors in Gastric Cancer | April 2006 | January 2012 | |
| NCT02988635 | Completed | Phase 3 | Early Palliative Care on Quality of Life of Advanced Cancer Patients | November 2014 | November 2016 |
| NCT01924533 | Completed | Phase 3 | Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer. | September 3, 2013 | March 27, 2023 |
| NCT05573776 | Completed | N/A | A Pilot Study of the Effect of High Protein Supplement and Exercise Therapy on Preservation of Skeletal Muscle Mass and Quality of Life in Patients With Gastric Cancer and Pancreatic Cancer Treated With Chemotherapy | August 1, 2020 | January 10, 2023 |
| NCT01269255 | Completed | Phase 1 | A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric Cancer | December 2009 | January 2012 |
| NCT05465512 | Completed | Using Radiomics to Predict Neoadjuvant Chemotherapy Efficacy | January 4, 2022 | July 10, 2022 | |
| NCT00183911 | Completed | Phase 2 | Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma | November 2003 | April 2007 |
| NCT00477880 | Completed | Phase 1 | Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer | April 2001 | September 2010 |
| NCT00512304 | Completed | Phase 2 | Adjuvant Treatment of Gastric Cancer With Chemotherapy and Chemoradiotherapy (TRACE) | August 2007 | |
| NCT02425930 | Completed | The Predictive Value of Complement C3 in Patients With Advanced Gastric Cancer | August 2013 | April 2015 | |
| NCT00287755 | Completed | Phase 2 | Clinical Trial of Chemosensitivity Test | March 2006 | March 2011 |
| NCT01824953 | Completed | Long-term Follow-up Prognosis of Atrophic Gastritis After 3 Years | January 2010 | August 2013 | |
| NCT03196791 | Completed | Phase 3 | Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient | October 10, 2017 | September 9, 2020 |
| NCT01428141 | Completed | Phase 1 | A Phase I Study of E7050 in Subjects With Solid Tumors | September 2011 | July 2013 |
| NCT01216644 | Completed | Phase 2/Phase 3 | 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer | August 2010 | May 2019 |
| NCT00629863 | Completed | N/A | Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer | September 2004 | January 2010 |
| NCT02040142 | Completed | Phase 2 | Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C | November 2011 | November 9, 2020 |
| NCT03007550 | Completed | N/A | Study On Safety Of Laparoscopic Total Gastrectomy For Clinical Stage I Gastric Cancer | January 4, 2017 | October 24, 2018 |
| NCT02983045 | Completed | Phase 1/Phase 2 | A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors | December 19, 2016 | April 28, 2022 |
| NCT03272984 | Completed | N/A | ERAS for Patients Received Neoadjuvant Chemotherapy | April 1, 2015 | July 6, 2017 |
| NCT04834661 | Completed | Performing Laparoscopic Surgery for Colorectal and Gastric Cancer Outside the Primary Registered Medical Institution | October 20, 2021 | December 31, 2021 | |
| NCT01497964 | Completed | Phase 1/Phase 2 | Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy | December 2011 | May 2013 |
| NCT00400179 | Completed | Phase 3 | A Safety and Efficacy Study in Patients With Gastric Cancer | May 2005 | April 2008 |
| NCT02347956 | Completed | Phase 1/Phase 2 | The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric Cancer | January 2015 | November 2015 |
| NCT02348229 | Completed | N/A | Effect of Enhanced Recovery After Surgery (ERAS) on C-reactive and Visceral Proteins | September 2013 | October 2014 |
| NCT00275951 | Completed | Phase 2 | Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer | December 2005 | June 2009 |
| NCT05800418 | Completed | Phase 1 | Clinical Study to Compare the Pharmacokinetics and Safety of Ramucirumab Injection With Cyramza ® in Healthy Male Volunteers | November 4, 2019 | February 18, 2020 |
| NCT03321630 | Completed | Phase 2 | A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on First or Subsequent Line Therapies | October 24, 2017 | January 16, 2024 |
| NCT00005956 | Completed | N/A | Biological Therapy in Treating Patients With Advanced Cancer | February 2000 | July 2002 |
| NCT02454673 | Completed | Therapeutic Individualization for Patients With Locally Advanced Gastric and Gastroesophageal Cancer | September 2013 | March 2015 | |
| NCT00215995 | Completed | Phase 2 | Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas | July 2003 | May 2007 |
| NCT00767377 | Completed | Phase 2 | Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC | May 2007 | March 2013 |
| NCT03486574 | Completed | Research for Associated Genes for Gastric Cancer in Family Member With Affected First-Degree Relatives | December 7, 2016 | December 31, 2022 | |
| NCT01671449 | Completed | Phase 3 | S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer | December 2012 | October 2015 |
| NCT04340440 | Completed | N/A | Curative D2 vs D1 Lymphadenectomy in Operable Gastric Carcinoma | December 2014 | February 2020 |
| NCT01838109 | Completed | N/A | Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery | April 2013 | April 2014 |
| NCT03976739 | Completed | Study on the Effect of Bile Reflux on Gastric Cancer and Its Precancerous Lesions: a Cross-sectional Study. | June 17, 2019 | December 31, 2019 | |
| NCT00596401 | Completed | The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer | September 2007 | December 31, 2021 | |
| NCT04660695 | Completed | Nasobiliary Drain Assisted EUS-guided Gastroenterostomies in Unresectable Malignant Gastric Outlet Obstruction | August 15, 2019 | May 12, 2021 | |
| NCT02647476 | Completed | Phase 3 | Postoperative Enteral Immunonutrition in Gastric Cancer | November 2004 | October 2015 |
| NCT00003427 | Completed | Phase 1 | Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer | April 1998 | April 2002 |
| NCT00152217 | Completed | Phase 3 | Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC) | September 2001 | December 2010 |
| NCT01625702 | Completed | N/A | Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer | June 2012 | December 2015 |
| NCT00033657 | Completed | Phase 2 | Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer | August 15, 2002 | October 2009 |
| NCT00737438 | Completed | Phase 2 | Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma | August 2008 | February 2015 |
| NCT00737373 | Completed | Phase 2 | Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer | August 2007 | March 2011 |
| NCT00489515 | Completed | Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder | February 1999 | August 2010 | |
| NCT01216813 | Completed | Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer | August 2010 | December 2010 | |
| NCT00021047 | Completed | Phase 1/Phase 2 | Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | July 2001 | June 2004 |
| NCT01953419 | Completed | Phase 2 | Phase II Study of Pemetrexed in Advanced or Recurrent Gastric Cancer After Chemotherapy | September 2010 | June 2014 |
| NCT03418428 | Completed | Intestinal Microbiome After Gastrectomy | April 1, 2018 | December 1, 2019 | |
| NCT00003157 | Completed | Phase 1 | Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach | February 1998 | May 2003 |
| NCT00004103 | Completed | Phase 2 | Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer | July 1998 | June 2009 |
| NCT01783951 | Completed | Phase 1/Phase 2 | Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer | February 1, 2013 | June 1, 2018 |
| NCT00003055 | Completed | Phase 2 | Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer | June 1997 | April 2001 |
| NCT01171924 | Completed | Phase 1 | A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors | July 2010 | October 2011 |
| NCT04188990 | Completed | N/A | Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition | June 15, 2020 | June 30, 2023 |
| NCT00310115 | Completed | Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy | April 2002 | August 2016 | |
| NCT01921673 | Completed | Phase 1/Phase 2 | Dovitinib Plus Docetaxel in Gastric Cancer | August 2013 | October 2016 |
| NCT00397904 | Completed | Phase 2 | Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin | October 2006 | September 2010 |
| NCT00376987 | Completed | Phase 2 | Zinc Supplements in Lowering Cadmium Levels in Smokers | December 2003 | June 2015 |
| NCT01148849 | Completed | Phase 1 | Safety Study of MGAH22 in HER2-positive Carcinomas | July 2010 | June 14, 2022 |
| NCT03802097 | Completed | N/A | Study About no Antimicrobial Prophylaxis in Totally Laparoscopic Distal Gastrectomy | December 27, 2018 | March 25, 2022 |
| NCT00183846 | Completed | Phase 1 | Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers | December 2000 | July 2009 |
| NCT01662869 | Completed | Phase 3 | A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer | November 2012 | December 2015 |
| NCT01456598 | Completed | N/A | Efficacy of Laparoscopic Subtotal Gastrectomy With D2 Lymph Node Dissection for Locally Advanced Gastric Cancer | November 21, 2011 | June 2, 2018 |
| NCT02191761 | Completed | Phase 1 | Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer | June 19, 2014 | May 20, 2015 |
| NCT00673673 | Completed | Phase 2 | FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer | May 2008 | July 2014 |
| NCT00639327 | Completed | Phase 2/Phase 3 | Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer | March 2008 | June 2011 |
| NCT04400383 | Completed | Phase 1 | Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors | June 4, 2020 | September 28, 2023 |
| NCT04338438 | Completed | Phase 2 | Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer | May 1, 2015 | January 31, 2020 |
| NCT01441310 | Completed | Phase 2 | Laparoscopic Sentinel Node Navigation Surgery for Gastric Cancer | July 2010 | August 2016 |
| NCT00834236 | Completed | N/A | Proteiomic Fingerprints of Gastric Juice | March 2008 | March 2011 |
| NCT00849615 | Completed | Phase 2 | Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction | February 2009 | January 2016 |
| NCT00576940 | Completed | Phase 4 | Standard and Immunostimulating Enteral Nutrition in Surgical Patients | June 2004 | September 2007 |
| NCT04088786 | Completed | Phase 1 | Phase I Trial HIPEC With Nal-irinotecan | October 22, 2019 | April 14, 2022 |
| NCT06365814 | Completed | ERAS for Gastric Cancer Patients After NACT | October 1, 2023 | April 1, 2024 | |
| NCT02120885 | Completed | Phase 3 | An Effect of an Individualized Physical Activity Intervention for Gastric Cancer Patient Undergoing Minimally Invasive Gastrectomy: a Phase III, Prospective Randomized Controlled Trial | March 14, 2014 | July 10, 2017 |
| NCT00054249 | Completed | Phase 2 | T900607 in Treating Patients With Gastroesophageal Junction Cancer | September 2002 | September 2010 |
| NCT05013775 | Completed | The Diagnostic Value of Staging Laparoscopy and Computed Tomography Response Assessment in Patients With Gastric Adenocarcinoma | January 15, 2019 | May 12, 2021 | |
| NCT00313872 | Completed | Phase 3 | Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer | May 2003 | January 2010 |
| NCT05030870 | Completed | N/A | Capnographic Monitoring in Gastrointestinal Endoscopy for Elderly Patients | September 1, 2021 | January 1, 2023 |
| NCT01158287 | Completed | Phase 2 | Sorafenib. ICORG 06-41, V4 | February 2009 | |
| NCT00014456 | Completed | Phase 1 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | March 2000 | October 2005 |
| NCT04770623 | Completed | Phase 2 | Docetaxel and Irinotecan in Gastric Cancer | March 5, 2021 | January 9, 2023 |
| NCT01851928 | Completed | Validation of a Nutrition Screening Tool | July 2011 | March 2013 | |
| NCT01059643 | Completed | Phase 2 | A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck | April 2011 | December 2012 |
| NCT03619681 | Completed | Phase 1 | Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancer | September 17, 2018 | August 26, 2022 |
| NCT00477711 | Completed | Phase 2 | A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer | March 2007 | February 2009 |
| NCT00032123 | Completed | Phase 2 | Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | June 2002 | May 2006 |
| NCT02725424 | Completed | Phase 2 | Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer | August 2015 | June 2019 |
| NCT00815113 | Completed | Screening for Gastric Cancer in High-risk Population | October 2009 | January 2018 | |
| NCT05124704 | Completed | N/A | Propofol EC50 for Inducing Loss of Consciousness in General Combined Epidural Anesthesia | July 1, 2021 | November 5, 2021 |
| NCT03032224 | Completed | Analysis of Body Composition in Relation to Outcome After Surgery in a Cohort of Patients With Esophageal Cancer | March 23, 2015 | July 23, 2020 | |
| NCT01830907 | Completed | Early Phase 1 | Efficacy of Preoperative Nutritional Support on Postoperative Outcome in Gastric Cancer Patients at Nutritional Risk by NRS-2002 | January 2012 | March 2013 |
| NCT01590719 | Completed | Phase 2 | A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer | July 2012 | October 2014 |
| NCT05274464 | Completed | A Recurrence Nomogram for Hepatoid Adenocarcinoma of the Stomach | April 1, 2004 | December 31, 2019 | |
| NCT00166881 | Completed | Phase 2 | Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin | June 2000 | June 2011 |
| NCT00454636 | Completed | Phase 2 | A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer. | March 2007 | July 2010 |
| NCT04724291 | Completed | N/A | MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients) | February 10, 2021 | June 10, 2023 |
| NCT02114359 | Completed | Phase 3 | Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer | February 2014 | February 2020 |
| NCT02903498 | Completed | Phase 2 | The Maintenance Treatment of UFT in Advanced Gastric Cancer | August 2009 | September 2016 |
| NCT00511264 | Completed | Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract | May 2007 | May 2008 | |
| NCT00003298 | Completed | Phase 2 | Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer | June 1, 1999 | May 2011 |
| NCT00011960 | Completed | Phase 2 | Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery | May 2001 | |
| NCT01657175 | Completed | N/A | Quality of Life After Oesophageal or Gastric Cancer Surgery | January 2009 | September 2014 |
| NCT00004127 | Completed | Phase 2 | Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach | February 2000 | August 2003 |
| NCT01065688 | Completed | Phase 3 | A Trial of Reconstruction After Distal Gastrectomy for Gastric Cancer | January 2009 | November 2013 |
| NCT00436241 | Completed | Phase 2 | A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer. | March 2007 | November 2010 |
| NCT00514020 | Completed | Phase 2 | Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | August 2007 | February 2011 |
| NCT03606928 | Completed | Phase 1/Phase 2 | mFLOT Chemotherapy as First-line Treatment in GC | July 1, 2018 | January 1, 2020 |
| NCT02796365 | Completed | N/A | Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy | June 2016 | December 2018 |
| NCT04161781 | Completed | A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer | November 12, 2019 | March 6, 2024 | |
| NCT01401907 | Completed | N/A | Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies | May 2011 | December 2019 |
| NCT04517708 | Completed | N/A | Effectiveness of Nutritional Interventions for Cancer Patients Undergoing Chemotherapy | January 15, 2016 | December 15, 2019 |
| NCT00711243 | Completed | Phase 1/Phase 2 | Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor | April 20, 2005 | February 25, 2011 |
| NCT00415168 | Completed | Phase 2 | Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer | December 2006 | July 2009 |
| NCT01364493 | Completed | Phase 2 | A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric Cancer | May 2011 | February 2014 |
| NCT03342937 | Completed | Phase 2 | KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer | January 11, 2018 | February 6, 2023 |
| NCT03978481 | Completed | Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study | January 30, 2019 | April 30, 2020 | |
| NCT03130790 | Completed | Phase 2/Phase 3 | Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line) | August 31, 2017 | February 22, 2019 |
| NCT00012363 | Completed | Phase 2 | S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus | April 2001 | April 2006 |
| NCT00957424 | Completed | N/A | Acceptability of Less Harmful Alternatives to Cigarettes | June 2009 | November 2011 |
| NCT03957460 | Completed | Accuracy of Continuous and Non-invasive Hemoglobin Monitoring | November 20, 2017 | December 29, 2017 | |
| NCT02918162 | Completed | Phase 2 | Perioperative Chemo and Pembrolizumab in Gastric Cancer | November 25, 2017 | February 28, 2023 |
| NCT00006081 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer | June 2000 | September 2005 |
| NCT00149201 | Completed | Phase 3 | A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis | November 2002 | April 2008 |
| NCT00006038 | Completed | Phase 2 | Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer | February 2000 | February 2003 |
| NCT04768686 | Completed | Phase 2 | FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer | May 18, 2021 | October 17, 2023 |
| NCT01516944 | Completed | Phase 2/Phase 3 | Perioperative Chemotherapy for Potentially Resectable Gastric Cancer | February 2012 | December 2018 |
| NCT01411176 | Completed | Phase 3 | Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy | September 2011 | June 2012 |
| NCT03061370 | Completed | Sarcopenia and Visceral Obesity in Esophageal and Gastric Cancer | January 1, 2010 | January 1, 2019 | |
| NCT02090153 | Completed | Phase 2 | Study of S-1 Plus LV for Advanced Gastric Cancer | July 2011 | March 2014 |
| NCT02682446 | Completed | The Efficacy of Serum Pepsinogen for Prediction of Metachronous Gastric Neoplasm | January 2007 | December 2015 | |
| NCT02490111 | Completed | Phase 3 | Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer | May 2015 | January 2018 |
| NCT01711242 | Completed | Phase 2 | Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma | January 2012 | January 2021 |
| NCT01388790 | Completed | Phase 2 | Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer | June 2011 | May 2013 |
| NCT00486356 | Completed | Phase 1 | Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer | October 1, 2004 | January 1, 2010 |
| NCT01152645 | Completed | Phase 2 | Study of ARQ 197 Monotherapy | June 2010 | August 2011 |
| NCT03985072 | Completed | Phase 1 | Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor | April 26, 2019 | February 17, 2022 |
| NCT04430842 | Completed | Phase 1 | Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S | July 20, 2020 | December 22, 2022 |
| NCT00252889 | Completed | Phase 1 | Doxil Topotecan Doublet Cancer Study | May 2004 | June 2008 |
| NCT00515411 | Completed | Phase 2 | Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma | October 23, 2006 | October 26, 2018 |
| NCT02052778 | Completed | Phase 1/Phase 2 | A Study of TAS-120 in Patients With Advanced Solid Tumors | July 21, 2014 | May 29, 2021 |
| NCT01945177 | Completed | N/A | RCT: WLE vs. NBI in Upper Gastrointestinal Endoscopy | January 2012 | December 2014 |
| NCT00260884 | Completed | Phase 3 | Phase III Study OF the Gastric Surgery on Advanced Stage Gastric Cancer | October 1993 | August 2004 |
| NCT02178956 | Completed | Phase 3 | A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer | October 2014 | September 20, 2017 |
| NCT00678535 | Completed | Phase 3 | Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer | June 2008 | February 2013 |
| NCT04490668 | Completed | Human Albumin and Anastomotic Leakage After Gastric Cancer Surgery | January 1, 2016 | December 30, 2019 | |
| NCT00003137 | Completed | Phase 2 | Irinotecan in Treating Patients With Advanced Cancer of the Stomach | December 1997 | July 2004 |
| NCT01234272 | Completed | Phase 4 | Comparison of the Analgesic Effect Between Intrathecal Morphine and IV-fentanyl Patient Controlled Analgesia (ITM-IVPCA) and Epidural PCA (PCEA) in Patients Undergoing Gastrectomy -Randomized Allocation Study- | August 2010 | June 2011 |
| NCT01138904 | Completed | Phase 2 | FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC) | September 2009 | September 2013 |
| NCT04383938 | Completed | Phase 1/Phase 2 | Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies | June 25, 2020 | April 30, 2022 |
| NCT00952003 | Completed | Phase 2 | Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients | July 2009 | June 2020 |
| NCT02999295 | Completed | Phase 1/Phase 2 | A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer | January 2017 | August 2019 |
| NCT00003125 | Completed | Phase 2 | Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | January 1998 | November 2004 |
| NCT04019808 | Completed | Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population | July 30, 2019 | December 31, 2023 | |
| NCT06281379 | Completed | N/A | Complete Mesogastric Excision With D2 Lympadenectomy for Gastric Cancer: | April 1, 2023 | January 1, 2024 |
| NCT04800991 | Completed | N/A | NuGa (Nutrition for Gastric Cancer Patients) | March 17, 2021 | October 8, 2021 |
| NCT01130337 | Completed | Phase 2 | A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer | July 2010 | June 2014 |
| NCT05280665 | Completed | Specialization in Gastric Cancer Surgery | February 14, 2022 | March 1, 2023 | |
| NCT02946671 | Completed | Phase 1 | Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients | March 2016 | March 2020 |
| NCT05301699 | Completed | Development and Validation of a Web-based Nomorgam to Predict Postoperative Complications | March 1, 2021 | March 30, 2022 | |
| NCT04834778 | Completed | Phase 1 | A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD) | June 8, 2021 | January 30, 2024 |
| NCT00123318 | Completed | Phase 3 | A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer | February 2003 | February 2012 |
| NCT00558155 | Completed | Phase 4 | The Impact of Immunostimulating Nutrition on the Outcome of Surgery | June 2001 | December 2005 |
| NCT05125614 | Completed | Gastric Cancer Survival Without Chemotherapy | May 1, 2020 | July 1, 2021 | |
| NCT01774786 | Completed | Phase 3 | A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer | June 10, 2013 | December 31, 2019 |
| NCT05130710 | Completed | The Impact of COVID-19 Pandemic on Clinical Presentation and Staging of Gastric Cancer | February 25, 2020 | February 25, 2021 | |
| NCT03485196 | Completed | The Relationship Between Microsatellite Instability and Efficacy of Fluorouracil Based Adjuvant Chemotherapy in Gastric Cancer After Operation | March 1, 2017 | April 1, 2021 | |
| NCT00938470 | Completed | Phase 2 | Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | January 2010 | March 2018 |
| NCT02332213 | Completed | Volatile Markers in Digestive Cancer | January 2014 | June 30, 2017 | |
| NCT02020252 | Completed | Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials | November 26, 2013 | December 2018 | |
| NCT02745509 | Completed | N/A | Extensive Intraoperative Peritoneal Lavage After Curative Gastrectomy for Locally Advanced Gastric Cancer (SEIPLUS) | March 2016 | November 2017 |
| NCT00398398 | Completed | Phase 2 | Study of XELOX With Cetuximab in Advanced Gastric Cancer | November 2006 | September 2008 |
| NCT01444521 | Completed | Phase 2 | Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer | April 2011 | May 2014 |
| NCT02563054 | Completed | Phase 3 | A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer | April 2003 | August 2010 |
| NCT02415023 | Completed | Phase 1/Phase 2 | A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric Cancer | November 9, 2014 | March 31, 2017 |
| NCT01411189 | Completed | Phase 3 | Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy | September 2011 | June 2012 |
| NCT02966509 | Completed | N/A | Engagement of Patients With Advanced Cancer | August 2013 | December 2016 |
| NCT00663741 | Completed | Phase 1 | Sorafenib Gastric Cancer Asian Phase I Study | May 2008 | April 2010 |
| NCT03123432 | Completed | N/A | Immunomodulating Nutrients in Perioperative Patients With Gastric Cancer | June 1, 2011 | September 1, 2016 |
| NCT02563548 | Completed | Phase 1 | A Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) With Pembrolizumab in Participants With Selected Hyaluronan High Solid Tumors | October 22, 2015 | March 26, 2019 |
| NCT00613665 | Completed | Phase 1 | Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults | February 2001 | April 2002 |
| NCT01824004 | Completed | Phase 2 | Postoperative Chemoradiotherapy With S-1 in Gastric Cancer | April 2009 | June 2012 |
| NCT02067754 | Completed | Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer | September 11, 2013 | February 9, 2018 | |
| NCT01415609 | Completed | Endoscopic Submucosal Dissection Registry | August 2010 | March 2012 | |
| NCT03486379 | Completed | Folfiri as Third Line of Treatment | March 2016 | March 23, 2018 | |
| NCT01163812 | Completed | Phase 2 | Clinical Trial for Laparoscopic D2 Gastrectomy | April 2006 | October 2006 |
| NCT03777540 | Completed | Gastric Cancer Surgery in Elderly Patients | January 1, 2010 | June 30, 2018 | |
| NCT00606619 | Completed | Phase 3 | Effects of Early Oral Feeding After Resection of Gastric Cancer | July 2008 | February 2009 |
| NCT04232020 | Completed | A Retrospective Validations Microsatellite Instability (MSI) Testing v Mismatch Repair (MMR) in Gastric Adenocarcinoma | February 7, 2020 | August 5, 2020 | |
| NCT00017043 | Completed | Phase 2 | BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy | February 2001 | January 2003 |
| NCT01839500 | Completed | A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric Cancer | April 25, 2013 | January 9, 2018 | |
| NCT03104283 | Completed | Phase 2 | Apatinib for the Elderly Advanced Gastric Cancer | June 5, 2017 | June 2, 2020 |
| NCT00017212 | Completed | Phase 2 | DX-8951f in Treating Patients With Metastatic Stomach Cancer | April 2001 | September 2003 |
| NCT01491698 | Completed | Phase 3 | Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma | December 2011 | August 2013 |
| NCT00003862 | Completed | Phase 2 | Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer | November 1999 | |
| NCT00718354 | Completed | Phase 3 | Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT | July 2008 | August 2010 |
| NCT00313599 | Completed | Phase 1 | Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors | February 2006 | December 2013 |
| NCT05025033 | Completed | Phase 2 | Chemotherapy Combined With Apatinib and PD-1 Antibody | May 30, 2019 | April 30, 2022 |
| NCT02746796 | Completed | Phase 2/Phase 3 | Study of ONO-4538 in Gastric Cancer | March 2016 | November 17, 2022 |
| NCT00004910 | Completed | Phase 1/Phase 2 | Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | January 2000 | February 2003 |
| NCT04791293 | Completed | The Model for End-Stage Liver Disease Sodium (MELD-Na) Score in Non-cirrhotic Patients With Gastric Cancer | December 1, 2020 | August 5, 2022 | |
| NCT02541461 | Completed | N/A | Body Composition After Laparoscopic Gastrectomy for Gastric Cancer | May 2015 | January 2017 |
| NCT00215514 | Completed | Early Phase 1 | Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma | September 2000 | July 2014 |
| NCT02089373 | Completed | N/A | A Pilot Study on Usefulness of Probe-based Confocal Laser Endomicroscopy Targeted Gastric Biopsy | March 2014 | March 2015 |
| NCT04660058 | Completed | Associations Among Serum and Gastric Juice Bile Acid Profile, Bile Acid-microbiota Cross-talk in Stomach and the Development of Gastric Cancer | December 20, 2020 | January 30, 2022 | |
| NCT01130805 | Completed | Phase 2 | A Study of Pazopanib With CAPEOX in AGC Patients | December 2010 | December 2015 |
| NCT00054457 | Completed | Phase 2 | Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction | September 2003 | February 2008 |
| NCT01041404 | Completed | Phase 3 | ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer | September 2005 | June 2010 |
| NCT01309256 | Completed | Multi-institutional Study on the Assessment of Robotic Surgery for Gastric Cancer | March 2011 | February 2013 | |
| NCT02815150 | Completed | N/A | Safety of 250ml Preoperative Carbohydrate Drink in Gastric Cancer Patients | April 1, 2016 | January 30, 2019 |
| NCT00537121 | Completed | Phase 1 | Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer | November 2006 | June 2013 |
| NCT01123876 | Completed | Phase 1 | Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor | March 2010 | January 2015 |
| NCT01257711 | Completed | N/A | A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer | October 9, 2008 | February 12, 2020 |
| NCT00733616 | Completed | Phase 2 | Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General Status | November 2008 | May 2012 |
| NCT05181306 | Completed | Long-term Oncologic Outcomes of Robotic Versus Laparoscopic Total Gastrectomy for Advanced Gastric Cancer | October 1, 2010 | July 30, 2016 | |
| NCT01983878 | Completed | Phase 2 | A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction Cancer | December 2013 | February 2016 |
| NCT04547153 | Completed | Phase 2 | Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC | January 15, 2021 | March 22, 2024 |
| NCT02848066 | Completed | Glycans Bound to Serum Haptoglobin: a Novel Gastric Cancer Tumor Biomarker | July 2015 | September 2017 | |
| NCT04205097 | Completed | N/A | Deep vs Moderate Neuromuscular Blocks on Remifentanil for Laparoscopic Gastrectomy | December 23, 2019 | December 2, 2020 |
| NCT05035602 | Completed | Google Location History Following Oesophagectomy and/or Gastrectomy | March 24, 2022 | December 31, 2023 | |
| NCT02024841 | Completed | Phase 1 | Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal Carcinomatosis | December 2013 | March 2018 |
| NCT01401075 | Completed | Phase 4 | RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients | March 2006 | April 2008 |
| NCT05585437 | Completed | Effect of Gastric Cancer Specialist Training Program in Laparoscopic Gastric Cancer Surgery（STP-LRG-1） | November 11, 2021 | December 25, 2021 | |
| NCT01132534 | Completed | A Randomized Study Comparing Autofluorescence Imaging(AFI) Followed by Narrow Band Imaging(NBI) With Videoendoscopy for the Detection of High Risk Lesions of Stomach | June 2007 | April 2008 | |
| NCT00738478 | Completed | Phase 3 | Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer Patients | February 2006 | December 2008 |
| NCT03430778 | Completed | N/A | Effect of Pneumoperitoneum on the Continuous and Non-invasive Hemoglobin Monitoring | January 1, 2019 | May 13, 2019 |
| NCT00845611 | Completed | Phase 1 | Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer | September 2008 | September 2010 |
| NCT04286984 | Completed | Implementation of a Patient Blood Management Program in Gastric Cancer Surgery | January 1, 2014 | December 31, 2018 | |
| NCT00978549 | Completed | Phase 3 | Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer | April 2008 | October 2010 |
| NCT04901585 | Completed | Enterotomy Closure and Minimally Invasive Gastrectomy | January 1, 2009 | April 1, 2021 | |
| NCT03343301 | Completed | Phase 1 | A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer | November 30, 2017 | January 31, 2019 |
| NCT00020787 | Completed | Phase 3 | Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer | July 2001 | December 2002 |
| NCT02442362 | Completed | Phase 2/Phase 3 | TOF Versus SOX in Metastatic Gastric Cancer | January 2012 | June 2014 |
| NCT00598546 | Completed | Quality of Life Among Long-Term Survivors of Resected Gastric Cancer | September 2004 | June 2009 | |
| NCT00150670 | Completed | Phase 3 | Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer | March 2002 | December 2006 |
| NCT02078700 | Completed | Phase 2 | Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study. | July 2013 | December 2014 |
| NCT00660205 | Completed | Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer | February 2008 | February 2011 | |
| NCT04209933 | Completed | Phase 4 | Helicobacter Pylori Eradication With Different Bismuth Quadruple Therapies | May 25, 2020 | August 30, 2020 |
| NCT01514110 | Completed | Phase 1/Phase 2 | Gastric Cancer RAD001 Study | January 23, 2008 | March 6, 2019 |
| NCT00130689 | Completed | Phase 2 | Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer | July 2005 | September 2010 |
| NCT01341197 | Completed | Fecal Screening Assay for Taiwanese Population | March 2011 | November 2012 | |
| NCT02080650 | Completed | N/A | Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) | March 2014 | July 19, 2016 |
| NCT02074124 | Completed | CT Perfusion Changes in GI Cancer During Adenosine Vasodilation Test | October 2012 | December 2013 | |
| NCT04099641 | Completed | Phase 2 | An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients | September 11, 2019 | October 26, 2022 |
| NCT02926716 | Completed | NBI for Identifying Resection Margin Status in Gastric Cancer | December 14, 2015 | December 29, 2016 | |
| NCT00113581 | Completed | Phase 1 | Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer | October 2002 | January 2007 |
| NCT05051670 | Completed | N/A | da Vinci SP Robotic Gastrectomy | December 16, 2021 | December 11, 2022 |
| NCT00017056 | Completed | Phase 2 | BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy | February 2001 | January 2002 |
| NCT01896531 | Completed | Phase 2 | A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer | August 14, 2013 | January 26, 2021 |
| NCT01461057 | Completed | Phase 2 | A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer | December 6, 2011 | October 31, 2017 |
| NCT01938313 | Completed | Phase 2 | Early Recovery After Surgery (ERAS) Versus Conventional Protocol After Laparoscopic Gastrectomy | August 2012 | April 2016 |
| NCT00003046 | Completed | Phase 1 | Interleukin-12 in Treating Patients With Cancer in the Abdomen | August 1997 | October 2001 |
| NCT00985192 | Completed | Phase 2 | Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer | September 2009 | May 2014 |
| NCT00183859 | Completed | Phase 1 | Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan | September 1999 | April 2009 |
| NCT02764268 | Completed | N/A | Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer | November 2, 2016 | April 15, 2019 |
| NCT03787537 | Completed | Nutritional Status and Nutrient Supply in Hospitalised Surgical Patients | August 1, 2017 | December 31, 2018 | |
| NCT05327231 | Completed | Phase 1 | IN10018 Monotherapy or in Combination With Docetaxel in Gastric or GEJ Adenocarcinoma | July 9, 2020 | March 31, 2022 |
| NCT03472365 | Completed | Phase 2 | A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer | April 2, 2018 | November 25, 2020 |
| NCT00040859 | Completed | Phase 2 | Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer | September 2002 | April 2008 |
| NCT00022139 | Completed | Phase 2 | Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | January 2002 | January 2009 |
| NCT02454647 | Completed | Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients | September 2013 | March 2015 | |
| NCT03788447 | Completed | N/A | Effect of Pneumoperitoneum on Remifentanil Requirements in the Surgical Pleth Index-guided Analgesia | June 4, 2019 | September 5, 2019 |
| NCT03515356 | Completed | N/A | Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy | June 13, 2018 | June 24, 2019 |
| NCT03778710 | Completed | Effect of Lymph Node Ratio in Gastric Cancer to Determine Recurrence Rate After Curative Resection | December 18, 2018 | February 20, 2019 | |
| NCT00887822 | Completed | Phase 3 | A Study of Bevacizumab (Avastin) Versus Placebo in Combination With Capecitabine (Xeloda) and Cisplatin as First-Line Therapy for Advanced Gastric Cancer | March 2009 | August 2014 |
| NCT00546468 | Completed | Phase 3 | Clinical Study on Laparoscopic Gastrectomy for Early Gastric Cancer (COACT_0301) | June 2003 | December 2010 |
| NCT00183872 | Completed | Phase 2 | Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma | April 14, 2005 | October 20, 2015 |
| NCT04476082 | Completed | Nutrition in Gastrointestinal Tumors | June 25, 2020 | December 6, 2022 | |
| NCT03042611 | Completed | Phase 3 | A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer | March 14, 2017 | September 23, 2020 |
| NCT02330913 | Completed | N/A | Novel Esophago-Jejunal Anastomosis Method During Totally Laparoscopic Total Gastrectomy | December 2014 | October 2015 |
| NCT00004604 | Completed | Phase 1 | Biological Therapy in Treating Patients With Metastatic Cancer | February 1997 | July 2002 |
| NCT01213004 | Completed | N/A | Evaluation of Respiratory Motion-Corrected Cone-Beam CT in Radiation Treatment of Thoracic and Abdominal Cancers | September 2010 | February 2018 |
| NCT03568110 | Completed | Frailty and Postoperative Outcomes After Gastric Cancer Surgery | March 5, 2019 | April 30, 2023 | |
| NCT04526886 | Completed | N/A | Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy | October 15, 2020 | March 7, 2023 |
| NCT00004235 | Completed | Phase 2 | Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach | January 2000 | August 2004 |
| NCT04929587 | Completed | Analysis of Influencing Factors of Preoperative Frailty in Elderly Patients With Gastric Cancer Based on the Health Ecology Theory | January 1, 2021 | February 2, 2022 | |
| NCT02064803 | Completed | N/A | Gastric Partitioning Procedure for the Treatment of Unresectable and Obstructive Distal Gastric Cancer | June 2013 | July 2020 |
| NCT01132755 | Completed | Phase 2 | Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage | May 2010 | August 16, 2017 |
| NCT00005599 | Completed | Phase 2 | Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer | February 2000 | August 2004 |
| NCT01913639 | Completed | Phase 2 | FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer | July 2013 | June 2019 |
| NCT02322593 | Completed | Phase 3 | Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer | December 2014 | May 2020 |
| NCT00003237 | Completed | Phase 2 | Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach | June 22, 1998 | |
| NCT03609892 | Completed | Phase 4 | Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy | August 1, 2018 | August 20, 2019 |
| NCT01679054 | Completed | Cost-minimization Analysis of Gastric Cancer Treatments in Hong Kong | October 2011 | July 2012 | |
| NCT00005060 | Completed | Phase 3 | Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer | November 1999 | March 2006 |
| NCT00202969 | Completed | Phase 3 | Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer | July 2005 | June 2007 |
| NCT00002783 | Completed | Phase 2 | Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer | May 1996 | January 2001 |
| NCT01170663 | Completed | Phase 3 | A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma | December 2010 | February 2017 |
| NCT00002615 | Completed | Phase 3 | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | June 1994 | December 2003 |
| NCT04316078 | Completed | N/A | A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies | March 15, 2020 | April 15, 2022 |
| NCT01522768 | Completed | Phase 2 | Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer | March 2012 | February 20, 2023 |
| NCT03528629 | Completed | N/A | A Study of IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma | May 17, 2018 | June 9, 2020 |
| NCT00836992 | Completed | Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer | January 2009 | July 27, 2015 | |
| NCT00005638 | Completed | Phase 1 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | October 1999 | April 2004 |
| NCT00858338 | Completed | Phase 2 | Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer | December 2002 | February 2012 |
| NCT00210184 | Completed | Phase 2 | Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer | July 21, 2004 | April 2010 |
| NCT01291407 | Completed | Phase 1 | A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer | November 2010 | September 2013 |
| NCT00019435 | Completed | Phase 1 | LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors | May 1998 | |
| NCT04040374 | Completed | N/A | Artificial Intelligence Versus Expert Endoscopists for Diagnosis of Gastric Cancer | July 1, 2019 | November 16, 2019 |
| NCT05068635 | Completed | Evaluation of the Efficacy of Distal Gastrectomy for the Treatment of Gastric Cancer (a Case Series) | January 1, 2013 | August 31, 2021 | |
| NCT04529135 | Completed | N/A | The Effect of Dexmedetomidine During Opioid Free Anesthesia on Postoperative Recovery After Gastrectomy | August 26, 2020 | June 20, 2022 |
| NCT01743365 | Completed | Phase 2 | Clinical Trial of Chemotherapy Combination Cisplatin-Fluorouracil-Afatinib in Patients With Inoperable Gastric Cancer | February 11, 2013 | July 29, 2019 |
| NCT01747551 | Completed | Phase 2 | FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer | January 2013 | July 26, 2017 |
| NCT03556345 | Completed | Phase 2 | A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer Subjects With the Overexpression of HER2 | July 10, 2018 | August 31, 2020 |
| NCT01672333 | Completed | Phase 2 | Response Rate and Side Effects of Preoperative Chemotherapy (TOX Regimen) in Patients With Locally Advanced Operable Gastric Adenocarcinoma | June 2008 | |
| NCT01444456 | Completed | Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia | October 2011 | ||
| NCT02276300 | Completed | Phase 1 | HER2-Peptide Vaccination of Patients With Solid Tumors | December 2014 | July 13, 2018 |
| NCT06337266 | Completed | A Novel Online Calculator to Predict Long-term Survival and Recurrence Risk of Patients With Gastric Adenocarcinoma | January 1, 2023 | March 19, 2024 | |
| NCT01874938 | Completed | Phase 2 | A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer | August 2013 | December 2014 |
| NCT04429841 | Completed | D2 Versus D1 Gastrectomy of Operable Gastric Cancer | January 2010 | June 2020 | |
| NCT05442502 | Completed | Safety and Efficacy of OGT Method Versus the Traditional Overlap Method | June 1, 2018 | March 1, 2022 | |
| NCT01147991 | Completed | Phase 1 | Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer | March 2005 | April 2011 |
| NCT00004911 | Completed | Phase 1/Phase 2 | Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction | January 2000 | February 2003 |
| NCT02274376 | Completed | Non-Interventional Study of Xeloda (Capecitabine) in Patients With Gastric Cancer | August 2008 | December 2012 | |
| NCT00004895 | Completed | Phase 2 | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | October 1999 | October 2002 |
| NCT00439608 | Completed | Phase 2 | Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer | October 2004 | April 2010 |
| NCT00365508 | Completed | Phase 4 | Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking | February 2006 | August 2009 |
| NCT01854255 | Completed | Phase 2 | Intraperitoneal Aerosol Chemotherapy in Gastric Cancer | November 2013 | November 2016 |
| NCT00681577 | Completed | Phase 1/Phase 2 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer | May 2008 | October 2009 |
| NCT00433602 | Completed | Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors | November 2006 | ||
| NCT01955096 | Completed | N/A | Fast Track Surgery With Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer: a Randomized Controlled Trial | September 2010 | October 2012 |
| NCT05606094 | Completed | Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer in East Asia | March 9, 2023 | November 30, 2023 | |
| NCT03471494 | Completed | GlobalSurg 3: Quality and Outcomes in Global Cancer Surgery | April 1, 2018 | April 23, 2019 | |
| NCT00019474 | Completed | Phase 2 | Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer | March 1998 | August 2000 |
| NCT02521649 | Completed | Phase 2 | Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer | September 1998 | January 2001 |
| NCT01719549 | Completed | Phase 2 | Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1 | September 2012 | November 2016 |
| NCT01971775 | Completed | Phase 3 | Clinical Study for Energy Based Devices in Open Gastrectomy for Gastric Cancer | August 2011 | |
| NCT03500471 | Completed | Robotic and Laparoscopic Total Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer | April 16, 2018 | August 30, 2021 | |
| NCT00215644 | Completed | Phase 2 | Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer | August 31, 2005 | August 31, 2008 |
| NCT02572687 | Completed | Phase 1 | A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies | February 19, 2016 | January 13, 2021 |
| NCT04686747 | Completed | COVID - 19 and Advanced Gastro-intestinal Cancer Treatment | January 1, 2021 | June 30, 2021 | |
| NCT05219539 | Completed | Questionnaire Survey of the Advanced Training Program for Laparoscopic Radical Gastrectomy | November 11, 2021 | December 20, 2021 | |
| NCT00137813 | Completed | Phase 2 | Avastin and Taxotere for Esophagogastric Cancer | August 2004 | September 2009 |
| NCT01466569 | Completed | Phase 1 | An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors | November 2011 | January 2013 |
| NCT04545632 | Completed | Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor | June 10, 2020 | June 24, 2021 | |
| NCT01338948 | Completed | Phase 1/Phase 2 | Image-guided Minimally Invasive Robotic Surgery Using Preoperative CT Scan for Gastric Cancer Patients | August 2009 | December 2009 |
| NCT00601705 | Completed | Phase 2 | Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach | January 5, 2008 | January 23, 2015 |
| NCT01633203 | Completed | Observational Study of Perioperative Chemotherapy in Gastric Cancer | August 2010 | December 2018 | |
| NCT00681252 | Completed | Phase 1/Phase 2 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer | May 2008 | April 2009 |
| NCT00004233 | Completed | Phase 2 | S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach | February 2001 | January 2007 |
| NCT01498289 | Completed | Phase 2 | S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer | February 2012 | September 19, 2019 |
| NCT00278863 | Completed | Phase 2 | Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial | November 2004 | January 2007 |
| NCT03238404 | Completed | N/A | Neoadjuvant Chemotherapy for Patients With Advanced Gastric Cancer in ERAS Programs for Radical Gastrectomy | August 1, 2015 | December 20, 2016 |
| NCT04015466 | Completed | Advanced GC Multi-omic Characterization in EU and CELAC Populations | June 12, 2019 | December 31, 2023 | |
| NCT00003192 | Completed | Phase 2 | Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus | March 1998 | August 2003 |
| NCT03730545 | Completed | N/A | Effect of Enteral Immunonutrition on Immune, Inflammatory Markers and Nutritional Status in Patients Undergoing Gastrectomy for Gastric Cancer | January 1, 2017 | September 20, 2018 |
| NCT00601510 | Completed | Phase 1 | Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer | November 2007 | January 2012 |
| NCT01576666 | Completed | Phase 1 | Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors | July 2012 | April 2015 |
| NCT00352833 | Completed | Phase 2 | Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma | July 2006 | September 2007 |
| NCT00003172 | Completed | Phase 2 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer | December 1997 | September 2004 |
| NCT03314649 | Completed | Peritoneal Lavage for Early Detecting Gene Mutation of Peritoneal Metastasis of Gastric Cancer | December 21, 2017 | January 1, 2019 | |
| NCT00154778 | Completed | Phase 2 | Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer | March 2003 | June 2005 |
| NCT00165464 | Completed | Phase 2 | Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer | August 2001 | April 2009 |
| NCT00423254 | Completed | Phase 1 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | February 2007 | November 2009 |
| NCT04440943 | Completed | Phase 1 | A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies | August 4, 2020 | April 6, 2023 |
| NCT00052910 | Completed | Phase 3 | Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer | December 2002 | December 2016 |
| NCT01857141 | Completed | N/A | Comparative Study on the Effects of Epidural Dexmedetomidine on Heart Rate Variability During General Anesthesia in Patients Undergoing Gastrectomy | February 2012 | August 2013 |
| NCT02706184 | Completed | Phase 3 | E. Coli Nissle in Oncology | July 2015 | January 2018 |
| NCT01824459 | Completed | Phase 3 | S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients | April 2013 | December 1, 2018 |
| NCT03662659 | Completed | Phase 2 | An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers | October 16, 2018 | January 18, 2024 |
| NCT06392750 | Completed | PWP1's Expression in Gastric Cancer. | May 1, 2021 | April 1, 2024 | |
| NCT00020826 | Completed | Assessing Quality of Life of Patients With Stomach Cancer | April 2001 | January 2004 | |
| NCT02538562 | Completed | Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea | October 11, 2011 | April 19, 2013 | |
| NCT00816543 | Completed | Phase 2 | Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma | December 2008 | May 2012 |
| NCT05397444 | Completed | Handgrip Strength (HGS) With HGS Asymmetry Are Associated With All-cause Mortality and Hospital Readmissions | March 1, 2021 | March 30, 2022 | |
| NCT00745381 | Completed | A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors | August 2008 | July 30, 2020 | |
| NCT04973631 | Completed | The Effects of Sex and Age Differences on Gastric Cancer : a Retrospective Study | May 2003 | January 2022 | |
| NCT04047004 | Completed | Phase 1 | Adjuvant PIPAC in Gastric Cancer Patients | March 11, 2020 | October 1, 2022 |
| NCT03329950 | Completed | Phase 1 | A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | December 1, 2017 | September 13, 2022 |
| NCT03793335 | Enrolling by invitation | Individually Tailored Strategies for the Precision Prevention of Gastric Cancer and Colorectal Cancer in the Community | April 14, 2019 | December 31, 2029 | |
| NCT06098898 | Enrolling by invitation | Early Phase 1 | Safety and Efficacy of NK510 to Treat Gastric Cancer | November 1, 2023 | November 1, 2024 |
| NCT00342654 | Enrolling by invitation | Nutrition Intervention Trials in Linxian Follow-up Study | May 20, 1999 | December 1, 2024 | |
| NCT06242613 | Enrolling by invitation | National Multicenter Cohort Study of Robot-Assisted Gastrectomy Versus Laparoscopy in Gastric Cancer | May 13, 2023 | December 31, 2029 | |
| NCT03900910 | Enrolling by invitation | N/A | Gastric Cancer Prevention for Indigenous Peoples | April 1, 2018 | December 31, 2025 |
| NCT03228095 | Enrolling by invitation | Volatiles in Breath and Headspace Analysis - Diagnostic Markers | July 24, 2017 | December 31, 2025 | |
| NCT02307812 | No longer available | Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France | |||
| NCT06349967 | Not yet recruiting | Phase 2 | Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancer | April 30, 2024 | May 30, 2027 |
| NCT06346197 | Not yet recruiting | Phase 3 | Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas | May 15, 2024 | May 15, 2028 |
| NCT05627414 | Not yet recruiting | Phase 2 | Conversion Therapy of Disitamab Vedotin Combined With Sintilimab and S-1 in HER2 Overexpression Gastric Cancer | January 1, 2023 | January 1, 2025 |
| NCT05318794 | Not yet recruiting | Phase 2 | Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer | November 2023 | July 2030 |
| NCT06094868 | Not yet recruiting | Phase 2 | Clinical Study of Fruquintinib Combined With Sintilimab and XELOX Regimen in the Treatment of Advanced Cancer | October 2023 | October 2026 |
| NCT06310473 | Not yet recruiting | Phase 2 | Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial | March 2024 | March 2028 |
| NCT04795063 | Not yet recruiting | N/A | Total Robotic Versus Robotic Assisted Distal Gastrectomy for Gastric Cancer | March 1, 2021 | January 1, 2027 |
| NCT05678205 | Not yet recruiting | Phase 1/Phase 2 | A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors | August 1, 2023 | April 2027 |
| NCT06161207 | Not yet recruiting | Phase 3 | 3D-4K-ICG Laparoscopic Gastrectomy for Gastric Cancer | January 1, 2024 | January 1, 2029 |
| NCT06229197 | Not yet recruiting | N/A | Billroth II With Braun Anastomosis After Radical Distal Gastrectomy for Gastric Cancer | February 1, 2024 | December 31, 2027 |
| NCT06464601 | Not yet recruiting | A Real-World Study of Neoadjuvant/Conversion Therapy for Locally Advanced or Metastatic Gastric Cancer | April 1, 2025 | March 31, 2027 | |
| NCT06437678 | Not yet recruiting | Phase 2 | Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer | May 27, 2024 | February 28, 2026 |
| NCT06241469 | Not yet recruiting | Phase 2 | Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study | February 3, 2024 | February 2, 2027 |
| NCT05356156 | Not yet recruiting | N/A | The Safe Study of Routine Closure of Mesenteric Defects Versus Non-closure After Radical Gastrectomy | April 2022 | March 2027 |
| NCT05396326 | Not yet recruiting | Phase 1 | A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancer | June 1, 2022 | December 31, 2025 |
| NCT06224738 | Not yet recruiting | Early Phase 1 | Human HER2-targeted Macrophages Therapy for HER2-positive Advanced Gastric Cancer With Peritoneal Metastases | March 1, 2024 | March 1, 2026 |
| NCT04160962 | Not yet recruiting | A Real World Study of Laparoscopic Preservation of the Pylorus Gastrectomy | January 2020 | January 2025 | |
| NCT05699278 | Not yet recruiting | Investigating the Experiences of Individuals With Gastric Cancer Participating in Clinical Trials | February 2024 | February 2026 | |
| NCT05608785 | Not yet recruiting | Phase 1/Phase 2 | Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes | January 1, 2023 | October 1, 2024 |
| NCT05648487 | Not yet recruiting | Phase 2 | HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal Metastasis | January 1, 2023 | December 31, 2027 |
| NCT05368636 | Not yet recruiting | Combining Tongue and Gastric Cancer Cascade With Artificial Intelligence | June 30, 2022 | June 30, 2025 | |
| NCT04168346 | Not yet recruiting | Phase 4 | Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer | November 2019 | November 2026 |
| NCT05241899 | Not yet recruiting | Phase 2 | A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancer | May 7, 2022 | May 7, 2025 |
| NCT05600608 | Not yet recruiting | N/A | Augmentation of Volatile Biomarkers of Oesophageal and Gastric Adenocarcinoma From the Tumour Lipidome | November 2022 | December 20, 2023 |
| NCT05346874 | Not yet recruiting | Phase 2 | Neoadjuvant TACiE in Locally Advanced Gastric Cancer | June 1, 2022 | May 1, 2025 |
| NCT05643677 | Not yet recruiting | Phase 2 | Fruquintinib Plus Irinotecan in the Treatment of Advanced Gastric Cancer | December 2022 | November 2025 |
| NCT05594381 | Not yet recruiting | Phase 2 | A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma. | October 2022 | October 2025 |
| NCT06335576 | Not yet recruiting | Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical Application | March 31, 2024 | December 31, 2026 | |
| NCT06093425 | Not yet recruiting | Phase 3 | Combination of TST001, Nivolumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma | October 31, 2023 | January 31, 2026 |
| NCT06295094 | Not yet recruiting | Phase 2 | The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients. | September 2024 | January 2028 |
| NCT04826107 | Not yet recruiting | Phase 2 | Study of DP303c Injection in Patients With Advanced or Metastatic Gastric Cancer | August 2021 | December 2024 |
| NCT05369117 | Not yet recruiting | N/A | Application of Indocyanine Green Labeled Fluorescent Laparoscopy in Proximal Gastric Cancer | May 31, 2022 | May 6, 2027 |
| NCT05934058 | Not yet recruiting | Genomic and Dietary Aspects in Gastric Cancer Risk | July 25, 2023 | July 25, 2027 | |
| NCT06308510 | Not yet recruiting | Detection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric Cancer | July 2024 | July 2028 | |
| NCT05948449 | Not yet recruiting | Phase 2 | To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. | July 2023 | July 2025 |
| NCT05445401 | Not yet recruiting | N/A | Pre-rehabilitation in Neoadjuvant Patients With Gastric Cancer | August 1, 2022 | June 30, 2026 |
| NCT06222944 | Not yet recruiting | Phase 2 | Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA | February 25, 2024 | August 25, 2026 |
| NCT06275997 | Not yet recruiting | N/A | GAIN Project: Gastric Cancer and Artificial Intelligence | June 10, 2024 | June 2028 |
| NCT05300945 | Not yet recruiting | Phase 2/Phase 3 | HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy | January 1, 2023 | December 31, 2028 |
| NCT06346080 | Not yet recruiting | N/A | Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment | August 1, 2024 | August 1, 2026 |
| NCT05468138 | Not yet recruiting | Phase 2 | PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery | August 25, 2022 | December 31, 2025 |
| NCT06197438 | Not yet recruiting | Phase 2 | Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer | January 1, 2024 | April 1, 2025 |
| NCT05235932 | Not yet recruiting | N/A | the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer | February 20, 2022 | February 20, 2027 |
| NCT06440018 | Not yet recruiting | INSPIRE: A Multi-Cancer Early Detection Study | June 20, 2024 | February 28, 2025 | |
| NCT05914610 | Not yet recruiting | Phase 3 | Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer | September 1, 2023 | July 30, 2028 |
| NCT05519202 | Not yet recruiting | Phase 2 | Exploratory Clinical Study of Penpulimab Combined With SOX in the Perioperative Treatment of Gastric Cancer | August 31, 2022 | August 31, 2024 |
| NCT05800080 | Not yet recruiting | N/A | An Exploratory Study of Immunotherapy Combined With Anlotinib and Chemotherapy in Perioperative Treatment of LAGC | April 2023 | February 2025 |
| NCT06339216 | Not yet recruiting | Phase 2 | A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer. | March 20, 2024 | November 30, 2026 |
| NCT05410847 | Not yet recruiting | Phase 2 | Nab-paclitaxel Plus Camrelizumab and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells | June 30, 2022 | June 30, 2025 |
| NCT06454435 | Not yet recruiting | Phase 2 | Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer | June 2024 | June 2027 |
| NCT06238167 | Not yet recruiting | Phase 2 | Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJC | April 1, 2024 | December 31, 2028 |
| NCT05751265 | Not yet recruiting | Phase 2 | Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancer | July 1, 2023 | June 1, 2025 |
| NCT06046846 | Not yet recruiting | N/A | Prehabilitation Via a Mobile Application in Oesophago-gastric Cancer | November 1, 2023 | January 1, 2025 |
| NCT05526339 | Not yet recruiting | N/A | HFNO Combined With NPA Reduces Hypoxia During Sedated Gastrointestinal Endoscopy In Obese Patients | September 2022 | May 2024 |
| NCT05385900 | Not yet recruiting | N/A | Immune Combined Targeted and Chemotherapy in Perioperative Treatment of Locally Advanced Gastric Cancer | June 30, 2022 | June 30, 2024 |
| NCT05928897 | Not yet recruiting | Phase 2 | Efficacy and Safety of Disitamab Vedotin Combined With Sintilimab | July 1, 2023 | July 1, 2025 |
| NCT05498194 | Not yet recruiting | Computational Prediction and Experimental Validation of Gastric Cancer Associated Neoantigens | August 15, 2022 | December 31, 2023 | |
| NCT05720533 | Not yet recruiting | Phase 2 | Disitamab Vedotin Combined With Sintilimab as First-line Treatment of Elderly Patients With Gastric Cancer | March 1, 2023 | March 1, 2025 |
| NCT06227325 | Not yet recruiting | Phase 2 | Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression | February 1, 2024 | December 31, 2025 |
| NCT03051152 | Not yet recruiting | N/A | D1 Versus D2 Lymphadenectomy in High Risk Elderly With Gastric Adenocarcinoma | March 1, 2017 | December 31, 2025 |
| NCT06461910 | Not yet recruiting | Phase 2 | Efficacy and Safety of Anti-PD-1, Thymosin, and SOX in Neoadjuvant Treatment of cStage III Gastric/GEJ Adenocarcinoma | June 2024 | December 2027 |
| NCT06213519 | Not yet recruiting | Phase 2 | HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis | February 20, 2024 | June 30, 2027 |
| NCT04656002 | Not yet recruiting | Phase 2 | As a Second-line Treatment for Metastatic Gastric Adenocarcinoma Patients, the Safety and Effective of Vactosertib Administration in Combination With Paclitaxel+Ramucirumab is Evaluated, and a Phase 2a Clinical Trial to Biomarkers | October 2022 | December 2024 |
| NCT04384601 | Not yet recruiting | Phase 3 | Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer | September 2021 | September 2027 |
| NCT06253611 | Not yet recruiting | Phase 2 | First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer | March 2024 | March 2029 |
| NCT06298916 | Not yet recruiting | Phase 1/Phase 2 | 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer | May 2024 | April 2026 |
| NCT06123637 | Not yet recruiting | N/A | Analgesia Nociception Index-guided Anesthesia and Standard Anesthesia | January 2, 2024 | December 30, 2024 |
| NCT06426654 | Not yet recruiting | Phase 1/Phase 2 | Sintilimab Combined With LDRT for Neoadjuvant Treatment of Locally Advanced dMMR/MSI-H Gastric Cancer | June 10, 2024 | August 30, 2027 |
| NCT06405113 | Not yet recruiting | Phase 2 | FMT+SOX+Sintilimab as First-line Treatment for Advanced Gastric Cancer | June 1, 2024 | June 1, 2027 |
| NCT06417892 | Not yet recruiting | Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma | May 15, 2024 | November 30, 2026 | |
| NCT06464965 | Not yet recruiting | Phase 1 | Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer | June 13, 2024 | June 2027 |
| NCT05447234 | Not yet recruiting | Early Phase 1 | TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First Chemotherapy | March 1, 2023 | March 1, 2028 |
| NCT06202716 | Not yet recruiting | Phase 2 | Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscore | April 2024 | April 2026 |
| NCT06414122 | Not yet recruiting | N/A | Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients | July 2024 | September 2026 |
| NCT06346054 | Not yet recruiting | N/A | Molecular Assessment for Gastro-Esophageal Cancer | July 1, 2024 | July 1, 2029 |
| NCT06134960 | Not yet recruiting | Phase 1 | NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor | November 16, 2023 | November 15, 2026 |
| NCT06384417 | Not yet recruiting | N/A | Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2 | June 2024 | December 2026 |
| NCT04640480 | Not yet recruiting | Phase 1 | Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors | June 21, 2024 | June 30, 2025 |
| NCT06115629 | Not yet recruiting | Phase 3 | Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) Trial | November 2023 | November 2029 |
| NCT06201585 | Not yet recruiting | N/A | Exploratory Study of Single-port Robot-assisted Gastrectomy | February 1, 2024 | August 1, 2024 |
| NCT06341647 | Not yet recruiting | Phase 1 | Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201 | August 31, 2024 | February 2029 |
| NCT06374901 | Not yet recruiting | Phase 2 | Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment. | April 25, 2024 | March 31, 2028 |
| NCT04677673 | Not yet recruiting | Phase 2/Phase 3 | Neoadjuvant Chemotherapy Plus Surgery Versus Surgery First For Elderly Gastric Cancer Patients | January 2021 | January 2027 |
| NCT06421220 | Not yet recruiting | N/A | Evaluation of the Efficacy and Safety of Indocyanine Green Tracing in 3D Fluorescent Laparoscopic Lymph Node Dissection for Gastric Cancer | May 20, 2024 | April 30, 2028 |
| NCT05661110 | Not yet recruiting | Biomarker Analysis of HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With Peritoneal Metastasis | January 1, 2023 | December 31, 2027 | |
| NCT05894824 | Not yet recruiting | Phase 1/Phase 2 | An Open Label, Single-arm, Multicenter Phase Ib/II Study to Evaluate the Safety and Efficacy of T-Dxd in Combination With Ramucirumab as a 2nd Line in Patients With HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma | June 1, 2023 | January 1, 2026 |
| NCT05361161 | Not yet recruiting | Phase 2 | Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC) | June 1, 2022 | December 1, 2025 |
| NCT06296706 | Not yet recruiting | Phase 3 | A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer | March 1, 2024 | June 1, 2027 |
| NCT06421324 | Not yet recruiting | N/A | Personalised Health Recommendations to the General Population Through an Integrated AI Guided | June 1, 2024 | December 31, 2026 |
| NCT06385691 | Not yet recruiting | Phase 2 | Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer. | April 29, 2024 | August 31, 2026 |
| NCT06305169 | Not yet recruiting | Measuring the Negative Predictive Value and Specificity of Serum Biomarkers in Gastric Cancer | April 1, 2024 | July 1, 2024 | |
| NCT06277908 | Not yet recruiting | Postoperative Morbidity and Mortality After Gastric Cancer Surgery | March 18, 2024 | December 31, 2024 | |
| NCT06202105 | Not yet recruiting | N/A | Comparison of Laparoscopic and Open Total Gastrectomy for Locally Advanced Gastric Cancer | January 2, 2024 | June 1, 2029 |
| NCT05510388 | Not yet recruiting | N/A | HFNO Reduces Hypoxia During Sedated Gastroscopy or Colonoscopy in High Risk Patients | September 1, 2022 | June 30, 2023 |
| NCT06266871 | Not yet recruiting | Phase 1/Phase 2 | SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric Cancer | March 10, 2024 | July 30, 2026 |
| NCT06419140 | Not yet recruiting | Phase 2 | Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy | June 1, 2024 | December 31, 2025 |
| NCT05113459 | Not yet recruiting | Phase 2 | Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer（RC48-C018） | December 18, 2021 | June 18, 2024 |
| NCT06306755 | Not yet recruiting | N/A | Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer | June 2024 | December 2034 |
| NCT05959226 | Not yet recruiting | N/A | Effect of Exercise and Enteral Nutrition on Survival | August 1, 2023 | August 1, 2028 |
| NCT06384300 | Not yet recruiting | N/A | Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in China | August 1, 2024 | July 31, 2027 |
| NCT06149923 | Not yet recruiting | Association Between ABO Polymorphism and Gastric/Colorectal Cancers | December 1, 2023 | January 1, 2026 | |
| NCT05687552 | Not yet recruiting | Role of 18F-FDG PET/CT in Gastric Cancer | January 2023 | January 2024 | |
| NCT06447636 | Not yet recruiting | Phase 2 | Perioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinoma | August 1, 2024 | August 2028 |
| NCT05227378 | Not yet recruiting | N/A | Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer | March 2022 | August 2025 |
| NCT06337084 | Recruiting | Phase 1 | Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors | April 10, 2024 | June 2025 |
| NCT05514769 | Recruiting | N/A | Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer | January 1, 2021 | December 31, 2024 |
| NCT03551951 | Recruiting | Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow | July 1, 2016 | June 30, 2026 | |
| NCT05238584 | Recruiting | N/A | Total Versus Partial Omentectomy in the Treatment of Gastric Cancer | January 1, 2022 | July 1, 2024 |
| NCT05687357 | Recruiting | Phase 2 | Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma | March 15, 2023 | August 31, 2027 |
| NCT04595929 | Recruiting | N/A | Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt- | February 10, 2020 | January 10, 2029 |
| NCT04843215 | Recruiting | N/A | A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer | January 1, 2021 | December 31, 2026 |
| NCT06043466 | Recruiting | Phase 1 | A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors | August 11, 2023 | December 31, 2027 |
| NCT03175224 | Recruiting | Phase 2 | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors | September 27, 2017 | November 30, 2026 |
| NCT03129139 | Recruiting | Phase 1 | A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors | October 10, 2017 | December 1, 2024 |
| NCT05647941 | Recruiting | Neo-adjuvant Chemotherapy Evluation in Gastric Cancer Patients Based on Circulating Exosomal LncRNA-GC1 | January 1, 2018 | December 30, 2022 | |
| NCT06206278 | Recruiting | Phase 2 | Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma | October 19, 2023 | December 2025 |
| NCT06078930 | Recruiting | Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms | April 6, 2021 | December 31, 2026 | |
| NCT01514045 | Recruiting | The Gastric Cancer Foundation: A Gastric Cancer Registry | April 2011 | December 2025 | |
| NCT05823272 | Recruiting | N/A | ONS in Gastric Cancer After Total Gastrectomy | March 22, 2024 | August 5, 2024 |
| NCT04744649 | Recruiting | Phase 2 | Neoadjuvant Immunotherapy and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial | March 12, 2021 | December 30, 2024 |
| NCT05156866 | Recruiting | Phase 1 | First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer | February 2, 2022 | January 15, 2026 |
| NCT05107674 | Recruiting | Phase 1 | A Study of NX-1607 in Adults With Advanced Malignancies | September 29, 2021 | February 28, 2026 |
| NCT06405009 | Recruiting | Prediction Model of Occult Omental Metastasis in Patients With Gastric Cancer | April 22, 2024 | June 30, 2024 | |
| NCT04958720 | Recruiting | Spanish Registry of Esophagogastric Cancer | April 27, 2020 | December 1, 2035 | |
| NCT03958019 | Recruiting | N/A | Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary Cancer | January 25, 2022 | December 1, 2024 |
| NCT06102759 | Recruiting | Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed | November 10, 2023 | October 10, 2026 | |
| NCT05642819 | Recruiting | REVOLUTION Surgery (REVOLUTION Surgery) | October 1, 2023 | December 2027 | |
| NCT06182644 | Recruiting | N/A | Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors | January 11, 2024 | September 1, 2025 |
| NCT05617469 | Recruiting | DLCS for Predicting Neoadjuvant Chemotherapy Response | July 1, 2022 | July 31, 2023 | |
| NCT04487717 | Recruiting | Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer | July 29, 2020 | January 29, 2027 | |
| NCT05898854 | Recruiting | Phase 2 | [68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer | February 15, 2024 | September 2035 |
| NCT04934618 | Recruiting | Phase 2 | A Phase II Study of Carelizumab Combined With Irinotecan and Apatinib of Second-line Treatment for Advanced Gastric Cancer | May 19, 2020 | May 19, 2025 |
| NCT04139135 | Recruiting | Phase 3 | A Clinical Study of HLX10 Combined With Chemotherapy Versus Placebo Combined With Chemotherapy for Neoadjuvant/Adjuvant Treatment of Gastric Cancer | December 12, 2019 | October 2024 |
| NCT05439993 | Recruiting | Phase 1/Phase 2 | Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma | March 1, 2022 | June 30, 2026 |
| NCT06202781 | Recruiting | Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy | July 1, 2022 | July 31, 2024 | |
| NCT05982301 | Recruiting | Phase 2 | Sintilimab Combined With Modified FLOT Regimen in the Treatment of Metastatic Gastric Cancer | February 9, 2023 | December 2025 |
| NCT03825861 | Recruiting | Phase 2 | Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer | February 23, 2017 | December 30, 2026 |
| NCT05252416 | Recruiting | Phase 1/Phase 2 | (VELA) Study of BLU-222 in Advanced Solid Tumors | April 7, 2022 | September 30, 2026 |
| NCT05644249 | Recruiting | N/A | PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer | December 1, 2022 | October 31, 2027 |
| NCT04260802 | Recruiting | Phase 1/Phase 2 | A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers | October 6, 2020 | September 30, 2026 |
| NCT05322577 | Recruiting | Phase 1 | A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer. | May 17, 2022 | April 1, 2028 |
| NCT04943406 | Recruiting | Peritoneal Lavage Liquid Biopsy in Patients With Gastric Cancer | May 8, 2020 | May 2025 | |
| NCT05470452 | Recruiting | N/A | Validating the Safety and Effectiveness of ENDOANGEL Upper Gastrointestinal Endoscope Image Auxiliary Diagnostic Software | July 28, 2021 | August 2022 |
| NCT05450835 | Recruiting | N/A | Safety of OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method | September 1, 2022 | February 28, 2026 |
| NCT04982939 | Recruiting | Phase 2 | Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer | June 21, 2021 | June 21, 2024 |
| NCT05453825 | Recruiting | Phase 2 | A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors | August 5, 2022 | December 15, 2024 |
| NCT05633342 | Recruiting | Project CADENCE (CAncer Detected Early caN be CurEd) | July 7, 2022 | May 2025 | |
| NCT05281380 | Recruiting | N/A | VITAMin Insufficiency in Esophagogastric Neoplasms | December 1, 2021 | November 1, 2024 |
| NCT04900818 | Recruiting | Phase 1 | Study of TJ033721 in Subjects With Advanced or Metastatic Solid Tumors | June 29, 2021 | December 2024 |
| NCT05867121 | Recruiting | Phase 1 | A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-Care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors | October 2, 2023 | December 30, 2025 |
| NCT04147078 | Recruiting | Phase 1 | Personalized DC Vaccine for Postoperative Cancer | June 1, 2019 | June 1, 2026 |
| NCT04108494 | Recruiting | N/A | A Trial of Total Versus Partial Omentectomy for Advanced Gastric Cancer in Gastrectomy | January 1, 2019 | December 31, 2025 |
| NCT05750290 | Recruiting | Phase 2 | CKD-702 Plus Irinotecan in Gastric Cancer | December 1, 2022 | December 31, 2025 |
| NCT06101277 | Recruiting | N/A | Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) | October 5, 2023 | January 5, 2031 |
| NCT05657080 | Recruiting | Cytosponge for Gastric Intestinal Metaplasia | October 16, 2023 | December 31, 2024 | |
| NCT06055439 | Recruiting | Phase 1/Phase 2 | A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy | May 2024 | May 2027 |
| NCT06431100 | Recruiting | a Single-arm, Single-center, Open Clinical Study | July 19, 2023 | November 19, 2026 | |
| NCT05816863 | Recruiting | Clinical Study of Pabolizumab for Neoadjuvant Immunotherapy of Locally Advanced Microsatellite-unstable Gastric Adenocarcinoma | March 1, 2023 | March 1, 2024 | |
| NCT05500508 | Recruiting | Phase 1/Phase 2 | Oral AMXT 1501 Dicaprate in Combination With IV DFMO | November 29, 2022 | September 30, 2024 |
| NCT05872295 | Recruiting | Phase 1 | IKS014 in Advanced Solid Tumors That Express HER2 | September 14, 2023 | September 2027 |
| NCT05566834 | Recruiting | Phase 1 | Minnelide™ Capsules Alone and in Combination With Paclitaxel in Advanced Gastric Cancer | November 2, 2020 | November 2024 |
| NCT04787354 | Recruiting | Phase 3 | Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX) | November 1, 2021 | December 31, 2027 |
| NCT04354662 | Recruiting | Phase 2 | Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer | September 26, 2019 | June 30, 2024 |
| NCT04727034 | Recruiting | N/A | Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy | March 2, 2021 | August 1, 2023 |
| NCT05208762 | Recruiting | Phase 1 | A Study of SGN-PDL1V in Advanced Solid Tumors | October 25, 2022 | December 31, 2026 |
| NCT05924789 | Recruiting | Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America | August 11, 2023 | June 17, 2024 | |
| NCT05159440 | Recruiting | Phase 1 | First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer | January 20, 2022 | December 15, 2025 |
| NCT06419244 | Recruiting | N/A | Myosteatosis in Oeso-gastric Cancer: Clinical Impacts | May 1, 2024 | May 31, 2026 |
| NCT05572684 | Recruiting | Phase 1/Phase 2 | A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors | October 6, 2022 | November 2025 |
| NCT05000554 | Recruiting | Phase 2 | The Safety and Efficacy of PD-1 Monoantrapical Chemotherapy in the Treatment of Local Advanced Stomach Cancer | July 2, 2021 | June 1, 2026 |
| NCT05002127 | Recruiting | Phase 2/Phase 3 | A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06) | January 15, 2022 | August 2028 |
| NCT04584008 | Recruiting | N/A | Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics | September 23, 2020 | February 2024 |
| NCT05683418 | Recruiting | Phase 1 | A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors | February 15, 2023 | December 2025 |
| NCT06440811 | Recruiting | Phase 1 | Preoperative Adjuvant SOX Plus PL-1 Antibody and FLOT Plus PD-1 Antibody for Locally Advanced dMMR Gastric Cancer | January 1, 2024 | March 1, 2025 |
| NCT06346392 | Recruiting | Phase 3 | AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2 | March 4, 2024 | October 9, 2026 |
| NCT05934331 | Recruiting | Phase 2 | A LM-302 Combined With Toripalimab Phase II Study | July 27, 2023 | January 1, 2026 |
| NCT03259867 | Recruiting | Phase 2 | Combination of TATE and PD-1 Inhibitor in Liver Cancer | July 1, 2017 | December 31, 2025 |
| NCT06157996 | Recruiting | Phase 2 | Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore | January 2024 | August 2026 |
| NCT04798820 | Recruiting | N/A | The Effect of Intensive Dietary Education on Nutritional Status After Gastrectomy(SING) | March 9, 2021 | February 2024 |
| NCT02012699 | Recruiting | Integrated Cancer Repository for Cancer Research | November 1, 2013 | December 2099 | |
| NCT04600466 | Recruiting | Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer | January 22, 2021 | January 22, 2025 | |
| NCT06035250 | Recruiting | AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy | September 10, 2023 | December 31, 2029 | |
| NCT05010863 | Recruiting | Gastric Cancer Marker Detection and Its Kit Development | January 1, 2021 | December 30, 2030 | |
| NCT05850130 | Recruiting | N/A | Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients | November 22, 2023 | December 2027 |
| NCT03878472 | Recruiting | Phase 2 | Neoadjuvant Immunotherapy for Resectable Gastric Cancer | April 1, 2019 | December 31, 2024 |
| NCT05412758 | Recruiting | N/A | Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE) | February 28, 2022 | October 2024 |
| NCT05052931 | Recruiting | Phase 2 | Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer | October 1, 2021 | December 31, 2023 |
| NCT06073483 | Recruiting | N/A | Exploratory Study of Toumai Endoscopic Surgery System for Remote Gastrectomy | October 15, 2023 | June 15, 2024 |
| NCT05537129 | Recruiting | N/A | Laparoscopic vs Open Total Gastrectomy for Gastric Cancer | October 1, 2022 | October 1, 2027 |
| NCT06413212 | Recruiting | Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing | August 4, 2023 | December 2024 | |
| NCT04850716 | Recruiting | Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric Cancer | April 27, 2021 | November 1, 2023 | |
| NCT05928819 | Recruiting | Evaluation of a Computer-aided Diagnosis System (CADx) in the Early Detection of Gastric Cancer in France. Cancer in France. | January 1, 2023 | August 31, 2024 | |
| NCT05540119 | Recruiting | Swedish Oesophago-Gastric Study | May 1, 2017 | August 31, 2023 | |
| NCT05379972 | Recruiting | Phase 2 | Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers | January 12, 2023 | December 2028 |
| NCT05652348 | Recruiting | Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer | December 8, 2022 | December 31, 2028 | |
| NCT04483076 | Recruiting | Phase 3 | Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer | January 13, 2021 | December 2028 |
| NCT05111626 | Recruiting | Phase 3 | Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer | March 14, 2022 | September 26, 2026 |
| NCT05379790 | Recruiting | Phase 1 | Concomitant Intraperitoneal and Systemic Chemotherapy in Patients With Extensive Peritoneal Carcinomatosis of Gastric Origin | May 25, 2022 | August 2024 |
| NCT04644068 | Recruiting | Phase 1/Phase 2 | Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies | November 12, 2020 | December 15, 2026 |
| NCT04840056 | Recruiting | Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis | April 15, 2021 | December 31, 2025 | |
| NCT05952375 | Recruiting | N/A | Exploratory Clinical Trial on the Safety, Efficacy, and Pharmacokinetics of XKDCT086 (iPD-1-Claudin18.2-CAR-T) in Claudin 18.2 Positive Advanced Solid Malignant Tumors: a Single Center, Single Arm, Dose-increasing Trial | March 1, 2023 | February 28, 2025 |
| NCT03253107 | Recruiting | Predicting Biomarker of Gastric Cancer Chemotherapy Response | November 30, 2015 | December 31, 2024 | |
| NCT04443478 | Recruiting | Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction Cancer | August 1, 2020 | July 1, 2026 | |
| NCT03961867 | Recruiting | Phase 3 | Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma | September 15, 2020 | September 2025 |
| NCT04597294 | Recruiting | Phase 3 | Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence | August 1, 2021 | December 2026 |
| NCT06363123 | Recruiting | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis | March 29, 2024 | April 2025 | |
| NCT06048458 | Recruiting | Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping | May 18, 2022 | February 2024 | |
| NCT05901779 | Recruiting | N/A | Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy | April 1, 2023 | May 1, 2024 |
| NCT04214990 | Recruiting | Phase 3 | Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients | February 15, 2020 | December 31, 2028 |
| NCT06275204 | Recruiting | H. Pylori Screen-and-treat Study in a Population of Young Adults | March 4, 2024 | December 1, 2026 | |
| NCT05854368 | Recruiting | N/A | Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer | July 3, 2023 | July 2025 |
| NCT03935893 | Recruiting | Phase 2 | Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers | December 3, 2019 | June 30, 2037 |
| NCT05561504 | Recruiting | Helicobacter Pylori Local Prevalence and Antibiotic Resistance | March 31, 2021 | December 31, 2035 | |
| NCT03597581 | Recruiting | Phase 1 | A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer | June 5, 2018 | December 31, 2024 |
| NCT04817826 | Recruiting | Phase 2 | TremelImumab aNd Durvalumab For the Non-operatIve Management (NOM) of MSI-high Resectable GC/GEJC. | April 1, 2021 | April 30, 2025 |
| NCT02751086 | Recruiting | Robotic, Laparoscopic and Open Gastrectomy Compared on Short and Long Term Outcomes | April 2016 | December 2024 | |
| NCT05483491 | Recruiting | Phase 1 | KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer | September 26, 2022 | December 31, 2028 |
| NCT06123455 | Recruiting | Phase 2 | Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer | August 1, 2023 | July 31, 2025 |
| NCT02584244 | Recruiting | Phase 1/Phase 2 | Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers | August 4, 2016 | April 2025 |
| NCT03505320 | Recruiting | Phase 2 | A Study to Assess the Antitumor Activity, Safety, Pharmacokinetics and Biomarkers of Zolbetuximab (IMAB362) in Participants With Claudin (CLDN) 18.2 Positive, Metastatic or Advanced Unresectable Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma and Locoregional Gastric or GEJ Adenocarcinoma | June 29, 2018 | December 31, 2026 |
| NCT04384757 | Recruiting | N/A | Comparison of Open and Laparoscopic Distal Gastrectomy for T4a Gastric Cancer | July 29, 2020 | December 31, 2025 |
| NCT06102785 | Recruiting | Fruquintinib Combined With TAS102 for Advanced Gastric Cancer | November 10, 2023 | October 10, 2026 | |
| NCT05462314 | Recruiting | Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies | March 29, 2022 | December 2025 | |
| NCT04999332 | Recruiting | Phase 2 | Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer | December 10, 2021 | December 31, 2025 |
| NCT04066335 | Recruiting | Study to Evaluate the Safety of Nanoxel M Inj. | September 18, 2019 | August 2024 | |
| NCT04943484 | Recruiting | ICG (Indocyanine Green) Imaging Fluorescence Technology in Surgical Treatment of Advanced Gastric Cancer | January 1, 2022 | November 30, 2024 | |
| NCT03716089 | Recruiting | Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site | October 11, 2018 | October 1, 2025 | |
| NCT06278064 | Recruiting | Exosome-based Liquid Biopsies for Upper Gastrointestinal Cancers Diagnosis | February 1, 2024 | June 30, 2025 | |
| NCT05216237 | Recruiting | Phase 2 | A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroesophageal Junction (GEJ) Cancer | February 15, 2022 | June 1, 2025 |
| NCT04762953 | Recruiting | Phase 2 | Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis | February 18, 2021 | June 2025 |
| NCT05714553 | Recruiting | Phase 1/Phase 2 | NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours | March 8, 2023 | January 2025 |
| NCT05581004 | Recruiting | Phase 1 | A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors | October 20, 2022 | October 31, 2025 |
| NCT06100003 | Recruiting | A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method | October 18, 2023 | December 1, 2025 | |
| NCT05259696 | Recruiting | Phase 1/Phase 2 | Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) | February 11, 2022 | June 2025 |
| NCT06196554 | Recruiting | Gastric Cancer Organoids in the Screening of Neoadjuvant Drugs | May 1, 2023 | June 28, 2024 | |
| NCT06054906 | Recruiting | Phase 2 | Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer | September 25, 2023 | December 31, 2025 |
| NCT05698992 | Recruiting | Rehabilitation and Recovery for Persons With Esophageal or Gastric Cancer | February 27, 2023 | December 31, 2027 | |
| NCT04379596 | Recruiting | Phase 2 | Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03) | June 3, 2020 | July 30, 2026 |
| NCT05775120 | Recruiting | Epidemiology of Helicobacter Pylori Infection in Moscow | July 1, 2022 | January 15, 2025 | |
| NCT05165264 | Recruiting | A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer | February 16, 2022 | December 31, 2026 | |
| NCT05438459 | Recruiting | Phase 1/Phase 2 | GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites | June 8, 2022 | June 8, 2027 |
| NCT05980481 | Recruiting | Phase 2/Phase 3 | A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer | August 4, 2023 | July 10, 2025 |
| NCT06038578 | Recruiting | Phase 2 | A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer | October 4, 2023 | August 31, 2025 |
| NCT06339307 | Recruiting | A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC Patients | February 15, 2024 | December 31, 2024 | |
| NCT05641896 | Recruiting | Phase 2 | Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers | April 28, 2023 | March 31, 2025 |
| NCT04191551 | Recruiting | The GAstric Precancerous Conditions Study | July 30, 2018 | June 30, 2026 | |
| NCT05789069 | Recruiting | Phase 1 | A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors | May 9, 2023 | December 2025 |
| NCT05498766 | Recruiting | Effect and Safety of Adjuvant Huaier Granule Versus Standard Chemotherapy Regimens in Gastric Cancer Patients | October 12, 2023 | June 30, 2028 | |
| NCT04863430 | Recruiting | Phase 2 | Apatinib With Oxaliplatin and S-1 Treatment for Advanced Hepatoid Adenocarcinoma Of The Stomach | May 11, 2021 | December 2025 |
| NCT05184946 | Recruiting | Phase 2 | Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinoma | October 9, 2021 | October 8, 2025 |
| NCT06128252 | Recruiting | N/A | Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer | October 1, 2023 | December 31, 2024 |
| NCT01917552 | Recruiting | Phase 3 | Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS | August 19, 2013 | August 1, 2026 |
| NCT05965466 | Recruiting | N/A | The Incidence of Gallstones After Gastrectomy | July 21, 2023 | January 1, 2024 |
| NCT05427214 | Recruiting | N/A | Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy | August 19, 2022 | October 2, 2024 |
| NCT04308837 | Recruiting | Phase 2 | A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation | December 3, 2018 | August 2025 |
| NCT05541783 | Recruiting | N/A | Laparoscopic-assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy for Gastric Cancer | September 15, 2022 | September 15, 2025 |
| NCT03745326 | Recruiting | Phase 1/Phase 2 | Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients | May 16, 2019 | December 1, 2028 |
| NCT04576858 | Recruiting | Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer | February 3, 2020 | July 2025 | |
| NCT05886075 | Recruiting | Early Phase 1 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors | March 30, 2023 | March 2025 |
| NCT05405530 | Recruiting | N/A | Nasal Mask Kit in Gastrointestinal Endoscopy | September 1, 2022 | October 2023 |
| NCT00927680 | Recruiting | Familial Colorectal Cancer Registry in Hispanics | July 2007 | January 2026 | |
| NCT05274048 | Recruiting | Phase 1 | Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients | June 24, 2022 | June 2027 |
| NCT04999761 | Recruiting | Phase 1 | AB122 Platform Study | June 1, 2021 | May 2026 |
| NCT03817268 | Recruiting | Phase 3 | Capecitabine or Observation for Patients With pT1N+M0 or pT2-3N0M0 Gastric Adenocarcinoma Undergoing R0 Resection | January 16, 2019 | January 30, 2026 |
| NCT05605522 | Recruiting | Phase 1 | A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours | February 7, 2023 | September 2025 |
| NCT04868877 | Recruiting | Phase 1/Phase 2 | A Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR and Anti-c-MET Bispecific Antibody, in Patients With Advanced NSCLC and Other Solid Tumors | April 28, 2021 | April 2025 |
| NCT05098132 | Recruiting | Phase 1 | Phase 1a/1b Study of STK-012 Monotherapy and in Combination With Pembrolizumab in Patients With Solid Tumors | January 25, 2022 | October 2025 |
| NCT06256328 | Recruiting | Phase 2 | A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer) | December 6, 2023 | December 31, 2027 |
| NCT04745988 | Recruiting | Phase 2 | An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer | November 11, 2021 | August 2027 |
| NCT06055387 | Recruiting | N/A | Frailty Assessment and Intervention in Elderly Patients With Gastric Cancer Receiving Gastrectomy and Adjuvant Chemotherapy | January 1, 2022 | December 31, 2025 |
| NCT03399253 | Recruiting | Phase 2/Phase 3 | Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor | December 10, 2017 | December 1, 2025 |
| NCT06451211 | Recruiting | Phase 2 | Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer | May 17, 2023 | November 2027 |
| NCT06300879 | Recruiting | N/A | A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique | January 1, 2024 | June 30, 2026 |
| NCT04997837 | Recruiting | Phase 3 | Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma | July 21, 2021 | October 21, 2027 |
| NCT06008054 | Recruiting | Phase 2 | A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors | November 16, 2023 | December 2025 |
| NCT04282044 | Recruiting | Phase 1 | Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies | January 8, 2021 | October 2026 |
| NCT05177068 | Recruiting | Phase 2 | Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer | May 6, 2022 | January 2025 |
| NCT05668910 | Recruiting | Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNA | September 1, 2022 | March 31, 2024 | |
| NCT05860374 | Recruiting | Early Phase 1 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors | March 2, 2023 | March 2, 2026 |
| NCT04232735 | Recruiting | N/A | Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE) | October 13, 2020 | September 30, 2023 |
| NCT03895008 | Recruiting | Comparing the Prognosis of Patients With Cardia and Non-cardia Gastric Cancer. | July 8, 2019 | December 31, 2024 | |
| NCT05919264 | Recruiting | Phase 1/Phase 2 | FOG-001 in Locally Advanced or Metastatic Solid Tumors | May 19, 2023 | August 31, 2027 |
| NCT05140746 | Recruiting | N/A | Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer | September 10, 2020 | September 10, 2027 |
| NCT06109467 | Recruiting | Phase 2 | Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer | January 12, 2024 | April 2028 |
| NCT05742568 | Recruiting | Phase 4 | Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology | December 1, 2022 | March 10, 2024 |
| NCT05514158 | Recruiting | Phase 1 | To Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Disitamab Vedotin Combined With RC98 in the Treatment of Subjects With HER2-expressing Locally Advanced or Metastatic Gastric Cancer (Including AEG) | September 28, 2022 | September 30, 2024 |
| NCT04198766 | Recruiting | Phase 1 | Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) | December 10, 2019 | May 15, 2026 |
| NCT05708950 | Recruiting | Phase 1/Phase 2 | A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) | March 3, 2023 | December 31, 2024 |
| NCT05721651 | Recruiting | Phase 2 | Efficacy and Safety of Fruquintinib in Combination With PD-1 Inhibitors as First-line Maintenance Therapy for Advanced HER-2 Negative Gastric Cancer: a Single-arm, Prospective, Exploratory Clinical Study | April 2023 | March 2026 |
| NCT06126406 | Recruiting | Phase 1 | Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors | November 6, 2023 | December 31, 2026 |
| NCT04214119 | Recruiting | EsophaCap for the Detection of Early Esophageal Carcinoma | January 12, 2016 | December 19, 2025 | |
| NCT05844371 | Recruiting | Phase 2 | Efficacy and Safety of Tirelizumab Plus Chemotherapy Versus Chemotherapy Alone in Patients With Lymph Node Positive Gastric Cancer After Surgery | April 1, 2021 | April 1, 2024 |
| NCT05702229 | Recruiting | Phase 2 | Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | January 16, 2023 | March 31, 2026 |
| NCT05122091 | Recruiting | Phase 2 | Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma | November 5, 2021 | November 30, 2024 |
| NCT03972956 | Recruiting | Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease | December 23, 2020 | December 23, 2026 | |
| NCT04511871 | Recruiting | Phase 1 | A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors | July 9, 2020 | March 29, 2025 |
| NCT04118114 | Recruiting | Phase 2 | Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors | September 3, 2019 | December 31, 2025 |
| NCT06313567 | Recruiting | Phase 3 | Metronomic Capecitabine in Stage III Gastric Cancer | March 10, 2024 | March 10, 2029 |
| NCT05739045 | Recruiting | Phase 2 | Nivolumab Combined With SOX Used in the Perioperative Treatment | November 3, 2022 | December 31, 2024 |
| NCT04805307 | Recruiting | Phase 1 | Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 | December 24, 2020 | October 2024 |
| NCT06227728 | Recruiting | Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer. | March 22, 2024 | December 31, 2026 | |
| NCT06046963 | Recruiting | Phase 2 | Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites | March 1, 2023 | March 2025 |
| NCT05002686 | Recruiting | Phase 2/Phase 3 | Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis | August 7, 2021 | August 1, 2024 |
| NCT06239194 | Recruiting | Phase 1/Phase 2 | Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors | June 12, 2024 | February 2029 |
| NCT06281860 | Recruiting | Phase 1 | Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration | November 24, 2023 | February 1, 2026 |
| NCT06006390 | Recruiting | Phase 1/Phase 2 | CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors | September 7, 2023 | August 31, 2026 |
| NCT06109805 | Recruiting | Plasma Metabolic Biomarkers for Gastric Cancer Diagnosis | October 20, 2023 | September 30, 2024 | |
| NCT04931654 | Recruiting | Phase 1/Phase 2 | A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer | September 28, 2021 | July 29, 2025 |
| NCT02047994 | Recruiting | Phase 4 | Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality | March 2013 | December 2035 |
| NCT05472857 | Recruiting | Phase 1 | Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression | August 8, 2022 | December 2024 |
| NCT02197351 | Recruiting | N/A | Narrow Band Imaging for Gastric Neoplasia | July 2014 | December 2023 |
| NCT05472532 | Recruiting | N/A | Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture) | February 14, 2023 | December 14, 2024 |
| NCT06464978 | Recruiting | N/A | Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy | May 30, 2024 | June 2026 |
| NCT03872947 | Recruiting | Phase 1 | A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors | April 26, 2019 | March 2025 |
| NCT04871204 | Recruiting | Phase 2 | Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients With Esophageal or Gastric Cancer | June 16, 2021 | December 2024 |
| NCT05541146 | Recruiting | Phase 2 | Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis | June 1, 2022 | January 2025 |
| NCT05536102 | Recruiting | Phase 2 | The Effectiveness and Safety of XELOX and Tislelizumab + PLD for Resectable Gastric Cancer (LidingStudy) | September 5, 2022 | September 30, 2027 |
| NCT06033482 | Recruiting | The Possible Range of No.12a Lymph Node Dissection of Locally Advanced Gastric Cancer | June 1, 2023 | December 31, 2024 | |
| NCT05420259 | Recruiting | N/A | Combined Exercise and Nutritional Intervention in GI Cancer Patients | March 21, 2022 | June 28, 2024 |
| NCT06432205 | Recruiting | The Effect of MDT Plus SDM on Survival Benefit of Advanced Gastric Cancer | November 9, 2023 | August 2025 | |
| NCT05192460 | Recruiting | N/A | Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver Cancer | March 28, 2022 | June 2025 |
| NCT04714190 | Recruiting | Phase 3 | A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression | March 24, 2021 | June 30, 2025 |
| NCT05144698 | Recruiting | Phase 1/Phase 2 | RAPA-201 Therapy of Solid Tumors | August 1, 2021 | December 31, 2024 |
| NCT06242470 | Recruiting | Phase 1 | A Study of MGC026 in Participants With Advanced Solid Tumors | March 6, 2024 | October 2028 |
| NCT06212700 | Recruiting | N/A | PRIORITY-CONNECT 2 Pilot Trial | February 12, 2024 | December 22, 2025 |
| NCT05438420 | Recruiting | Phase 1/Phase 2 | Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors | January 12, 2023 | June 30, 2026 |
| NCT05583201 | Recruiting | Early Phase 1 | NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors | October 13, 2022 | June 1, 2026 |
| NCT05977478 | Recruiting | N/A | Characterization of Tissue Biochemical Composition in Gastric Precancerous/Cancerous Lesions | October 27, 2022 | March 31, 2024 |
| NCT03493880 | Recruiting | The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative Treatments | September 1, 2015 | September 1, 2025 | |
| NCT04140526 | Recruiting | Phase 1/Phase 2 | Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC | September 16, 2020 | December 31, 2027 |
| NCT06232395 | Recruiting | Early Detection and Post-operative Monitoring of Gastric Cancer | February 18, 2024 | February 17, 2026 | |
| NCT06395519 | Recruiting | Phase 1 | A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies | May 2024 | December 2026 |
| NCT04593134 | Recruiting | N/A | Effectiveness of Exercise Program in Improving Quality of Life in Patients With Gastric Cancer Undergoing Gastrectomy | November 10, 2020 | October 31, 2025 |
| NCT06371586 | Recruiting | Phase 2 | Neo-Sequence 2：NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC | March 1, 2024 | March 1, 2027 |
| NCT05722275 | Recruiting | Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics | January 1, 2023 | December 31, 2028 | |
| NCT05070247 | Recruiting | Phase 1/Phase 2 | A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors | April 14, 2022 | August 11, 2026 |
| NCT01815853 | Recruiting | Phase 3 | Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer | June 2013 | December 2025 |
| NCT04535414 | Recruiting | Phase 2 | Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers | June 22, 2023 | December 31, 2027 |
| NCT06028737 | Recruiting | Phase 2/Phase 3 | Total Neoadjuvant Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer | August 25, 2023 | December 2031 |
| NCT02838836 | Recruiting | Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers | July 1, 2016 | June 1, 2024 | |
| NCT05878964 | Recruiting | Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors. | May 22, 2023 | September 22, 2024 | |
| NCT02139605 | Recruiting | N/A | "Phase III Randomized Trial Comparing D2 vs D3 Lymphadenectomy With Gastric Cancer Following Neoadjuvant Chemotherapy | July 5, 2013 | August 31, 2026 |
| NCT04547725 | Recruiting | N/A | Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal Carcinomatosis | September 16, 2020 | September 16, 2028 |
| NCT06316882 | Recruiting | N/A | Opportunistic Gastric Cancer Screening | February 3, 2023 | December 31, 2024 |
| NCT06383793 | Recruiting | Comparative Analysis of Short-Term Therapeutic Effects Between the π-Shaped and Overlap Methods for Esophagogastrostomy in Totally Laparoscopic Total Gastrectomy | April 1, 2024 | December 30, 2025 | |
| NCT05804331 | Recruiting | The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study | March 14, 2023 | September 14, 2028 | |
| NCT06079554 | Recruiting | Microbiota and Metabolomics of Intestinal Type of Gastric Cancer | March 31, 2024 | August 30, 2025 | |
| NCT05215574 | Recruiting | Phase 1 | Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors | March 31, 2022 | March 2026 |
| NCT06451393 | Recruiting | Predicting Gastric Cancer Response to Chemo With Multimodal AI Model | February 1, 2013 | December 30, 2026 | |
| NCT06362070 | Recruiting | N/A | Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy | January 31, 2024 | July 31, 2025 |
| NCT06264921 | Recruiting | Phase 1 | A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors | February 23, 2024 | May 2025 |
| NCT04250402 | Recruiting | The Incidence of Gallstones After Gastric Cancer Surgery | February 14, 2020 | December 30, 2023 | |
| NCT04498767 | Recruiting | N/A | Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) | June 10, 2021 | February 1, 2030 |
| NCT06010862 | Recruiting | Phase 1 | Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors | September 30, 2023 | September 30, 2026 |
| NCT05239143 | Recruiting | Phase 1 | P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors | February 15, 2022 | April 2039 |
| NCT05955833 | Recruiting | Phase 1 | 89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study | June 26, 2023 | April 30, 2024 |
| NCT06219941 | Recruiting | Phase 2 | AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 | December 13, 2023 | January 19, 2027 |
| NCT06102772 | Recruiting | Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer | November 10, 2023 | October 10, 2026 | |
| NCT05515796 | Recruiting | Phase 2 | Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors | September 1, 2022 | December 31, 2025 |
| NCT05489211 | Recruiting | Phase 2 | Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) | September 6, 2022 | August 19, 2026 |
| NCT05563272 | Recruiting | Phase 2 | 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors | June 6, 2023 | December 29, 2025 |
| NCT04149691 | Recruiting | Phase 1 | Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies | July 19, 2019 | June 2024 |
| NCT04107077 | Recruiting | Phase 2 | Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer | March 14, 2024 | June 1, 2025 |
| NCT05723718 | Recruiting | MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatment | December 20, 2022 | December 31, 2028 | |
| NCT06257264 | Recruiting | Phase 1 | A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors | February 28, 2024 | December 31, 2026 |
| NCT05075993 | Recruiting | Phase 1 | Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors | November 12, 2021 | February 2, 2027 |
| NCT06395935 | Recruiting | N/A | Wecare Study in Gastric Cancer Survivors | April 1, 2024 | March 30, 2026 |
| NCT05827614 | Recruiting | Phase 1 | Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), in Subjects With Tumors With Oncogene Amplifications | March 24, 2023 | September 30, 2027 |
| NCT05349227 | Recruiting | N/A | Comprehensive Outcomes for After Cancer Health | June 23, 2022 | December 2025 |
| NCT05550974 | Recruiting | Articulated Laparoscopic Instruments Clinical Study | September 2022 | December 2024 | |
| NCT03740256 | Recruiting | Phase 1 | Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors | December 14, 2020 | December 30, 2038 |
| NCT05411133 | Recruiting | Phase 1 | Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients | May 30, 2022 | August 2025 |
| NCT05052801 | Recruiting | Phase 3 | Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression | March 7, 2022 | August 18, 2025 |
| NCT04500392 | Recruiting | N/A | High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity | May 6, 2021 | January 2024 |
| NCT03421288 | Recruiting | Phase 2 | Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With GC/GEJ and High Immune Responsiveness | September 14, 2018 | December 31, 2027 |
| NCT05728606 | Recruiting | N/A | Robot-assisted D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers | January 20, 2023 | June 20, 2024 |
| NCT04284943 | Recruiting | N/A | Surgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery | December 1, 2020 | December 2023 |
| NCT04396821 | Recruiting | Phase 1/Phase 2 | A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors | May 28, 2020 | December 31, 2024 |
| NCT05187338 | Recruiting | Phase 1/Phase 2 | Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors | November 1, 2021 | October 30, 2025 |
| NCT05126290 | Recruiting | CTNNA1 Familial Expansion Study | March 16, 2021 | January 1, 2026 | |
| NCT05344339 | Recruiting | N/A | Billroth-II Modified Versus Roux-en-Y After Distal Gastrectomy for Gastric Cancer | October 8, 2022 | April 30, 2025 |
| NCT06325891 | Recruiting | Microbiota in Gastric Cancer by Gastric Mucosal Brushing | February 1, 2024 | May 31, 2025 | |
| NCT04791254 | Recruiting | Anorexia iN Cancer Patients: ANCHOR | July 15, 2021 | April 2026 | |
| NCT06341595 | Recruiting | Phase 2 | Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM | April 1, 2024 | December 31, 2026 |
| NCT06221748 | Recruiting | Phase 2/Phase 3 | DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy | February 22, 2024 | December 2027 |
| NCT05057013 | Recruiting | Phase 1/Phase 2 | HMBD-001 in Advanced HER3 Positive Solid Tumours | November 10, 2021 | September 2026 |
| NCT06370143 | Recruiting | A Study Collecting Health Information to Understand and Prevent Gastric Cancer | April 11, 2024 | April 11, 2036 | |
| NCT05991947 | Recruiting | Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer | December 1, 2021 | December 31, 2025 | |
| NCT06023966 | Recruiting | A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative Surgery | September 1, 2023 | March 31, 2026 | |
| NCT06036563 | Recruiting | Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing | September 1, 2023 | December 2025 | |
| NCT04613570 | Recruiting | N/A | SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up | January 2, 2021 | December 31, 2026 |
| NCT05538195 | Recruiting | Phase 1/Phase 2 | Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors | June 7, 2022 | June 7, 2025 |
| NCT06172478 | Recruiting | Phase 2 | A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors | February 26, 2024 | April 30, 2026 |
| NCT03627728 | Recruiting | Phase 2 | Study Maintenance Regorafenib vs Placebo, no Progression Patients After I Line Chemotherapy Metastatic Gastric Cancer | June 13, 2018 | December 31, 2022 |
| NCT05086692 | Recruiting | Phase 1/Phase 2 | A Beta-only IL-2 ImmunoTherapY Study | August 27, 2021 | December 30, 2026 |
| NCT06253650 | Recruiting | Phase 2 | Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease | March 1, 2024 | March 1, 2028 |
| NCT04725994 | Recruiting | Phase 1 | Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer | June 28, 2021 | March 31, 2024 |
| NCT05076279 | Recruiting | N/A | Safety and Efficacy of Single or Reduced Ports Laparoscopic Gastrectomy for Advanced Gastric Cancer (SPACE-01) | November 15, 2021 | August 31, 2026 |
| NCT06383559 | Recruiting | Phase 2 | Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients | December 1, 2023 | September 1, 2026 |
| NCT04740346 | Recruiting | N/A | Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP) | July 5, 2021 | June 30, 2026 |
| NCT04557969 | Recruiting | Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis | December 18, 2020 | December 30, 2040 | |
| NCT05494086 | Recruiting | N/A | Dual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer | August 1, 2022 | December 31, 2029 |
| NCT06354036 | Recruiting | N/A | Transhiatal Tunnel Valvuloplasty for Reconstruction Following the Laparoscopic Proximal Gastrectomy | March 1, 2023 | March 1, 2025 |
| NCT05029869 | Recruiting | Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description | October 4, 2021 | October 1, 2024 | |
| NCT05187182 | Recruiting | Phase 1 | CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer | June 2, 2023 | June 30, 2027 |
| NCT05861947 | Recruiting | Phase 1 | A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies | August 26, 2023 | June 2025 |
| NCT03941561 | Recruiting | Phase 3 | S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC） | January 1, 2019 | May 1, 2027 |
| NCT05646290 | Recruiting | Validation of a Model for Predicting Anastomotic Leakage | January 6, 2022 | April 6, 2024 | |
| NCT05539430 | Recruiting | Phase 1 | Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma | April 18, 2023 | December 2025 |
| NCT05918094 | Recruiting | Phase 3 | Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma | April 30, 2023 | December 2028 |
| NCT05788484 | Recruiting | Phase 1 | A Study of CDX-585 in Patients With Advanced Malignancies | May 11, 2023 | February 2026 |
| NCT05180799 | Recruiting | Phase 1/Phase 2 | A Phase 1/2 Study of BA3071 as Monotherapy and in Combination With a PD-1 Blocking Antibody in Patients With Advanced Solid Tumors | August 3, 2022 | June 30, 2025 |
| NCT05891171 | Recruiting | Phase 1 | Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers | October 13, 2023 | August 2025 |
| NCT05956847 | Recruiting | The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric | August 10, 2023 | July 30, 2030 | |
| NCT06186089 | Recruiting | Effect of Gastrectomy on Gut Microbiome and Cognitive Function | January 20, 2024 | June 2026 | |
| NCT06031779 | Recruiting | Application of Serum Bile Acid Profile in the Diagnosis of Gastric Cancer | May 1, 2023 | July 1, 2024 | |
| NCT05517408 | Recruiting | N/A | Dose Exploration of Ciprofol for Sedation in Gastrointestinal Endoscopic Diagnosis and Treatment of Obese Patients. | September 19, 2022 | August 13, 2023 |
| NCT05930860 | Recruiting | Efficacy and Safety of ESD for the Treatment of Superficial Gastric Neoplasms | December 12, 2021 | December 12, 2031 | |
| NCT05975749 | Recruiting | Phase 2 | Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer | January 1, 2023 | January 1, 2029 |
| NCT04157985 | Recruiting | Phase 3 | Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors | November 15, 2019 | October 2028 |
| NCT05901376 | Recruiting | MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection | April 25, 2023 | June 2025 | |
| NCT05277766 | Recruiting | Phase 1 | Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer | November 21, 2022 | January 1, 2027 |
| NCT06155383 | Recruiting | Phase 2 | Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma. | November 27, 2023 | December 31, 2027 |
| NCT05632939 | Recruiting | Phase 1/Phase 2 | ASKB589 in Combination With CAPOX and Sintilimab in Patients With Advanced, and Unresectable G/GEJ Cancer. | February 10, 2023 | February 10, 2026 |
| NCT05638269 | Recruiting | A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China | March 1, 2022 | December 2025 | |
| NCT05415098 | Recruiting | Phase 1 | Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas | September 30, 2022 | September 30, 2025 |
| NCT04674267 | Recruiting | N/A | Resilience and Equity in Aging, Cancer, and Health (REACH) | January 18, 2022 | December 31, 2024 |
| NCT05899985 | Recruiting | N/A | Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation | March 21, 2024 | February 2030 |
| NCT06076265 | Recruiting | Quantitative Detection of CEA mRNA in the Smog and Tissue Exudate Whole Process Collected During Laparoscopic (Robotic) Radical Gastrectomy in Gastric Cancer Patients | December 1, 2022 | October 2023 | |
| NCT05771584 | Recruiting | Phase 2 | Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric Cancer | July 4, 2023 | June 15, 2026 |
| NCT05858736 | Recruiting | Phase 1 | Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors | July 11, 2023 | June 15, 2025 |
| NCT05513144 | Recruiting | Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer | December 24, 2021 | February 28, 2025 | |
| NCT04022109 | Recruiting | Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach | November 1, 2019 | December 2026 | |
| NCT05029102 | Recruiting | Phase 2 | TAS-102 and Anlotinib in ≥3 Lines mGC | September 1, 2021 | December 31, 2024 |
| NCT03787056 | Recruiting | N/A | Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients | December 4, 2018 | January 4, 2028 |
| NCT05842187 | Recruiting | N/A | In Vitro Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric Cancer | March 3, 2023 | December 31, 2024 |
| NCT06047379 | Recruiting | Phase 1/Phase 2 | Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis | November 1, 2023 | August 31, 2026 |
| NCT04609176 | Recruiting | Phase 2 | Study of Camrelizumab (SHR-1210) and Apatinb Based Therapies for Alpha-fetoprotein (AFP)-Producing Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | November 18, 2020 | December 31, 2024 |
| NCT06254300 | Recruiting | N/A | Online Exercise Program During Perioperative Treatment in Adults With Gastric Cancer | March 23, 2022 | December 31, 2025 |
| NCT06342427 | Recruiting | Stomach Cancer Exosome-based Detection | March 15, 2023 | March 15, 2025 | |
| NCT04033107 | Recruiting | Phase 2 | High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors | July 1, 2020 | December 2024 |
| NCT04184960 | Recruiting | AG & IM in CA Stomach Protocol | December 5, 2019 | March 31, 2024 | |
| NCT05618821 | Recruiting | Phase 2 | Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection for Remnant Gastric Cancer | June 3, 2022 | April 1, 2028 |
| NCT06075849 | Recruiting | Phase 1 | Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent | October 25, 2023 | January 2025 |
| NCT05238883 | Recruiting | Phase 1 | A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors | March 10, 2022 | December 2026 |
| NCT04734821 | Recruiting | N/A | Fluorescence Image Guided Foregut Surgery | April 1, 2021 | April 1, 2024 |
| NCT04871412 | Recruiting | Phase 3 | The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage II | April 4, 2022 | December 1, 2025 |
| NCT05494060 | Recruiting | Phase 2 | XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma | March 16, 2022 | February 2027 |
| NCT03526835 | Recruiting | Phase 1/Phase 2 | A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors | May 2, 2018 | June 2025 |
| NCT06005493 | Recruiting | Phase 1/Phase 2 | Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors | July 11, 2023 | December 11, 2026 |
| NCT04675138 | Recruiting | Development of a Clinical Decision Support System With Artificial Intelligence for Cancer Care | August 20, 2020 | December 31, 2024 | |
| NCT05715632 | Recruiting | N/A | New Adjuvant Treatment of Locally Advanced Resectable Gastric Cancer With Carelizumab and XELOX | February 1, 2023 | March 1, 2025 |
| NCT06028724 | Recruiting | A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN) | May 26, 2023 | May 31, 2030 | |
| NCT04069273 | Recruiting | Phase 2 | Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma | December 1, 2020 | December 10, 2025 |
| NCT05551416 | Recruiting | The EpiGASTRIC/EDGAR Project: New Strategies for the Early Detection and Prevention of Gastric Cancer | September 9, 2021 | December 31, 2026 | |
| NCT06027242 | Recruiting | N/A | Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy | February 21, 2023 | August 30, 2026 |
| NCT05447221 | Recruiting | Automatic Evaluation of the Severity of Gastric Intestinal Metaplasia With Pathology Artificial Intelligence Diagnosis System | August 1, 2022 | December 31, 2023 | |
| NCT03924466 | Recruiting | Phase 2 | Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients | April 1, 2019 | December 2024 |
| NCT05720598 | Recruiting | N/A | Staging LaParoscopy to Assess Lymph NOde InvoLvement in Advanced GAstric Cancer | November 4, 2022 | November 4, 2024 |
| NCT00899626 | Recruiting | Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients | June 2002 | October 2030 | |
| NCT03874871 | Recruiting | Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients | March 20, 2019 | March 1, 2025 | |
| NCT03385018 | Recruiting | N/A | Trial for Application of Laparoscopic Total Gastrectomy With Lymph Node Dissection for Gastric Cancer (KLASS-06) | April 5, 2018 | December 31, 2027 |
| NCT05253053 | Recruiting | Phase 1/Phase 2 | To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | April 13, 2022 | December 2024 |
| NCT05360680 | Recruiting | Phase 1 | A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers | June 14, 2022 | December 2026 |
| NCT05853172 | Recruiting | Phase 2 | Surgical Conversion of Candonilimab (AK104) Plus Paclitaxel, S-1 and Apatinib for Unresectable Advanced G/GEJ Cancer | March 21, 2023 | December 21, 2025 |
| NCT05831488 | Recruiting | Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal Cancer | March 1, 2023 | March 1, 2024 | |
| NCT04631731 | Recruiting | Phase 1/Phase 2 | Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity | December 15, 2020 | December 10, 2025 |
| NCT06194981 | Recruiting | Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage | January 11, 2024 | May 31, 2024 | |
| NCT02562963 | Recruiting | Phase 1/Phase 2 | Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor | November 2015 | December 2024 |
| NCT06078982 | Recruiting | Phase 1 | Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric Cancer | June 6, 2023 | August 2025 |
| NCT06105515 | Recruiting | N/A | Laparoscopic and Endoscopic Collaborative Surgery as Rescue-treatment for Advanced Gastric Cancer | April 17, 2024 | February 1, 2027 |
| NCT05864144 | Recruiting | Phase 1/Phase 2 | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors | May 31, 2023 | June 2027 |
| NCT05871099 | Recruiting | Phase 3 | Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not | November 20, 2022 | November 20, 2039 |
| NCT03250091 | Recruiting | Surveillance of Patients With Precancerous Lesions of the Stomach | June 19, 2017 | December 2027 | |
| NCT06243757 | Recruiting | A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers | January 8, 2024 | January 8, 2036 | |
| NCT06349044 | Recruiting | N/A | A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies. | March 20, 2024 | December 31, 2025 |
| NCT05497739 | Recruiting | Phase 2 | Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer | June 28, 2022 | June 20, 2024 |
| NCT04808466 | Recruiting | Phase 2 | Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy | September 18, 2021 | September 1, 2025 |
| NCT04923932 | Recruiting | Phase 2 | Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients | July 27, 2021 | October 2025 |
| NCT06313801 | Recruiting | Phase 2 | Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions | January 19, 2023 | January 19, 2026 |
| NCT05566899 | Recruiting | N/A | Pilot Study of Stomach Cancer Early Detection and Prevention With Endoscopy | February 8, 2023 | August 1, 2024 |
| NCT03190941 | Recruiting | Phase 1/Phase 2 | Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients | September 21, 2017 | June 29, 2028 |
| NCT04447352 | Recruiting | Phase 3 | HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT) | December 17, 2020 | May 1, 2027 |
| NCT01342653 | Suspended | Phase 2 | Clinical Trial at Neoadjuvant Peritoneal and Systemic Chemotherapy Plus HIPEC in Gastric Carcinomatosis | January 2011 | January 2017 |
| NCT00209664 | Suspended | Phase 2 | Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer | January 2004 | December 2008 |
| NCT00209729 | Suspended | Phase 1/Phase 2 | Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer. | April 2005 | March 2010 |
| NCT00048529 | Suspended | Phase 2 | Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus | September 2002 | |
| NCT00568529 | Suspended | Phase 2 | Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer | October 2007 | February 2010 |
| NCT04714983 | Suspended | Phase 1 | DNX-2440 for Resectable Colorectal Liver Metastasis | February 15, 2021 | December 31, 2026 |
| NCT05101616 | Suspended | Phase 1/Phase 2 | A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer | July 1, 2022 | January 1, 2027 |
| NCT05233007 | Suspended | Upper GI Serial Tumour Biopsies | January 25, 2022 | October 2028 | |
| NCT04368702 | Suspended | N/A | CONFIRM: Magnetic Resonance Guided Radiation Therapy | May 1, 2021 | June 18, 2024 |
| NCT02908451 | Terminated | Phase 1 | A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer | April 24, 2017 | February 28, 2021 |
| NCT00394602 | Terminated | Chemoradiation-Induced Nausea and Emesis: Quality of Life | April 7, 2004 | May 8, 2019 | |
| NCT02393248 | Terminated | Phase 1/Phase 2 | Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) | February 27, 2015 | December 17, 2021 |
| NCT05579444 | Terminated | Systems Biology of Gastrointestinal and Related Diseases | November 11, 2022 | November 29, 2023 | |
| NCT01450696 | Terminated | Phase 3 | A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer | December 2011 | August 2015 |
| NCT03025152 | Terminated | N/A | Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Radical Gastrectomy for Gastric Cancer | November 11, 2016 | July 20, 2019 |
| NCT02346955 | Terminated | Phase 1 | Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001) | February 2015 | February 2017 |
| NCT00387348 | Terminated | Phase 3 | Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer | March 2006 | April 2011 |
| NCT03576131 | Terminated | Phase 1/Phase 2 | GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors | April 30, 2018 | October 12, 2021 |
| NCT00023634 | Terminated | Phase 1 | S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer | June 2001 | November 2008 |
| NCT02283359 | Terminated | Phase 1 | Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus | December 2014 | January 2016 |
| NCT04508140 | Terminated | Phase 2 | Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis | June 17, 2020 | December 2, 2022 |
| NCT01813253 | Terminated | Phase 3 | Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer | May 13, 2013 | February 19, 2018 |
| NCT00595985 | Terminated | Phase 2 | Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer | July 2007 | January 2009 |
| NCT02005484 | Terminated | Phase 2 | A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression | January 2004 | February 2008 |
| NCT02080416 | Terminated | Early Phase 1 | Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors | July 2014 | February 2016 |
| NCT01212887 | Terminated | Phase 1 | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer | August 2007 | April 2010 |
| NCT01697072 | Terminated | Phase 3 | First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma | October 2012 | August 2015 |
| NCT01683864 | Terminated | Phase 2/Phase 3 | Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer | September 2012 | May 2015 |
| NCT00354224 | Terminated | Phase 2 | Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer | January 2005 | August 2008 |
| NCT00903396 | Terminated | Phase 2 | Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer | September 2009 | May 2013 |
| NCT00004099 | Terminated | Phase 3 | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | July 1999 | |
| NCT03525392 | Terminated | Phase 1 | Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. | May 3, 2018 | April 28, 2021 |
| NCT00155883 | Terminated | Phase 2 | Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer | June 2004 | July 2005 |
| NCT00511576 | Terminated | Phase 1 | Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors | August 2007 | March 2009 |
| NCT02318901 | Terminated | Phase 1/Phase 2 | Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer | October 2014 | August 2018 |
| NCT05013554 | Terminated | Phase 1 | Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors | August 16, 2021 | January 15, 2024 |
| NCT02485834 | Terminated | Phase 2 | FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer | August 2015 | August 2018 |
| NCT05354856 | Terminated | Phase 4 | The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer. | March 11, 2022 | December 30, 2023 |
| NCT01260194 | Terminated | Phase 4 | A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer | June 2011 | January 2015 |
| NCT05363605 | Terminated | Phase 1/Phase 2 | A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours | April 20, 2022 | September 8, 2023 |
| NCT00503321 | Terminated | Phase 2/Phase 3 | Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma | October 2006 | August 2011 |
| NCT00683787 | Terminated | Phase 2 | Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | May 2008 | March 2011 |
| NCT04683939 | Terminated | Phase 1/Phase 2 | Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors | January 18, 2022 | July 24, 2023 |
| NCT01665274 | Terminated | Phase 2 | Efficiency of XELOX Neoadjuvant Chemotherapy in Gastric Cancer | September 2013 | September 2022 |
| NCT03511222 | Terminated | Phase 1 | Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors | September 11, 2018 | May 28, 2020 |
| NCT00130936 | Terminated | Phase 1/Phase 2 | Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates | October 2005 | November 2007 |
| NCT03253185 | Terminated | Phase 1 | A Study of SC-007 in Subjects With Advanced Cancer | September 13, 2017 | April 2, 2018 |
| NCT04106167 | Terminated | Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy | June 11, 2019 | August 11, 2023 | |
| NCT03721042 | Terminated | N/A | Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples | October 11, 2018 | October 1, 2020 |
| NCT00448682 | Terminated | Phase 2 | Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery | June 2005 | March 2010 |
| NCT01980810 | Terminated | Phase 2 | First Line Chemotherapy for Advanced Cancer | September 2013 | February 2016 |
| NCT02150447 | Terminated | Phase 3 | The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding | June 2009 | May 2017 |
| NCT05012397 | Terminated | Phase 2 | Milademetan in Advanced/Metastatic Solid Tumors | November 1, 2021 | October 15, 2023 |
| NCT02207959 | Terminated | Phase 1 | Gastric In Vivo Study | January 2015 | June 2015 |
| NCT00539968 | Terminated | Phase 1/Phase 2 | A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) | June 2007 | December 2009 |
| NCT02102022 | Terminated | Phase 1/Phase 2 | Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma | November 2014 | February 2020 |
| NCT01641939 | Terminated | Phase 2/Phase 3 | A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer | September 3, 2012 | April 30, 2016 |
| NCT03342417 | Terminated | Phase 2 | Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients | February 14, 2018 | May 29, 2019 |
| NCT00923052 | Terminated | The Natural History of Solid Organ Cancer Stem Cells (SOCSC) | February 9, 2009 | May 7, 2015 | |
| NCT03621982 | Terminated | Phase 1 | Study of ADCT-301 in Patients With Selected Advanced Solid Tumors | November 9, 2018 | December 14, 2022 |
| NCT01611506 | Terminated | Phase 1/Phase 2 | Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer | February 2012 | December 2012 |
| NCT00848783 | Terminated | Phase 2 | Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers | May 2008 | September 2012 |
| NCT02788214 | Terminated | Helicobacter Pylori Genome Project (HpGP) | July 27, 2016 | May 15, 2020 | |
| NCT01433861 | Terminated | Phase 3 | Laparoscopy-assisted Proximal Gastrectomy Versus and Laparoscopy-assisted Total Gastrectomy | July 2012 | November 2012 |
| NCT04077372 | Terminated | N/A | Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers | September 16, 2019 | October 11, 2020 |
| NCT01814345 | Terminated | Her 2 Testing in Indian Patients With Gastric Cancer | June 2013 | February 2017 | |
| NCT01365130 | Terminated | Phase 2 | Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen | June 2011 | August 2013 |
| NCT05233436 | Terminated | Phase 1 | PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors | February 24, 2022 | October 16, 2023 |
| NCT02358863 | Terminated | N/A | Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach | February 2015 | November 2016 |
| NCT02726399 | Terminated | Phase 2 | Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancer | March 18, 2016 | February 26, 2019 |
| NCT01457846 | Terminated | Phase 2 | Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer | November 2011 | February 2015 |
| NCT03150628 | Terminated | Phase 2 | Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study | August 1, 2017 | April 23, 2018 |
| NCT00103103 | Terminated | Phase 2 | Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer | March 2005 | August 2005 |
| NCT03471468 | Terminated | N/A | Kinetics of Microparticles Under Chemotherapy in Patients With Gastric or Pancreatic Cancer | July 23, 2018 | January 2, 2020 |
| NCT00524186 | Terminated | Phase 1 | Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer | May 2007 | April 2016 |
| NCT00012246 | Terminated | Phase 2 | Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | July 2002 | July 2006 |
| NCT00896467 | Terminated | Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy | September 2007 | November 2010 | |
| NCT03890198 | Terminated | Early Phase 1 | A Phase 1 Study of LCAR-C182A Cells in the Treatment of Advanced Gastric Cancer and Pancreatic Ductal Adenocarcinoma | April 22, 2019 | March 6, 2020 |
| NCT04178460 | Terminated | Phase 1 | A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment | February 3, 2020 | March 2, 2022 |
| NCT01702558 | Terminated | Phase 2 | A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC) | December 3, 2012 | May 31, 2017 |
| NCT05687617 | Terminated | Phase 2 | Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma. | December 15, 2022 | March 27, 2024 |
| NCT01219543 | Terminated | Phase 1 | A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase. | November 2010 | December 2012 |
| NCT02489214 | Terminated | Phase 1/Phase 2 | Donafenib Monotherapy for Previously Treated Metastatic Gastric Cancer | May 16, 2016 | June 13, 2019 |
| NCT00335959 | Terminated | Phase 2 | S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery | May 2006 | |
| NCT02137343 | Terminated | Phase 3 | A Phase 3 Study of Rilotumumab (AMG 102) With Cisplatin and Capecitabine (CX) as First-line Therapy in Gastric Cancer | July 2014 | June 2015 |
| NCT02720926 | Terminated | Phase 1 | Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer | September 2011 | January 2012 |
| NCT04933227 | Terminated | Phase 2 | A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ) | August 6, 2021 | November 17, 2023 |
| NCT00568971 | Terminated | Phase 2 | Study of Weekly DCF to Treat Advanced Gastric Cancer | April 2007 | June 2008 |
| NCT04510285 | Terminated | Phase 2 | A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection | August 10, 2020 | December 30, 2022 |
| NCT00165594 | Terminated | Phase 1/Phase 2 | A Study of E7070 in Patients With Gastric Cancer | February 2005 | August 2006 |
| NCT03840967 | Terminated | Phase 2 | A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma | July 9, 2019 | February 22, 2023 |
| NCT01716546 | Terminated | Phase 1/Phase 2 | Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric Cancer | July 2011 | January 2015 |
| NCT03707028 | Terminated | Phase 1/Phase 2 | A Study to Evaluate Safety, Tolerability, and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced Gastric or Gastroesophageal Junction Cancer | October 1, 2018 | August 24, 2021 |
| NCT04408599 | Terminated | Phase 1/Phase 2 | A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors | June 10, 2020 | July 7, 2023 |
| NCT01123473 | Terminated | Phase 2 | Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer | December 2010 | September 2014 |
| NCT04187872 | Terminated | Phase 1 | LITT and Pembrolizumab in Recurrent Brain Metastasis | January 10, 2020 | December 1, 2023 |
| NCT02748551 | Unknown status | Phase 3 | A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric Cancer | April 2016 | April 2022 |
| NCT04631757 | Unknown status | Phase 2 | Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma | December 15, 2020 | December 31, 2023 |
| NCT01787539 | Unknown status | Phase 2/Phase 3 | The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer | February 2013 | February 2022 |
| NCT04907864 | Unknown status | Phase 2 | Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE) | January 31, 2020 | June 30, 2022 |
| NCT03098758 | Unknown status | Molecular Analysis in Peritoneal Washing Citology for Locally Advanced Gastric Cancer | May 8, 2017 | April 2020 | |
| NCT02130752 | Unknown status | N/A | Ultrasonic Scalpel vs. Monopolar Electrocautery for D2 Distal Gastric Carcinoma Surgery | October 2014 | October 2022 |
| NCT01836120 | Unknown status | Phase 2 | A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer | April 2013 | June 2017 |
| NCT02817425 | Unknown status | Phase 2/Phase 3 | A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer | May 2013 | May 2019 |
| NCT04401124 | Unknown status | Status of Management of Surgery in Beijing During COVID-19 | May 25, 2020 | June 7, 2020 | |
| NCT01341756 | Unknown status | Phase 2 | Palliative Radiotherapy for Symptomatic Locally Advanced Gastric Cancer: A Phase II Trial | July 2009 | July 2012 |
| NCT02078362 | Unknown status | ADCC Against Gastric Cancer Cells | September 2013 | May 2018 | |
| NCT04843397 | Unknown status | Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO Study | June 1, 2021 | September 15, 2022 | |
| NCT01180166 | Unknown status | Phase 2 | Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer | May 2010 | September 2013 |
| NCT04517448 | Unknown status | Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy | October 16, 2020 | March 15, 2022 | |
| NCT04235556 | Unknown status | Integrated Care Pathway in Oncology (PASSION) | February 21, 2020 | December 31, 2022 | |
| NCT02292914 | Unknown status | N/A | Prospective Analysis of Robot-Assisted Surgery | March 10, 2014 | July 10, 2020 |
| NCT04005365 | Unknown status | Phase 2 | Clinical Study of Propranolol Combined With Neoadjuvant Chemotherapy in Gastric Cancer | November 20, 2019 | June 1, 2020 |
| NCT03021200 | Unknown status | N/A | Laser Fluorescence in Cancer Surgical Treatment | July 12, 2016 | December 10, 2020 |
| NCT05275062 | Unknown status | Early Phase 1 | Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma | February 15, 2022 | May 1, 2024 |
| NCT04913896 | Unknown status | CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy | June 1, 2021 | June 1, 2023 | |
| NCT04281576 | Unknown status | N/A | Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Chemotherapy as First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma | December 19, 2019 | September 2021 |
| NCT04086888 | Unknown status | Real World Study of Immune Checkpoint Inhibitors for Advanced Gastric Cancer | December 12, 2016 | June 20, 2020 | |
| NCT01088204 | Unknown status | Phase 2 | Feasibility Study of Laparoscopy-assisted D2 Distal Gastrectomy to Treat Advanced Gastric Cancer | June 2010 | December 2016 |
| NCT03393403 | Unknown status | N/A | Comparison of the Effect of Intravenous and Perineural Dexmedetomidine in Gastric Cancer Surgery | December 23, 2017 | December 31, 2020 |
| NCT04139070 | Unknown status | Phase 1 | Electrochemotherapy for Non-curable Gastric Cancer | June 15, 2020 | July 1, 2021 |
| NCT02549911 | Unknown status | Phase 2 | HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis | September 2015 | September 2017 |
| NCT02674373 | Unknown status | Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer Treatment | September 2015 | September 2019 | |
| NCT04835246 | Unknown status | N/A | Evaluating Diagnostic Performance of Spectra IMDx System for Detection of Gastric Cancer and Precancerous Lesions | October 7, 2019 | July 31, 2021 |
| NCT00004236 | Unknown status | Phase 2 | Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer | August 1998 | |
| NCT04713891 | Unknown status | Phase 1 | A Study of KF-0210 in Advanced Solid Tumors Patients | March 9, 2021 | December 31, 2022 |
| NCT03156777 | Unknown status | Application Value of CTCs Detection for Advanced Gastric Cancer Patients | January 2016 | December 2020 | |
| NCT04278222 | Unknown status | Phase 2 | Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric or Gastro-esophageal Junction Cancer (APICAL-GE) | February 10, 2020 | August 31, 2022 |
| NCT02461407 | Unknown status | Phase 2/Phase 3 | Study of Anlotinib in Patients With Gastric Cancer(ALTER0503) | June 2015 | December 2017 |
| NCT01803503 | Unknown status | Phase 2 | Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors | May 2013 | April 2018 |
| NCT03219593 | Unknown status | Phase 2 | Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer | September 7, 2017 | February 2020 |
| NCT03392103 | Unknown status | Phase 2 | Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical Resection | January 2017 | December 2019 |
| NCT03931044 | Unknown status | N/A | Fluorescence Image-Guided Lymphadenectomy in Robotic Gastrectomy | April 2019 | June 2020 |
| NCT03229096 | Unknown status | Phase 2 | Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer | February 1, 2017 | December 1, 2021 |
| NCT01178775 | Unknown status | N/A | Development and Validation of Perceived Fatigue Meaning Scale on Walking Program | September 2008 | December 2011 |
| NCT04632459 | Unknown status | Phase 2 | Pembrolizumab Plus Ramucirumab in Metastatic Gastric Cancer | June 16, 2021 | December 1, 2022 |
| NCT04351321 | Unknown status | N/A | The Safety of Totally Laparoscopic Versus Laparoscopy-Assisted Total Gastrectomy. | July 2020 | August 2023 |
| NCT05061082 | Unknown status | Genomic Evolution of Metastasis in Gastric Cancer | October 26, 2021 | October 31, 2022 | |
| NCT04440800 | Unknown status | Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment | July 2020 | September 2021 | |
| NCT01627119 | Unknown status | The Functional and Clinicopathological Roles and Therapeutic Implication of Connective Tissue Growth Factor in Peritoneal Metastasis of Gastric Cancer | July 2009 | June 2012 | |
| NCT04864821 | Unknown status | Early Phase 1 | Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor | May 14, 2021 | May 14, 2023 |
| NCT01527409 | Unknown status | N/A | The Efficacy of Health Partnership Program for Cancer Patients | February 2012 | June 2013 |
| NCT03939962 | Unknown status | Phase 2 | Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma | July 24, 2019 | May 30, 2024 |
| NCT01160419 | Unknown status | Phase 2 | Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer | December 2009 | May 2014 |
| NCT01704664 | Unknown status | N/A | Perioperative Immunonutrition, Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patients | March 2007 | October 2022 |
| NCT02215837 | Unknown status | Phase 2 | Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer | August 2014 | May 2018 |
| NCT01167049 | Unknown status | Phase 2 | Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis | August 2009 | December 2013 |
| NCT03333967 | Unknown status | The Real World Study of Apatinib for Gastric Cancer Treatment in Anhui Province | September 1, 2017 | September 1, 2020 | |
| NCT02172690 | Unknown status | N/A | Laparoscopic Staging for Locally Advanced Gastric Cancer in Chinese Patients | June 2014 | December 2017 |
| NCT01798251 | Unknown status | Phase 2 | XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach | December 2012 | December 2015 |
| NCT02500199 | Unknown status | Phase 1 | Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors | June 2015 | June 2021 |
| NCT00961077 | Unknown status | Phase 2 | Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer | August 2009 | August 2012 |
| NCT01764087 | Unknown status | Phase 1/Phase 2 | A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors | December 2012 | May 2016 |
| NCT01228045 | Unknown status | Phase 2 | A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer | February 2011 | December 2016 |
| NCT02805829 | Unknown status | Phase 1/Phase 2 | Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer | January 2017 | January 2020 |
| NCT03013712 | Unknown status | Phase 1/Phase 2 | A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer | January 2017 | December 2020 |
| NCT03271073 | Unknown status | Phase 2 | A Study of Apatinib Combined With S1 in Patients With Advanced Gastric Cancer | February 1, 2016 | January 31, 2019 |
| NCT02800005 | Unknown status | N/A | Effect of Obesity on Surgical Outcomes and Survival for Gastric Cancer | July 2015 | December 2017 |
| NCT01962376 | Unknown status | Phase 4 | Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasis | February 2013 | April 2015 |
| NCT00447746 | Unknown status | N/A | A Comparison Between D1 and D2 Lymphadenectomy in Gastric Cancer : A Prospective Randomized Controlled Trial | March 2007 | March 2014 |
| NCT05039333 | Unknown status | Clinical Study to Prove Safety and Effectiveness When Applying RUS™ Surgical Navigation | September 1, 2021 | June 23, 2022 | |
| NCT02226380 | Unknown status | Phase 2 | FOLFOX6 as Neoadjuvant Chemotherapy in Local Advanced Gastric Cancer | October 2013 | |
| NCT04777162 | Unknown status | Phase 2 | Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer | March 2021 | May 2023 |
| NCT02961296 | Unknown status | Helicobacter Pylori Antibiotic Susceptibility Testing of Korea | October 2016 | December 2018 | |
| NCT02510469 | Unknown status | Phase 2/Phase 3 | Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells | July 2015 | July 2018 |
| NCT02311595 | Unknown status | Phase 2 | A Phase II Clinical Trial of Reduced Port Totally Laparoscopic Distal Gastrectomy With D2 Lymph Node Dissection | December 2014 | March 2015 |
| NCT03733639 | Unknown status | Phase 4 | Tisseel® as a Reinforcement of Esophagojejunal Anastomoses | July 21, 2020 | July 1, 2022 |
| NCT01766765 | Unknown status | Phase 4 | Early Jejunostomy Nutrition Minimizes Time to Chemotherapy | April 2013 | June 2014 |
| NCT03952442 | Unknown status | N/A | Nutrition Education Program for Postoperative Patients With Gastric Cancer | February 21, 2019 | December 31, 2020 |
| NCT04288661 | Unknown status | N/A | Perianastomotic Drain After Gastrectomy (DRAG) | February 28, 2020 | June 2024 |
| NCT04000425 | Unknown status | Potential Clinical Utilities of Circulating Tumor DNA in Gastric Cancer | December 1, 2018 | May 31, 2021 | |
| NCT00591045 | Unknown status | Phase 2 | Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer | January 2008 | December 2012 |
| NCT03478449 | Unknown status | N/A | The Criteria for Lymph Node Sorting for Pathological Examination in Gastric Cancer | April 1, 2018 | December 30, 2020 |
| NCT02537171 | Unknown status | Phase 3 | Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer | July 2015 | October 2016 |
| NCT01558947 | Unknown status | Phase 2 | Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer | January 2011 | June 2013 |
| NCT02572050 | Unknown status | Phase 2 | Assessment of a Robotic Distal Gastrectomy on Non-inferiority of N2 Area Nodal Dissection | October 2015 | December 2021 |
| NCT04842916 | Unknown status | InteGRAtive Analysis of tuMor, Microenvironment, immunitY and Patient Expectation for Personalized Response Prediction in Gastric Cancer | September 22, 2020 | September 22, 2023 | |
| NCT01905969 | Unknown status | Predictive Biomarkers in Stage II/III Gastric Cancer for Adjuvant Chemotherapy | October 2012 | March 2016 | |
| NCT02352571 | Unknown status | Phase 1 | Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer | January 2015 | June 2017 |
| NCT03398226 | Unknown status | Bone Microstructure After Gastrectomy Evaluating by Using HR-pQCT | September 18, 2017 | March 31, 2023 | |
| NCT04555304 | Unknown status | Phase 2 | Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy | September 15, 2020 | January 15, 2022 |
| NCT03517332 | Unknown status | Circulating Tumor DNA Exposure in Peripheral Blood | January 1, 2015 | December 31, 2019 | |
| NCT01910948 | Unknown status | Phase 4 | Perioperative Application of Omega-3 Polyunsaturated Fatty Acids in Gastric Cancer Patients | June 2013 | March 2014 |
| NCT04607057 | Unknown status | Phase 4 | Supplemental Parenteral Nutrition During Postgastrectomy in Nutritionally at Risk Patient | December 22, 2020 | October 30, 2022 |
| NCT01584336 | Unknown status | Phase 2 | Laparoscopy-assisted Total Gastrectomy for Clinical Stage I Gastric Cancer (KLASS-03) | October 2012 | March 2014 |
| NCT02644148 | Unknown status | Phase 2 | Uncut Roux-en-Y Gastrojejunostomy for Early Gastric Cancer Patients | February 2016 | February 2019 |
| NCT01863420 | Unknown status | The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy to GI Cancer | November 2012 | October 2015 | |
| NCT05228743 | Unknown status | N/A | Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer | September 1, 2020 | October 31, 2023 |
| NCT02509806 | Unknown status | Phase 2/Phase 3 | Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer | July 2015 | December 2017 |
| NCT02980861 | Unknown status | Phase 3 | Laparoscopic Versus Open Gastrectomy With Splenic Hilum Lymph Nodes Dissection | January 2017 | June 2020 |
| NCT02426762 | Unknown status | Phase 2 | Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery | February 2015 | October 2015 |
| NCT02041312 | Unknown status | Serum Cholesterol and Gastric Neoplasm | February 2014 | June 2019 | |
| NCT03941626 | Unknown status | Phase 1/Phase 2 | Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies | September 1, 2019 | December 1, 2021 |
| NCT03575637 | Unknown status | Phase 2 | Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer | July 2018 | June 2021 |
| NCT03813784 | Unknown status | Phase 3 | A Study to Evaluate SHR-1210 in Combination With Capecitabine + Oxaliplatin Sequenced by SHR-1210 + Apatinib as First-line Therapy in Treatment of Advanced Gastric Cancer | March 7, 2019 | March 2023 |
| NCT04869618 | Unknown status | N/A | Validation of an Artificial Intelligence System Based on Raman Spectroscopy for Diagnosis of Gastric Premalignant Lesions and Early Gastric Cancer | May 2021 | March 2023 |
| NCT03065257 | Unknown status | Endoscopic Resection Multicenter Registry | March 15, 2017 | April 2020 | |
| NCT02436395 | Unknown status | N/A | Povidone-iodine and the Normal Saline Cleaning the Incision for the SSIs | May 2015 | December 2018 |
| NCT01464918 | Unknown status | N/A | Safety and Efficacy of Using MASTER to Perform Endoscopic Submucosal Dissection in Human | November 2011 | December 2012 |
| NCT01963702 | Unknown status | Phase 2 | A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGC | August 2012 | December 2014 |
| NCT05019794 | Unknown status | Phase 2 | Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations | May 13, 2020 | December 30, 2023 |
| NCT04782791 | Unknown status | Phase 2 | Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric Cancer | May 1, 2022 | May 31, 2024 |
| NCT03601988 | Unknown status | Phase 3 | Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric Cancer | July 28, 2018 | July 28, 2022 |
| NCT03121729 | Unknown status | N/A | Enhanced Recovery After Surgery Program for Gastric Cancer: a Multi-center Study | June 21, 2017 | December 2018 |
| NCT04657848 | Unknown status | N/A | Preliminary Efficacy Analysis of Cheng's Giraffe Reconstruction After Proximal Gastrectomy | June 1, 2020 | June 1, 2023 |
| NCT01305993 | Unknown status | Phase 2 | Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric Cancer | May 2011 | |
| NCT03236051 | Unknown status | N/A | Multimodal Analgesia in Laparoscopic Radical Gastrectomy With Gastric Cancer: a Multi-center Study | February 10, 2017 | August 30, 2018 |
| NCT02464215 | Unknown status | N/A | Effect of Laparoscopy-Assisted Distal Gastrectomy for Locally Advanced Gastric Cancer | March 1, 2014 | August 31, 2020 |
| NCT02784470 | Unknown status | Phase 3 | Study of Gastroduodenal Metallic Stent vs Gastrojejunostomy | October 2015 | January 2020 |
| NCT05287672 | Unknown status | Retrospective Study of Effect of Adjuvant Chemoradiation of Gastric Carcinoma on Local Control and Survival | June 2022 | December 2023 | |
| NCT00134095 | Unknown status | Phase 2 | S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer | September 2004 | |
| NCT04652986 | Unknown status | Outcomes of Laparoscopic Gastrectomy | January 2004 | December 2022 | |
| NCT04980950 | Unknown status | N/A | "The Impact of Immunonutrition on Gut Microbiota-related Aspects in Colorectal Cancer and Gastric Cancer Patients" | August 1, 2021 | July 1, 2022 |
| NCT00985556 | Unknown status | Phase 2 | Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer | January 2009 | |
| NCT02179463 | Unknown status | Compare Different Response Evaluations to Neoadjuvant Chemotherapy for Gastric Cancer | June 2014 | December 2017 | |
| NCT02640898 | Unknown status | N/A | Docetaxel-based Chemoradiotherapy Plus Periradiation Chemotherapy Compared With INT 0116 Adjuvant Arm in Gastric Cancer | December 2015 | December 2022 |
| NCT04198051 | Unknown status | N/A | The Clinical Study of Adjuvant Chemotherapy on Intestinal and Urethral Flora in Patients With Gastric and Colon Cancer | December 20, 2019 | May 1, 2021 |
| NCT03708783 | Unknown status | N/A | Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for AGC | July 1, 2018 | December 30, 2023 |
| NCT00183898 | Unknown status | Phase 2 | Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer | December 28, 2004 | December 28, 2019 |
| NCT02942329 | Unknown status | Phase 1/Phase 2 | Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer | October 2016 | October 2018 |
| NCT05397548 | Unknown status | Use of Circulating Exosomal LncRNA-GC1 to Monitor Gastric Cancer | May 1, 2022 | December 2023 | |
| NCT03015675 | Unknown status | Phase 3 | IV Ascorbic Acid in Advanced Gastric Cancer | March 12, 2017 | December 2019 |
| NCT02216955 | Unknown status | Nutrition and Lifestyle Study Cohort of Gastric Cancer in China | January 2009 | ||
| NCT01679340 | Unknown status | Phase 2 | A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery | April 2011 | June 2018 |
| NCT03478943 | Unknown status | The Real World Study of Apatinib for Gastric Cancer Treatment in Henan Province | January 30, 2016 | December 1, 2020 | |
| NCT05203549 | Unknown status | Consistency Between Treatment Responses in PDO Models and Clinical Outcomes in Gastric Cancer | May 1, 2021 | June 30, 2023 | |
| NCT01271582 | Unknown status | Phase 4 | Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients | January 2009 | December 2019 |
| NCT02024217 | Unknown status | Phase 2 | Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric Carcinoma | March 2012 | August 2015 |
| NCT01795768 | Unknown status | Phase 2 | Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours | September 2012 | September 2015 |
| NCT01456455 | Unknown status | Gastric Cancer Metastasized to the Central Nervous System (CNS) | August 2011 | August 2020 | |
| NCT04501887 | Unknown status | The Efficacy of Precision Treatment for Gastric Cancer Guided by Molecular Profiling | January 1, 2021 | July 1, 2023 | |
| NCT01996059 | Unknown status | Phase 3 | Functional Jejunal Interposition Improve Nutritional Status After Total Gastrectomy | July 2012 | June 2022 |
| NCT02529878 | Unknown status | Phase 2 | Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancer | August 2015 | August 2019 |
| NCT02915393 | Unknown status | System Biology of Spleen Deficiency Syndrome | September 2016 | December 2019 | |
| NCT05095636 | Unknown status | Phase 2 | Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer | March 17, 2021 | September 2023 |
| NCT04258644 | Unknown status | Phase 2 | Camrelizumab in Combination With Apatinib Mesylate, Paclitaxel-albumin and S-1 for Translational Treatment of Gastric Cancer | March 1, 2020 | February 28, 2023 |
| NCT01978444 | Unknown status | N/A | Study on Laparoscopic D2 Lymphadenectomy Plus Complete Mesogastrium Excision（D2+CME）for Advanced Gastric Cancer | September 2014 | October 2023 |
| NCT04062058 | Unknown status | Phase 2 | A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer | November 20, 2019 | September 21, 2023 |
| NCT01836991 | Unknown status | Phase 2 | D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer | January 2012 | January 2017 |
| NCT02110628 | Unknown status | Phase 3 | Roux-en-Y vs. Roux-en-Y+ Pouch for D2 Total Gastrectomy | August 2014 | August 2022 |
| NCT02833363 | Unknown status | Difference of Gastric Microbiota in the Process of Correa's Model. | July 2016 | February 2017 | |
| NCT02694081 | Unknown status | Phase 2 | The Advantages and Disadvantages Between Uncut Roux-en-Y Reconstruction and Billroth II Reconstruction After Laparoscopy-assisted Distal Gastrectomy for Gastric | February 2016 | February 2017 |
| NCT02596256 | Unknown status | Phase 2 | Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301) | April 2016 | February 2019 |
| NCT02525237 | Unknown status | Phase 2 | Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer | August 2015 | August 2017 |
| NCT02806661 | Unknown status | N/A | Comparison of Vagus Nerve-preserving RADG and Conventional RADG for AGC | July 2016 | July 2018 |
| NCT04410887 | Unknown status | Phase 1/Phase 2 | Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC) | December 2020 | March 2022 |
| NCT02641925 | Unknown status | N/A | Omentectomy for Metabolic Syndrome in Gastric Cancer Patients | August 2015 | August 2020 |
| NCT03428425 | Unknown status | Phase 2 | A Study of HIPEC Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells | February 2018 | January 2024 |
| NCT04006821 | Unknown status | Phase 2 | PD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric Adenocarcinoma | July 25, 2019 | August 1, 2022 |
| NCT02030561 | Unknown status | Phase 1/Phase 2 | NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer | January 2014 | August 2018 |
| NCT01100814 | Unknown status | Expression of S100A2 and Trefoil Factor Family Members in Epstein-Barr Virus Related Gastric Cancer | September 2011 | December 2014 | |
| NCT03413514 | Unknown status | N/A | Real World Evidence for the Cycle of Neoadjuvant Chemotherapy in Gastric Cancer With Shared Decision Making | January 3, 2018 | January 3, 2023 |
| NCT05390684 | Unknown status | Predictive Model to Early Diagnosis of Anastomotic Leak After Esophagectomy and Gastrectomy. | May 1, 2022 | December 31, 2023 | |
| NCT01795027 | Unknown status | Phase 3 | Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer | September 2011 | June 2018 |
| NCT04358341 | Unknown status | Phase 2 | Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer | June 17, 2020 | December 1, 2022 |
| NCT01542294 | Unknown status | Phase 1/Phase 2 | SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer | June 2011 | April 2017 |
| NCT04385316 | Unknown status | Clinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid Biopsy | September 1, 2019 | December 31, 2020 | |
| NCT02008422 | Unknown status | Phase 3 | Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer | August 2013 | August 2016 |
| NCT04367025 | Unknown status | Phase 2 | Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer | May 2020 | May 2023 |
| NCT03257280 | Unknown status | N/A | Trial on Impact on the Hospital Stay, of an Early Oral Nutrition Protocol Applied to Patients After Total Gastrectomy. (DOPGT_2015) | October 20, 2017 | September 2023 |
| NCT02325453 | Unknown status | Robotic, Laparoscopic and Open Surgery for Gastric Cancer Compared on Surgical, Clinical and Oncological Outcomes | May 2015 | January 2020 | |
| NCT05071755 | Unknown status | Gastrectomy Outcomes in Elderly Patients | November 1, 2021 | March 1, 2022 | |
| NCT01739894 | Unknown status | Phase 2 | Feasibility Study of Intraperitoneal Paclitaxel | January 2013 | August 2018 |
| NCT01090505 | Unknown status | Phase 2 | Study of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer | November 2009 | December 2015 |
| NCT01426646 | Unknown status | Phase 2 | S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer | September 2011 | September 2016 |
| NCT01718626 | Unknown status | Phase 2 | Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric Cancer | October 2012 | December 2014 |
| NCT03638206 | Unknown status | Phase 1/Phase 2 | Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies | March 1, 2018 | March 1, 2023 |
| NCT02413476 | Unknown status | Phase 2/Phase 3 | Comparison of Surgical,Clinical and Oncological Outcomes Between Robotic-assisted and Laparoscopic-assisted Gastrectomy | May 2015 | May 2018 |
| NCT01889303 | Unknown status | Phase 2 | Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer | May 2013 | December 2023 |
| NCT03734926 | Unknown status | Phase 1 | A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors | November 13, 2018 | October 31, 2021 |
| NCT04071184 | Unknown status | Phase 1 | Study of Alofanib in Patients With Metastatic Gastric Cancer | May 26, 2019 | December 1, 2020 |
| NCT02248519 | Unknown status | N/A | Laparoscopic Versus Open Gastrectomy for Gastric Cancer | December 2014 | December 2023 |
| NCT03801668 | Unknown status | Phase 3 | Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma | March 8, 2019 | March 31, 2023 |
| NCT05430841 | Unknown status | N/A | Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT | June 1, 2022 | December 31, 2023 |
| NCT02583659 | Unknown status | The First-line Combined Chemotherapy for Advanced Gastric Cancer: A Prospective Observational Clinical Study | January 2013 | January 2018 | |
| NCT04957407 | Unknown status | The Research of Constructing a Risk Assessment Model for Gastric Cancer Based on Machine Learning | January 1, 2019 | December 31, 2022 | |
| NCT02901301 | Unknown status | Phase 1/Phase 2 | Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer | February 6, 2017 | October 2021 |
| NCT01468389 | Unknown status | Phase 3 | Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric Junction | November 2011 | June 2013 |
| NCT02349724 | Unknown status | Phase 1 | A Clinical Research of CAR T Cells Targeting CEA Positive Cancer | December 2014 | December 2019 |
| NCT03001726 | Unknown status | To Observe the Efficacy and Safety by Comparing Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With Radical Resection Versus Chemotherapy Alone in Advanced Gastric Cancer With Single Non-curable Factor. | January 2017 | December 2023 | |
| NCT00178698 | Unknown status | Phase 2 | Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors | July 2002 | June 2014 |
| NCT02623153 | Unknown status | Phase 2 | Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer | January 2016 | December 2019 |
| NCT03613142 | Unknown status | N/A | Comparison Between Double Tract Anastomosis and Esophagogastrostomy After Radical Proximal Gastrectomy | January 1, 2019 | December 30, 2021 |
| NCT04147481 | Unknown status | N/A | Effects of Abdominal Nerve Block on Postoperative Recovery in Patients Undergoing Gastrointestinal Surgery | October 21, 2019 | December 31, 2020 |
| NCT02404753 | Unknown status | Phase 2 | A Comparison of Laparoscopic With Open Distal Gastrectomy in Advanced Gastric Cancer After Neoadjuvant Chemotherapy | April 2015 | November 25, 2022 |
| NCT03221400 | Unknown status | Phase 1/Phase 2 | PEN-866 in Patients With Advanced Solid Malignancies | August 29, 2017 | June 2023 |
| NCT02602249 | Unknown status | Phase 1 | Clinical Safety and Preliminary Efficacy of MUC1-DC-CTL Treatment in Stage IV Gastric Cancer. | October 2017 | April 2020 |
| NCT03480256 | Unknown status | Phase 1 | Study to Evaluate SHR6390 Combined With Pyrotinib in Patients With HER2 Positive Gastric Cancer | July 27, 2018 | August 2020 |
| NCT01198392 | Unknown status | Phase 3 | Trial of S-1 Plus Cisplatin in Gastric Cancer | September 2008 | December 2011 |
| NCT01779583 | Unknown status | Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients ("EXO-PPP Study") | January 2013 | ||
| NCT01927328 | Unknown status | Phase 4 | Iron Replacement in Oesophagogastric Neoplasia | August 2013 | August 2017 |
| NCT01747707 | Unknown status | Phase 2 | Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer | September 2012 | May 2014 |
| NCT03668418 | Unknown status | Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos | June 1, 2018 | May 31, 2022 | |
| NCT00677456 | Unknown status | Phase 1 | Evaluation of Four Reconstructions After Total Gastrectomy | January 2008 | January 2013 |
| NCT02595086 | Unknown status | N/A | Comparison of Laparoscopic Pylorus Preserving Gastrectomy Versus Laparoscopic Distal Gastrectomy | July 2015 | June 2023 |
| NCT00722228 | Unknown status | Phase 1/Phase 2 | Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors | July 2008 | January 2022 |
| NCT02436018 | Unknown status | N/A | WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal Endoscopy | March 2015 | November 2016 |
| NCT03453164 | Unknown status | Phase 1/Phase 2 | Checkpoint Inhibitor and Radiotherapy for Recurrent Gastric Cancer (CIRCUIT) | March 28, 2018 | February 28, 2021 |
| NCT03273920 | Unknown status | N/A | Robotic Versus Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer | September 25, 2017 | September 25, 2022 |
| NCT04778345 | Unknown status | N/A | Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric Cancer | March 2021 | March 2023 |
| NCT04637048 | Unknown status | Observational Study on Patients With Hepatobiliary Tumors | February 16, 2017 | December 1, 2023 | |
| NCT01283893 | Unknown status | Standardization of D2 Lymphadenectomy and Surgical Quality Control: KLASS-02-QC | December 2010 | August 2013 | |
| NCT04915807 | Unknown status | Real-world Data (RWD) of Ramucirumab Plus Paclitaxel | June 2021 | September 2023 | |
| NCT03276156 | Unknown status | Phase 1 | Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer | February 23, 2016 | February 22, 2018 |
| NCT03958812 | Unknown status | Diagnostic Power Comparison Between VOCs and CTCs | June 15, 2019 | December 31, 2020 | |
| NCT03117023 | Unknown status | Phase 3 | The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer | April 15, 2017 | June 1, 2017 |
| NCT03960060 | Unknown status | Phase 1 | A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors | May 16, 2019 | June 30, 2023 |
| NCT03484949 | Unknown status | N/A | Web-Mediated Risk Assessment for Endoscopic Screening of Gastric Cancer | December 1, 2017 | December 1, 2020 |
| NCT02756455 | Unknown status | Procalcitonin Reveals Early Dehiscence in Gastric Surgery: the PREDIGS Study | January 2015 | December 2016 | |
| NCT02662348 | Unknown status | Phase 1 | T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System | February 2016 | November 2017 |
| NCT01406249 | Unknown status | Phase 2 | XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancer | August 2011 | December 2017 |
| NCT05051423 | Unknown status | "Mechanisms and Biomarkers of Response and Resistance to Current Targeted Therapies in Gastric Cancer" (THERRES) | November 1, 2019 | January 2022 | |
| NCT03680261 | Unknown status | Phase 3 | Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy | October 1, 2018 | September 30, 2023 |
| NCT00172861 | Unknown status | Cyclooxygenase-2-Associated Factors and Gastric Carcinogenesis Mechanisms-Clinical Association and Genomic Investigation | January 2005 | ||
| NCT01528059 | Unknown status | Phase 2/Phase 3 | Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes | February 2012 | March 2013 |
| NCT00980603 | Unknown status | Phase 2 | Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer | November 2008 | May 2011 |
| NCT01662739 | Unknown status | Cremona Population-Based Gastric Tumors Registry | January 2010 | December 2018 | |
| NCT01412294 | Unknown status | Phase 2 | XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer | July 2011 | December 2017 |
| NCT01227772 | Unknown status | Phase 1/Phase 2 | Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer | November 2010 | June 2017 |
| NCT02607826 | Unknown status | N/A | Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors | November 2016 | March 2019 |
| NCT02852096 | Unknown status | N/A | Assessing Her2/Neu Expression in Gastric Cancer With Dual or Multiple Tumor Tissue Paraffin Blocks | November 2015 | December 2019 |
| NCT03179579 | Unknown status | Phase 3 | Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric Cancer | August 1, 2017 | August 1, 2022 |
| NCT01197118 | Unknown status | Phase 2 | Postoperative Sequence Chemoradiotherapy Compared With Chemotherapy Alone for Advanced Gastric Cancer | September 2010 | May 2011 |
| NCT04342910 | Unknown status | Phase 3 | Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC | September 21, 2020 | September 1, 2022 |
| NCT00343668 | Unknown status | Phase 2 | S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer | September 2005 | July 2008 |
| NCT05029453 | Unknown status | Phase 4 | Apatinib Combined With Chemotherapy Versus Chemotherapy in Second-line Gastric Cancer Receiving Prior Anti-PD-1 Therapy | August 26, 2021 | March 3, 2023 |
| NCT01471132 | Unknown status | Phase 2 | Sequential HIPEC of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum Metastasis | September 2011 | September 2015 |
| NCT00553683 | Unknown status | Phase 1/Phase 2 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | October 2007 | July 2014 |
| NCT05410535 | Unknown status | Phase 4 | To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy | September 15, 2021 | September 30, 2022 |
| NCT04136600 | Unknown status | Phase 2 | EGFR Monoclonal Antibody for Advanced Gastric Cancer | July 1, 2019 | December 31, 2021 |
| NCT01675258 | Unknown status | Identifying Saliva Markers of Patients With Stomach, Colorectal (Including Pre-cancer Polyp) and Pancreatic Cancers | September 2012 | ||
| NCT01637350 | Unknown status | Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes | August 2012 | December 2016 | |
| NCT02867839 | Unknown status | Phase 3 | Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer | April 24, 2017 | February 10, 2024 |
| NCT02272894 | Unknown status | A Trial to Evaluate the Superior Mesenteric Vein (14V) Lymphadenectomy for Distal Advanced Gastric Cancer | July 2014 | December 2016 | |
| NCT03598348 | Unknown status | Phase 3 | Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer | January 16, 2018 | October 16, 2020 |
| NCT01655641 | Unknown status | Phase 2/Phase 3 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery | July 2012 | July 2014 |
| NCT02585908 | Unknown status | Phase 1/Phase 2 | Safety and Efficacy of γδ T Cell Against Gastric Cancer | December 2019 | December 2022 |
| NCT01650766 | Unknown status | Study of S1 Efficacy and Toxicity as Second-line Treatment on Inoperable or Advanced Gastric Cancers | February 2012 | October 2012 | |
| NCT01979549 | Unknown status | Adverse Events During Upper Gastrointestinal Endoscopy | December 2013 | December 2014 | |
| NCT05100446 | Unknown status | Early Phase 1 | Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection | May 1, 2021 | December 31, 2022 |
| NCT03642093 | Unknown status | Phase 4 | HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo Surgery | August 1, 2018 | May 2019 |
| NCT02776527 | Unknown status | Phase 4 | A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant Chemotherapy | April 2016 | April 2017 |
| NCT00197431 | Unknown status | Phase 2 | Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer | January 2004 | |
| NCT04202484 | Unknown status | Phase 2 | Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma | February 1, 2020 | February 1, 2023 |
| NCT03277144 | Unknown status | N/A | Incidence of Duodenal Stump Fistula After Gastrectomy for Gastric Cancer. A Randomized Controlled Trial | September 11, 2017 | October 1, 2019 |
| NCT04251403 | Unknown status | Early Phase 1 | Novel Approach to Surveillance of Gastric Lesions | February 2020 | February 2021 |
| NCT00172627 | Unknown status | Association and Mechanism Between Cyclooxygenase-2 and Interleukin-6 in Gastric Cancer | January 2005 | ||
| NCT02970539 | Unknown status | Phase 1 | Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers | December 8, 2016 | December 31, 2022 |
| NCT00075465 | Unknown status | Phase 2 | Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach | April 2001 | |
| NCT01375738 | Unknown status | N/A | Improving Diabetes by Reconstruction Methods in Gastric Cancer Patients With Diabetes Mellitus | July 2011 | May 2014 |
| NCT01444755 | Unknown status | The Effect of Neoadjuvant Chemotherapy on Locally Advanced Gastric Cancer | January 2009 | April 2012 | |
| NCT03485105 | Unknown status | Prediction of Benefit From Adjuvant Chemotherapy for pT1N1 Gastric Cancer | November 1, 2017 | November 1, 2019 | |
| NCT02648841 | Unknown status | Phase 3 | A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection. | July 2015 | June 2022 |
| NCT00005607 | Unknown status | Phase 2 | Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus | February 2000 | |
| NCT00010270 | Unknown status | Phase 1 | LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | April 2001 | |
| NCT00197470 | Unknown status | N/A | Cytokine Gene Polymorphisms in Gastric Diseases | January 2000 | |
| NCT01674959 | Unknown status | Phase 2 | Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients | October 2011 | December 2017 |
| NCT00674167 | Unknown status | Phase 2 | The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinoma | May 2007 | December 2017 |
| NCT02356276 | Unknown status | Phase 3 | Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2 | May 11, 2015 | January 2022 |
| NCT00687843 | Unknown status | Phase 3 | Study of TS-1 or TS-1 + PSK for Gastric Cancer Patients | June 2008 | March 2016 |
| NCT04434963 | Unknown status | Safety and Feasibility of Reversible Induction Strategy | February 1, 2021 | December 1, 2021 | |
| NCT04107142 | Unknown status | Phase 1 | Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour | December 1, 2019 | March 1, 2021 |
| NCT01157598 | Unknown status | Phase 3 | Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection | September 2009 | |
| NCT03144843 | Unknown status | Phase 2 | Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer. | January 13, 2017 | January 31, 2020 |
| NCT03766945 | Unknown status | Fatigue and QoL Among Gastric Cancer Patients Undergoing Abdominal Surgery | July 27, 2017 | July 25, 2019 | |
| NCT03210298 | Unknown status | International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) | January 2016 | September 2022 | |
| NCT01048463 | Unknown status | Phase 3 | Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor | December 2009 | January 2012 |
| NCT03079596 | Unknown status | N/A | ERAS (Early Recovery After Surgery) Protocol After Laparoscopic Total Gastrectomy and Proximal Gastrectomy | October 1, 2019 | December 31, 2022 |
| NCT01621919 | Unknown status | Concentration of S-1 Metabolites in Tear and Plasma of Patients Receiving TS-1 | December 2010 | May 2013 | |
| NCT03492827 | Unknown status | N/A | Evaluation of the Preventive Effect of Chlorhexidine Acetate Gargle for Upper Gastrointestinal Tract Infection After ESD | June 1, 2017 | September 2019 |
| NCT03391687 | Unknown status | Incidence of Pancreatic Fistula After Radical Gastrectomy | December 1, 2017 | November 30, 2018 | |
| NCT04294589 | Unknown status | Evaluation of NETs in Patients With Solid Cancers Associated With a High Risk of Venous Thromboembolic Events | July 1, 2019 | December 2020 | |
| NCT00452751 | Unknown status | Phase 3 | Comparison of Laparoscopic Versus Open Gastrectomy for Gastric Cancer: A Prospective Randomized Trial | February 2006 | May 2014 |
| NCT02780921 | Unknown status | Phase 3 | Effect of Prehabilitation in Gastroesophageal Adenocarcinoma: Study Protocol of a Multicentric, Randomised Control Trial | January 2017 | March 2018 |
| NCT04567069 | Unknown status | Phase 1/Phase 2 | Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment | September 2020 | June 2022 |
| NCT04027088 | Unknown status | N/A | Effect of Preoperative Immunonutrition in Upper Digestive Tract | August 10, 2019 | December 31, 2021 |
| NCT01848015 | Unknown status | Circulating Tumor Cells (CTCs) in Advanced Gastric Cancer | June 2013 | June 2016 | |
| NCT02752698 | Unknown status | N/A | Domestic Surgical Robot Clinical Study | January 1, 2015 | December 30, 2021 |
| NCT02423278 | Unknown status | Phase 2/Phase 3 | The Long-term Effect of D4 Lymphadenectomy for Gastric Cancer | January 2010 | December 2020 |
| NCT05027347 | Unknown status | Detection of Plasma Circulating Tumor DNA in Gastric Cancer | October 10, 2021 | September 30, 2023 | |
| NCT04155671 | Unknown status | Phase 2 | POF Versus FOLFOX Plus IP Paclitaxel in AGC | December 1, 2019 | June 30, 2023 |
| NCT02457624 | Unknown status | Gastric Cancer Screening Quality Improvement System Establishment | March 2008 | December 2020 | |
| NCT03909997 | Unknown status | Severe Complications After Gastrectomy for Esophagogastric Junction and Gastric Cancer | April 5, 2019 | April 5, 2022 | |
| NCT02711033 | Unknown status | Phase 2 | Laparoscopic-assisted Total Gastrectomy Versus Open Total Gastrectomy With Splenic Hilum Lymph Nodes Dissection | October 2015 | April 2019 |
| NCT03977220 | Unknown status | Phase 1 | Nab-paclitaxel Combined With S-1 Treating Diffuse Type of Stage Ⅲ Gastric Cancer | January 1, 2020 | December 31, 2023 |
| NCT04258657 | Unknown status | Phase 2 | Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric Cancer | March 1, 2020 | December 31, 2022 |
| NCT01927146 | Unknown status | Lauren Classifications and HER2 Status in Gastric Cancer Patients | July 2013 | ||
| NCT00003617 | Unknown status | Phase 3 | Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach | March 1995 | |
| NCT04947995 | Unknown status | Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric Cancer | June 15, 2021 | June 15, 2023 | |
| NCT04352894 | Unknown status | N/A | Intraoperative ICG Fluorescence Imaging for Peritoneal Carcinomatosis Detection | September 2020 | September 2021 |
| NCT03654534 | Unknown status | Phase 3 | Oral Nutritional Supplements Compared With Standard Diet in Postoperative Gastric Cancer Patients With Adjuvant Chemotherapy | April 16, 2019 | June 15, 2021 |
| NCT03410732 | Unknown status | Phase 2 | Dendritic Cell-based Immunotherapy in Treatment Gastric Cancer | July 1, 2017 | December 1, 2020 |
| NCT01331928 | Unknown status | Phase 2 | Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric Cancer | January 2011 | |
| NCT03349398 | Unknown status | N/A | Uncut Roux-en-Y vs Roux-en-Y | November 10, 2017 | June 2, 2020 |
| NCT04327050 | Unknown status | N/A | Magnetic Anchoring Guided Endoscopic Submucosal Dissection for Early Gastric Caner | May 1, 2020 | April 30, 2021 |
| NCT04886193 | Unknown status | N/A | FLOT Combined With PD-1 in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal Metastasis | April 16, 2021 | May 2023 |
| NCT02949258 | Unknown status | Phase 2 | Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer | January 2017 | January 2021 |
| NCT03475615 | Unknown status | Phase 3 | A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites | March 16, 2018 | December 31, 2020 |
| NCT03865810 | Unknown status | Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol in Gastric Surgery for Cancer | October 22, 2019 | March 22, 2020 | |
| NCT03829345 | Unknown status | Phase 2 | A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer | July 2, 2019 | February 14, 2022 |
| NCT04801459 | Unknown status | N/A | Study on the Peristaltic Direction of GI Anastomosis in Roux-en-Y Reconstruction | April 2, 2021 | March 31, 2024 |
| NCT02002416 | Unknown status | Prognostic Value and Clinical Pathology of c-MET Expression and Amplification in Gastric Carcinoma | January 2006 | December 2014 | |
| NCT03427684 | Unknown status | Phase 1/Phase 2 | Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer | May 1, 2016 | December 31, 2020 |
| NCT02140034 | Unknown status | N/A | Extensive Peritoneal Lavage After Curative Gastrectomy for Gastric Cancer: A Randomised Controlled Trial | May 2013 | May 2016 |
| NCT04348643 | Unknown status | Phase 1/Phase 2 | Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer | February 20, 2020 | April 30, 2024 |
| NCT02610218 | Unknown status | Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer | April 2016 | December 2018 | |
| NCT00088816 | Unknown status | Phase 2 | S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer | April 2003 | |
| NCT04365946 | Unknown status | Microbiome Analysis in Gastric Intestinal Metaplasia and in Gastric Cancer and Subtypes Correlation | April 18, 2020 | May 15, 2023 | |
| NCT04149015 | Unknown status | Phase 2 | Neoadjuvant POF in the Treatment of Locally Advanced Gastric Cancer | November 2019 | December 31, 2023 |
| NCT03007446 | Unknown status | Phase 2 | The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer | November 2016 | November 2018 |
| NCT02250209 | Unknown status | Phase 2 | T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy | July 2014 | December 2017 |
| NCT03694977 | Unknown status | Phase 2 | Biomarker Study of PDR001 in Combination With MCS110 in Gastric Cancer | January 17, 2019 | December 31, 2019 |
| NCT03957564 | Unknown status | Phase 2 | Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer | May 28, 2019 | May 20, 2024 |
| NCT03046745 | Unknown status | Gastric Cancer Registry for Epidemiology and Molecular Risk Factor | August 2016 | April 2022 | |
| NCT02504229 | Unknown status | Phase 2 | DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment | November 2014 | |
| NCT02375997 | Unknown status | Phase 3 | Early Palliative Care in Metastatic Esophageal Squamous Carcinoma (ESCC) and Gastric Cancer | October 2014 | October 2018 |
| NCT03258034 | Unknown status | Phase 2 | A Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer | August 24, 2017 | October 22, 2021 |
| NCT04989153 | Unknown status | Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer | March 5, 2016 | December 6, 2023 | |
| NCT04440605 | Unknown status | A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis | July 1, 2020 | October 2022 | |
| NCT04641455 | Unknown status | N/A | Use of Mucolytic Solution Before Upper Endoscopy | December 1, 2020 | June 30, 2021 |
| NCT04891900 | Unknown status | N/A | TQB2450 (PD-L1 Inhibitor) Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma | May 2021 | April 2022 |
| NCT00963092 | Unknown status | Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer | August 2002 | ||
| NCT03372681 | Unknown status | N/A | Comparative Study of Antiperistaltic vs Isoperistaltic Billroth II + Braun Anastomosis for Postoperative Reflux | January 1, 2018 | December 31, 2022 |
| NCT03049345 | Unknown status | N/A | Gastric Cancer Sentinel Lymph Node Mapping | July 1, 2016 | September 30, 2022 |
| NCT01486472 | Unknown status | S-1-induced Lacrimal Drainage Obstruction | November 2010 | December 2013 | |
| NCT00005876 | Unknown status | Phase 2 | Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery | April 2000 | |
| NCT00024063 | Unknown status | Phase 1 | SU006668 in Treating Patients With Advanced Solid Tumors | ||
| NCT04065282 | Unknown status | Phase 2 | The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma. | August 6, 2019 | March 1, 2022 |
| NCT00865982 | Unknown status | Phase 2 | Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer | September 2008 | September 2015 |
| NCT02401971 | Unknown status | Phase 4 | Irinotecan Plus Thalidomide in Second Line Advanced Gastric Cancer | August 2014 | August 2018 |
| NCT04624282 | Unknown status | Metabonomics Study of Chronic Gastritis and Gastric Carcinoma | November 1, 2020 | May 31, 2021 | |
| NCT03263741 | Unknown status | Phase 2 | Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric Cancer | April 1, 2017 | September 1, 2020 |
| NCT03264807 | Unknown status | Phase 3 | Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer | August 6, 2015 | December 31, 2021 |
| NCT03817411 | Unknown status | Phase 2 | Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer | January 25, 2019 | January 25, 2021 |
| NCT01761461 | Unknown status | Phase 3 | Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial | February 6, 2013 | December 2020 |
| NCT04963088 | Unknown status | Phase 1/Phase 2 | TISLELIZUMAB Combined With Anlotinib and Chemotherapy(XELOX) in the Treatment of Advanced Gastric Carcinoma | March 6, 2021 | March 20, 2024 |
| NCT01224652 | Unknown status | Phase 3 | Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy | ||
| NCT05395780 | Unknown status | Phase 2 | A Phase 2 Study to Evaluate the Safety and Efficacy of Max-40279-01 in Patients With Advanced Gastric Cancer or Gastroesophageal Junction Cancer | June 2022 | December 2023 |
| NCT01980407 | Unknown status | Phase 2 | Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) in Patients With Advanced Gastric Cancer | November 2013 | March 2016 |
| NCT04345783 | Unknown status | Phase 2 | Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancer | January 1, 2018 | June 30, 2022 |
| NCT02672774 | Unknown status | N/A | Novel Endoscopic Imaging Methods for the Evaluation of Blood Vessels in Gastrointestinal Cancers | October 2015 | September 2017 |
| NCT04976660 | Unknown status | Phase 1/Phase 2 | TT-4 as a Single Agent in Subjects With Advanced Selected Solid Tumors | December 15, 2022 | September 30, 2023 |
| NCT03784040 | Unknown status | Phase 1 | Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study. | February 21, 2019 | March 1, 2024 |
| NCT03093688 | Unknown status | Phase 1/Phase 2 | Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor | March 1, 2017 | June 30, 2023 |
| NCT03251430 | Unknown status | Bone Microstructure by Using HR-pQCT in Long Courses After Gastrectomy | September 20, 2017 | March 31, 2019 | |
| NCT02632201 | Unknown status | Phase 1/Phase 2 | Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis | September 2015 | September 2017 |
| NCT02024438 | Unknown status | Phase 3 | Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in Advanced Gastric Cancer | December 2013 | December 2017 |
| NCT01742806 | Unknown status | N/A | Clinical Study for the Impact of Bio-absorbable Felt (NEOVEIL®) With Fibrin Sealant on Removal of Drainage Tube After Minimally Invasive Gastrectomy for Gastric Cancer | October 2012 | June 2013 |
| NCT03894384 | Unknown status | The Value of TFF3 in Diagnosis of Gastric Cancer | December 1, 2019 | November 1, 2022 | |
| NCT02736552 | Withdrawn | Phase 3 | Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB. | March 2016 | March 2023 |
| NCT03766607 | Withdrawn | Phase 2 | Trastuzumab Beyond Progression in HER2 Positive Metastatic Gastric Cancer | September 30, 2019 | June 30, 2022 |
| NCT05181865 | Withdrawn | Phase 1/Phase 2 | Phase 1/2a Study to Evaluate FL-301 in Patients With Advanced Solid Tumors | January 2022 | January 18, 2022 |
| NCT02446379 | Withdrawn | Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery | |||
| NCT00025532 | Withdrawn | Phase 1 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | April 2001 | |
| NCT02713984 | Withdrawn | Phase 1/Phase 2 | A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer | March 2016 | July 2019 |
| NCT04591028 | Withdrawn | Phase 4 | A Study to Evaluate Indocyanine Green Lymphangiography to Improve Lymphadenectomy in Gastric Cancer Patients | January 2022 | August 10, 2022 |
| NCT03682744 | Withdrawn | Phase 1 | CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC) | September 13, 2018 | March 2021 |
| NCT03704077 | Withdrawn | Phase 2 | An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | October 31, 2019 | September 30, 2024 |
| NCT00209612 | Withdrawn | Phase 1/Phase 2 | Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC. | April 2004 | March 2009 |
| NCT05411679 | Withdrawn | Phase 2 | EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung Cancer | April 2023 | December 2024 |
| NCT06090318 | Withdrawn | Phase 1/Phase 2 | Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss | May 19, 2023 | May 30, 2023 |
| NCT05431244 | Withdrawn | N/A | Pilot Study of Antiviral Treatment in Combination With Low-dose Gemcitabine in EBV-associated Gastric Cancer (EBVaGC) | July 1, 2022 | July 1, 2024 |
| NCT04105062 | Withdrawn | Phase 1/Phase 2 | LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric Surgery | December 31, 2021 | December 31, 2023 |
| NCT02519140 | Withdrawn | Phase 3 | Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections | August 1, 2014 | November 30, 2022 |
| NCT00387530 | Withdrawn | Phase 2 | Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer | May 2006 | January 2008 |
| NCT00429078 | Withdrawn | Phase 1 | Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer | July 2007 | April 2011 |
| NCT01470742 | Withdrawn | Phase 3 | Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer | September 2010 | December 2015 |
| NCT01070290 | Withdrawn | Phase 2 | A Study of ARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy Regimen | ||
| NCT00017537 | Withdrawn | Phase 1 | Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer | March 2000 | March 2005 |
| NCT00588263 | Withdrawn | Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer | July 2000 | July 2018 | |
| NCT05043987 | Withdrawn | Phase 1 | Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers | November 16, 2022 | November 16, 2022 |
| NCT04868747 | Withdrawn | N/A | The Effect of Perioperative Lidocaine Infusion on Neutrophil Extracellular Trapping | April 1, 2021 | April 2, 2021 |
| NCT02063412 | Withdrawn | Nursing and Pharmacy Care Between Capecitabine and 5-Fluoruracil Regimens | August 2013 | April 2014 |